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ABSTRACT 
 
Cocaine	addiction	has	both	genetic	and	environmentally	driven	components.	Relatively	
recently	several	groups	have	suggested	that	epigenetic	regulation	of	gene	expression	
might	be	the	mechanism	linking	environmental	influence	and	inheritance	in	drug	
addiction.	We	have	shown	previously	that	embryonic	cocaine	exposure	increases	
physiological	and	behavioral	sensitivity	to	the	drug	in	longitudinal	adults.		In	this	study,	
we	provide	evidence	that	the	effects	of	embryonic	pre-exposure	to	cocaine	are	
intergenerational	in	zebrafish.	In	addition,	we	show	how	gene	expression	in	the	
zebrafish	telencephalon,	which	includes	the	teleost	equivalent	of	the	nucleus	
accumbens,	changes	during	acute	cocaine	treatment	during	behavioral	testing.	These	
experiments	outline	gene	expression	pathways	not	extensively	studied	in	the	context	of	
cocaine	response.	We	show	how	embryonic	exposure	to	cocaine	affects	these	gene	
expression	pathways	when	the	longitudinal	animals	are	acutely	exposed.	Finally,	we	
show	how	chronic	embryonic	exposure	affects	these	same	pathways	in	5-day	old	
embryos.	
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	 1	
INTRODUCTION	 2	
	 3	
Dependency	diseases	as	characterized	by	the	Diagnostic	and	Statistical	Manual	 4	
of	Mental	Disorders-IV	(DSM-IV)	are	a	repeated	maladaptive	behaviors	generating	 5	
impairment	or	distress	[1].	These	disorders,	including	substance	abuse	disorders,	have	 6	
been	characterized	as	diseases	as	they	disrupt	basic	biological	and	behavioral	function.	 7	
Physical	addiction	refers	to	a	biological	phenomenon	with	both	positive	and	negative	 8	
symptoms.	Positive	symptoms	include	the	rewarding	psychological	and	physiological	 9	
response	associated	with	using.	Tolerance	is	also	associated	with	physical	addiction,	in	 10	
which	the	body’s	response	to	a	rewarding	substance	is	attenuated	following	its	first	 11	
exposure.	As	a	result,	in	substance	abuse,	recurrent	use	will	require	more	of	the	 12	
substance	to	obtain	the	same	physiological	response	as	that	experienced	by	a	first	time	 13	
user.	Additionally,	physical	addiction	can	include	a	hypersensitivity	to	a	situation	when	 14	
there	is	a	potential	for	substance	exposure	or	addictive	situation.	This	would	involve	 15	
increased	impulsivity	and	drive	to	indulge	in	the	substance.	Physical	addiction	can	be	 16	
associated	with	physical	withdrawal	for	substance	and	is	often	a	cause	for	recurrent	use	 17	
and	periods	of	relapse.	Withdrawal	produces	many	of	the	negative	symptoms	comorbid	 18	
with	physical	addiction	including	depressive	symptoms,	lack	of	concentration,	 19	
hypersensitivity	to	pain,	and	detrimental	behaviors.	Psychologically,	addiction	can	also	 20	
apply	to	a	situation	like	gambling,	but	this	disorder	has	been	redefined	by	the	DSM-IV	as	 21	
substance-independent	dependency	[1].	Diagnostically,	dependency	diseases	have	 22	
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recently	come	to	have	a	dimensional	aspect	with	each	component	used	to	determine	 23	
severity	and	distinguish	between	dependency	and	abuse.		There	are	three	identified	 24	
components	thought	to	contribute	to	the	continuance	of	abuse	and	dependence	and	 25	
they	include	1)	the	substance	and	its	physiologic	action,	2)	the	individual	that	is	using	 26	
the	substance,	and	3)	the	user’s	social	environment	including	their	relationships	and	 27	
family	history	[2].	The	listed	components	of	the	potential	for	abuse	and	dependence	 28	
imply	addiction	is	a	multifaceted	disease	including	biological,	psychological,	and	 29	
sociological	factors.	Biological	aspects	of	addiction	stem	from	the	release	of	 30	
neurotransmitters	and	the	stimulation	of	positive	reward	as	a	direct	result	of	substance	 31	
use.	Rewarding	events	or	compounds	stimulate	the	activity	of	the	ventral	tegmental	 32	
area,	which	projects	dopaminergic	neurons	to	areas	like	the	nucleus	accumbens	and	the	 33	
prefrontal	cortex.	Repeated	substance	use	to	has	been	thought	to	change	synaptic	 34	
connections	within	this	neuronal	system,	called	the	mesolimbic	system.		It	has	been	 35	
shown	that	this	activation	of	the	mesolimbic	system	occurs	with	rewarding	chemical	 36	
substances,	including	drugs	of	abuse	[3].	Stimulation	of	the	dopaminergic	neurons	of	 37	
this	pathway	have	been	thought	to	not	only	reinforce	drug	use,	but	motivate	behaviors	 38	
[4].	This	positive	reinforcement	model	has	been	widely	accepted	as	a	model	for	many	 39	
biological	mechanisms	of	addiction.		 40	
	 41	
Societal	Impacts	of	Addiction	 42	
Addiction	remains	a	large	problem	with	a	broad	range	of	societal	impacts	despite	 43	
continued	legislative	bans	worldwide.	In	a	study	conducted	by	the	US	Department	of	 44	
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Health	and	Human	Services,	as	many	as	10.2	percent	of	the	US	population	over	the	age	 45	
of	12	have	recent	illicit	drug	use	[5].	In	a	similar	survey,	the	Substance	Abuse	and	Mental	 46	
Health	Services	Administration	concluded	that	7.3	percent	of	females	ages	12	and	above	 47	
reported	to	have	used	illicit	drugs.	Globally,	around	7	percent	of	the	population	 48	
between	the	ages	of	15	through	64	had	recently	used	either	cannabis,	opioid,	cocaine,	 49	
or	a	type	of	amphetamine	[6].	This	accounts	for	roughly	324	million	people.	 50	
Furthermore,	global	deaths	reported	in	2012	due	to	substance	abuse	ranged	from	 51	
95,000	to	225,000	people.	Additional	impacts	of	substance	abuse	include	increase	 52	
incidence	of	HIV	infection	and	incarceration.	WHO	estimates	place	the	global	 53	
percentage	of	IV	drug	users	currently	living	with	HIV	as	high	as	13.1	percent,	with	 54	
variations	occurring	demographically.	In	the	United	States,	roughly	50	percent	of	the	 55	
federal	prison	population	stems	from	crime	related	to	illicit	drugs	[7,	8].	An	American	 56	
study	of	the	financial	cost	of	substance	abuse,	opioid	poisoning	and	overdose	have	 57	
accounted	for	an	estimated	22.6	billion	dollars	that	included	emergency	room	visits,	 58	
inpatient	treatment,	and	overall	losses	in	productivity	[9].	Emergency	room	visits	for	 59	
opioid	poisoning	were	often	shown	to	coincide	with	alcohol	or	other	illicit	drug	use.	 60	
Drug	statistics	are	often	comorbid	for	other	substances	leading	to	a	fluctuation	in	the	 61	
numbers	reported.	Despite	this	limitation,	the	large	impacts	of	drug	use	remain	 62	
constant.	 63	
Reward	and	the	Reward	Circuitry		 64	
As	previously	mentioned,	addiction	is	a	multifaceted	mental	state	that	leads	to	 65	
its	maladaptive	behaviors.	Of	importance	is	its	biological	component.	Generally	 66	
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speaking,	substance	use	generates	a	physiological	response	perceived	as	rewarding	in	 67	
the	mesolimbic	system.	Activation	of	this	pathway	causes	the	release	of	 68	
neurotransmitters	producing	the	physiological	rewarding	response.	This	perceived	 69	
reward	alters	behavior	to	increase	the	frequency	of	this	reward.	This	reward	serves	as	a	 70	
type	of	memory	that	is	generated	by	changes	in	synaptic	firing,	increased	 71	
neurotransmitter	release,	and	protein	synthesis.	These	responses	are	governed	by	 72	
genes	in	these	brain	regions.	The	repeated	use	or	exposure	to	a	substance	has	been	 73	
shown	to	create	neuroplastic	changes	in	gene	expression	as	a	means	of	learning	and	 74	
potentiation	of	the	behavior	[10-12].	It	is	this	plasticity	of	gene	expression	that	produces	 75	
maladaptive	behaviors	and	recurrent	drug	use.	For	the	purpose	of	this	thesis,	I	will	focus	 76	
on	the	illicit	drug,	cocaine.	Cocaine	use	generally	includes	feelings	of	pleasure,	mania	 77	
and	alertness,	paranoia,	flightiness,	and	anxiety	[13].	The	power	of	cocaine	as	it	relates	 78	
to	addiction	and	other	drug-seeking	behaviors	stems	from	its	activity	in	the	nigrostriatal	 79	
and	mesolimbic	dopaminergic	neurons	and	VTA.	Cocaine	crosses	the	blood	brain	barrier	 80	
via	passive	diffusion	and	has	recently	been	shown	to	use	the	assistance	of	carrier	 81	
proteins	on	dopaminergic	neurons	for	cellular	uptake	[14,	15].	After	it	has	crossed	this	 82	
barrier,	cocaine	has	been	shown	to	increase	dopamine	concentration	and	inhibit	its	 83	
reuptake	by	dopamine	transporter	proteins	upon	binding	to	the	dopamine	transporter.	 84	
Increased	dopamine	concentration	generates	reward	and	is	implicated	in	drug	addiction	 85	
[16].	Within	the	VTA	reside	numerous	GABAergic	and	dopaminergic	neurons	with	both	 86	
neuronal	groups	sending	projections	to	the	nucleus	accumbens	and	the	prefrontal	 87	
cortex	[17].	These	regions	are	also	home	to	the	opioid	receptors	that	mediate	the	sense	 88	
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of	pleasure	as	well	as	receptors	responsible	for	the	stimulatory	effect	of	cocaine		[18].		 89	
Moreover,	dopamine	released	in	these	areas	has	been	shown	to	occur	over	relatively	 90	
large	areas	and	at	axosomatic	and	axodendritic	synapses	[19].	This	release	of	dopamine	 91	
is	reported	to	also	occur	due	to	stimulation	from	GABAergic	responsive	neuronal	 92	
connections	[20].	The	reported	research	thus	supports	the	idea	that	these	neuronal	 93	
pathways	including	the	VTA,	the	prefrontal	cortex,	and	the	nucleus	accumbens,	are	 94	
synaptically	linked.	It	is	through	these	pathways	that	cocaine	exposure	can	stimulate	a	 95	
physiological	response	generating	physical	and	psychologic	addition.	Because	of	 96	
cocaine’s	ability	to	inhibit	the	reuptake	of	dopamine,	dopamine	transporter	knock-out	 97	
studies	have	been	done.	Knock-out	of	functional	dopamine	transport	still	produced	mice	 98	
that	self-administered	cocaine	[21].		 99	
Cocaine	has	been	implicated	to	block	monoamine	transport	in	other	neuron	 100	
transporters	as	well,	indicating	the	possibility	that	redundancy	pathways	can	still	 101	
develop	reward	following	cocaine	exposure	[22].	Further,	research	has	shown	that	 102	
knock-in	gene	mutations	of	dopamine	transporters	insensitive	to	cocaine	in	an	 103	
otherwise	functional	dopaminergic	system	still	allowed	for	rewarding	behavior	when	 104	
exposed	to	other	rewarding	compounds.	[23,	24].	In	this	experiment,	a	dopamine	 105	
transporter	was	inserted	into	a	transgenic	mouse	that	was	insensitive	to	cocaine.	The	 106	
mutation	attenuated	cocaine	reward	while	permitting	normal	food	reward	behaviors	as	 107	
well	as	normal	rewarding	behaviors	for	other	dopamine	transporter	agonists	like	 108	
amphetamines,	demonstrating	the	complexity	of	this	reward	system.	In	a	study	using	a	 109	
cocaine	relapse	paradigm,	it	was	shown	that	after	sustained	cocaine	administration	 110	
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dopamine	concentrations	were	significantly	lower	in	striatal	and	caudal	brain	regions	 111	
following	the	treatment	[25].	This	corresponded	to	anhedonia	and	subsequent	relapse.	 112	
Research	has	suggested	that	some	behavioral	changes	may	be	correlated	to	alterations	 113	
in	tissue	migration	within	the	reward	pathways	[26].	It	is	important	to	note	that	though	 114	
these	modifications	in	brain	structure	may	occur,	these	changes	seem	to	have	no	effect	 115	
on	overall	brain	volume	suggesting	that	changes	occurring	in	cocaine-exposed	brains	are	 116	
related	to	the	organization	and	the	neurophysiology	of	neuronal	projections.	Cocaine	 117	
has	been	shown	to	decrease	arborization	in	the	substantia	nigra,	the	area	of	the	brain	 118	
responsible	for	reward	and	movement	[27].	Those	neuronal	projections	responsive	to	 119	
the	inhibitory	neurotransmitter	GABA	have	been	shown	to	be	affected	by	cocaine	 120	
exposure,	resulting	in	changes	in	GABAergic	neuronal	patterning	as	they	extend	into	the	 121	
medial	prefrontal	cortex	from	the	ventral	prelimbic	cortex	[28].	As	differentiation	of	 122	
patterning	was	observed,	it	should	be	noted	that	overall	cell	number	was	not	found	to	 123	
be	significantly	changed.	It	appears	that	changes	in	brain	biology	are	generating	altered	 124	
behaviors.	 125	
How	do	these	biological	reward	pathways	determine	susceptibility	to	substance	 126	
abuse	and	addiction?	The	answers	lie	in	unique	gene	polymorphisms	and	changes	to	 127	
gene	expression	resulting	from	substance	exposure.	Recently,	several	gene	 128	
polymorphisms	have	been	implicated	in	increased	addiction	susceptibility	[29,	30].	 129	
Polymorphisms	in	a	mu	opioid	receptor	and	in	the	BDNF	sequence	have	been	highly	 130	
investigated	in	their	contribution	to	substance	abuse	disorders.	Reward	pathways	and	 131	
critical	brain	regions	are	highly	plastic	and	readily	changed.	This	means	that	these	 132	
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regions	function	and	synaptic	connection	as	well	as	the	expression	of	genes	governing	 133	
these	regions	can	be	modified	by	substance	use.	Gene	expression	within	these	regions	 134	
has	been	thought	to	reinforce	behavior	and	contribute	to	motivational	cues	for	drug	 135	
use.	Within	the	study	of	addiction	there	are	several	genes	of	interest	that	have	been	 136	
highly	studied.			 137	
	 138	
Gene	Expression	Changes	Regulate	Reward	 139	
A	gene	shown	to	moderate	the	release	of	dopamine	within	the	brain	is	brain- 140	
derived	neurotropic	hormone	or	BDNF	[31].	Neuronal	projections	found	within	the	VTA	 141	
have	been	reported	as	substantial	sources	of	the	BDNF	protein	[32].	Consequently,	 142	
BDNF	activation	can	stimulate	multiple	enzymatic	pathways	involved	in	dopamine	 143	
release	and	BDNF’s	importance	in	dopaminergic	neuronal	development	has	been	 144	
supported	in	the	literature	[33].	Bdnf	binds	to	a	tyrosine	kinase	linked	receptor,	TrkB,	 145	
and	dimerizes	allowing	the	complexed	protein	to	phosphorylate	downstream	targets.	 146	
TrkB	signaling	has	been	indicated	to	provide	anti-apoptotic	activity	in	neurons	of	the	 147	
VTA	and	prevents	loss	of	excitatory	neurons	in	the	forebrain	[34].	These	signaling	 148	
cascades	generated	through	Bdnf	and	other	neurotrophin	signals	have	been	implicated	 149	
in	memory	consolidation	and	neuronal	plasticity	[35].	Using	these	signaling	pathways,		 150	
Bdnf	has	been	shown	to	promote	the	recurrent	use	of	cocaine	and	drugs	of	abuse	in	 151	
animal	models	[36-38].	Studies	of	acute	cocaine	exposure	indicated	an	increase	in	Bdnf	 152	
activity	in	the	nucleus	accumbens	and	a	tendency	to	self-administer	cocaine	[36].	 153	
Animals	treated	with	anti-BDNF	antibodies	to	suppress	BDNF	activity	in	that	brain	 154	
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region,	in	contrast,	showed	a	decrease	in	TrkB	signaling,	attenuated	cocaine	self- 155	
administration,	and	weakened	tendency	for	relapse.	In	another	study,	exogenous	 156	
supplementation	of	BDNF	in	the	medial	prefrontal	cortex	following	self-administration	 157	
training	led	to	decreases	in	cocaine-seeking	behavior	[39].	These	results	taken	together	 158	
suggest	Bdnf	protein	has	differing	effects	within	different	regions	of	the	brain.	Dose- 159	
dependent	experiments	have	shown	differential	Bdnf	mRNA	and	protein	concentrations	 160	
within	the	medial	prefrontal	cortex	and	striatum	of	the	mouse	brain	[40].		In	an	 161	
experiment	conducted	by	Fumagalli	et	al.	(2007)	acute	cocaine	administration	led	to	a	 162	
robust	increase	in	Bdnf	mRNA	expression	in	the	prefrontal	cortex.	Researchers	allowed	 163	
for	repeated	cocaine	administration	and	demonstrated	an	upregulation	of	a	 164	
transcription	factor	that	lead	to	increased	Bdnf	expression	[40].	This	upregulation	 165	
generated	neuroplastic	changes	in	Bdnf	expression.	Studies	using	transgenic	animals	 166	
suggested	nucleotide	substitutions	in	the	Bdnf	sequence	itself	can	affect	substance	use	 167	
[30].	Human	association	data	has	addressed	a	link	between	compulsive	alcohol	 168	
consumption	and	the	allelic	alteration	of	a	valine	for	a	methionine	at	position	66	in	the	 169	
BDNF	sequence	leading	to	decreased	activity	of	this	protein	[41].	Taking	advantage	of	 170	
this	knowledge,	researchers	generated	transgenic	mice	expressing	this	allelic	 171	
substitution	and	demonstrated	increased	alcohol	consumption	when	compared	against	 172	
wildtype	allelic	mice	[30].	BDNF	is	only	one	of	several	genes	associated	with	addiction	 173	
research.	Another	promising	gene	encoding	a	transcription	factor	is	FBJ	murine	 174	
osteosarcoma	viral	oncogene	homolog	B	or	simply,	FosB.		 175	
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FosB	is	a	member	of	the	fos	gene	family	and	has	been	documented	to	play	roles	 176	
in	motivation,	reward,	memory,	and	drug-induced	neuroplasticity	[42-44].	FosB	 177	
possesses	two	isoforms	and	can	be	found	as	its	shortened	isoform,	∆FosB,	within	the	 178	
nucleus	accumbens	and	the	striatum	[45].	Both	isoforms	of	FosB,	FosB	and	∆FosB,	have	 179	
been	shown	to	be	expressed	there,	but	∆FosB	was	found	to	be	relatively	more	stable	 180	
than	its	longer	isoform	[46].	Fos	family	genes	have	been	indicated	as	a	mechanism	for	 181	
natural	rewarding	processes	including	exercise,	food	in-take,	and	some	sexual	activities	 182	
[42,	43,	45].	Drugs	of	abuse	also	stimulate	this	gene	family.	Acute	exposure	to	rewarding	 183	
drugs	indicated	increases	in	the	ratio	of	∆FosB	to	FosB.	Interestingly	however,	this	trend	 184	
was	shown	not	continue	under	chronic	use	conditions,	suggesting	the	shorter	isoform	 185	
plays	a	more	dominant	role	in	this	neuroplasticity	of	reward	pathways.	In	a	recent	study	 186	
with	transgenic	mice,	mice	were	produced	to	allow	for	exogenous	stimulation	of	the	 187	
∆FosB	isoform	in	neurons	of	the	nucleus	accumbens	[47].	Stimulation	of	these	neurons	 188	
led	to	significant	augmentation	of	the	rewarding	effects	of	cocaine.	Additional	studies	 189	
investigated	the	effects	of	overexpressing	∆FosB	within	striatal	neurons	[48].	In	these	 190	
transgenic	animals,	over-expression	in	striatal	neurons	led	to	rapid	acquisition	of	 191	
cocaine	self-administration	at	lower	cocaine	dosages.	The	results	of	this	study	imply	that	 192	
overexpression	of	this	protein	within	the	striatal	neurons	enhances	the	rewarding	 193	
properties	of	cocaine	in	the	animal	and	potentiates	self-administration	and	suggested	 194	
an	explanation	for	relapse	following	a	withdrawal	period.	Studying	the	effects	of	opioid	 195	
abuse	on	∆FosB	displayed	a	similar	result.	Using	a	transgenic	mouse	model,	researchers	 196	
found	inducible	over-expression	of	∆FosB	lead	to	increased	morphine	reward	and	 197	
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increased	physical	dependence	[44].	Studies	to	understand	a	role	of	∆FosB	in	alcohol	 198	
addiction	are	limited.	A	recent	study	investigating	the	use	of	electroacupuncture	as	a	 199	
treatment	option	shed	some	insight	on	this	problem.	Using	electroacupuncture,	there	 200	
was	a	decrease	in	alcohol	consumption	in	rats	when	compared	to	sham-tested	animals	 201	
[49].	The	authors	found	a	corresponding	increase	in	the	shorter	∆Fosb	isoform	in	the	 202	
core	nucleus	accumbens	and	dorsal	striatal	neurons	when	compared	to	untreated	 203	
animals.	These	results	suggested	that	increased	alcohol	consumption	occurred	with	an	 204	
increased	ratio	of	∆Fosb/FosB	[49].	The	role	of	the	genes	BDNF	and	FosB	provide	sound	 205	
evidence	of	the	neuroplasticity	of	our	brains	following	drug	use	and	abuse.		 206	
	 207	
Factors	Contributing	to	the	Potential	for	Substance	Abuse	 208	
An	interesting	caveat	to	the	genetic	vulnerability	to	addiction	later	in	life	relies	 209	
on	one’s	personality.	One	well-documented	endophenotype	linked	to	substance	abuse	 210	
is	impulsivity.	Impulsivity	is	an	innate	characteristic	that	is	considered	evolutionarily	 211	
beneficial	when	occurring	in	a	small	number	of	individuals	in	a	population	as	it	increases	 212	
potential	for	advantageous	risk	taking	[50].	This	increased	risk	taking	has	also	been	 213	
demonstrated	in	individuals	more	likely	to	have	a		psychiatric	or	substance	abuse	 214	
disorder	[51,	52].	As	human	studies	are	often	correlative	and	confounded	with	 215	
numerous	variables,	animal	models	are	a	valuable	resource.	In	an	experiment	using	 216	
adult	rats,	animals	were	behaviorally	tested	to	select	for	a	high-impulsivity	phenotype	 217	
and	this	cohort	was	demonstrated	more	likely	to	persistently	use	cocaine	regardless	of	 218	
foot	shock	[53].	Studies	using	brain	imaging	techniques	suggested	reduction	of	 219	
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dopamine	receptor	2/3	in	rats’	ventral	striatum	was	predictive	of	substance	abuse	and	 220	
impulsivity	[54].	Imaging	studies	have	suggested	differential	brain	region	volumes	and	 221	
increased	impulsivity	in	human	adolescents	[55].	Impulsivity	studies	have	been	 222	
conducted	regarding	alcohol	consumption	as	well.	Mice	with	postnatal	early	and	late	 223	
alcohol	exposure	displayed	poorer	decision	making	skills	when	tested	as	adults	[56].	 224	
These	studies	support	a	role	for	genetic	makeup	in	mediating	or	contributing	to	 225	
behavioral	consequences	that	underlie	substance	abuse	disorders.		 226	
Environmental	factors	can	also	contribute	to	subsequent	substance	abuse	 227	
disorder	later	in	an	individual’s	life.	A	well-studied	environmental	factor	includes	 228	
premature	exposure	to	rewarding	substances.	In	studies	using	a	prolonged	alcohol	 229	
administration	model	system,	alcohol	led	to	changes	in	reward	pathway	neurochemistry	 230	
in	a	dose-dependent	manner	[57].	Sustained	alcohol	exposure	led	to	increases	in	the	 231	
concentrations	of	the	monoamines	serotonin	and	dopamine.	Research	also	indicated	 232	
that	prenatal	exposure	to	alcohol	led	to	altered	grouping	behaviors	[58].		The	increase	in	 233	
alcohol	concentration	during	embryonic	development	decreased	shoaling	within	 234	
treatment	groups	of	adult	zebrafish.	Another	environmental	contributor	to	addiction	is	 235	
the	exposure	to	stress.	Research	has	demonstrated	that	early	life	stresses	in	male	mice	 236	
produced	adult	mice	that	self-administered	methamphetamine	significantly	more	than	 237	
unstressed	controls	[59].	A	similar	result	was	obtained	when	pregnant	dams	 238	
experienced	stressful	stimulation,	which	led	to	increased	self-administration	of	 239	
morphine	in	their	pups	during	adult	behavioral	testing	[60].	Social	environment	can	also	 240	
effect	an	organism’s	susceptibility	to	substance	abuse.	Cohorts	of	mice	raised	in	 241	
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differing	levels	of	arousal,	as	determine	by	opportunities	for	voluntary	exercise,	larger	 242	
living	space,	or	toys,	were	shown	to	have	differential	conditioned	preference	to	cocaine	 243	
[61].	This	research	concluded	that	increased	environmental	enrichment	demonstrated	a	 244	
protective	quality	against	substance	abuse.		 245	
Another	prevalent	environmental	influence	is	nicotine,	which	acts	to	change	the	 246	
amount	of	the	neurotransmitter	dopamine	present	within	the	reward	pathways.	Intake	 247	
of	nicotine	provides	the	brain	with	elevated	concentrations	of	dopamine	leading	to	the	 248	
reward	circuitry	being	activated	by	the	interaction	of	the	tobacco	alkaloid	and	nicotinic	 249	
acetylcholine	receptors	(nAChRs)	on	VTA	dopamine	neurons	[62,	63].	Cigarette	smoke	 250	
introduces	numerous	free	radicals	leading	to	an	increase	in	fatty	acid	peroxidation,	and	 251	
this	increase	is	synergistic	with	simultaneous	alcohol	administration	[64].	Lipid	 252	
peroxidation	can	lead	to	changes	in	mitochondrial	membrane	structure,	action	 253	
potentiation,	and	synaptic	cleft	action.	In	adolescent	rats	tested	using	a	nicotine	 254	
infusion	paradigm,	researchers	adduced	that	increased	mRNA	expression	of	p53	was	 255	
shown	in	multiple	brain	regions	as	a	direct	result	of	cellular	damage	[65].	Embryonic	 256	
nicotine	exposure	has	been	indicated	to	have	both	physical	and	behavioral	alterations	in	 257	
animal	models.	Nicotine	exposed	dams	produced	offspring	with	gender	specific	 258	
locomotion	alterations,	increases	in	nicotinic	receptor	densities,	increases	in	anxious	 259	
behaviors,	learning	deficiencies,	increased	vulnerability	to	nicotine	consumption,	and	 260	
increased	impulsivity	[66-69].	These	changes	are	thought	to	occur	due	to	alterations	in	 261	
gene	expression	in	the	cholinergic	system.	Gestational	nicotine	exposure	was	associated	 262	
with	increased	expression	of	various	nAChRs	in	the	forebrain	of	fetal	rats	[70].	 263	
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Longitudinally,	early	exposure	led	to	decreases	in	dopamine	release	from	the	nucleus	 264	
accumbens	in	adolescent	rats	[71].	These	results	provide	evidence	that	early	exposure	 265	
to	exogenous	stressors	can	have	robust	effects	on	the	developing	organism.	The	 266	
influence	our	environment	has	on	our	behaviors	has	been	well	documented,	but	how	 267	
these	behavioral	changes	come	to	be	is	still	being	investigated.		 268	
	 269	
Early	Drug	Exposure	Produces	Longitudinal	Effects	 	 270	
The	result	of	pharmacologic	insult	to	the	developing	individual	during	critical	 271	
developmental	periods	has	been	associated	with	long	term	structural,	behavioral,	and	 272	
physiological	implications.	The	Substance	Abuse	and	Mental	Health	Services	 273	
Administration	reported	5.4	percent	of	pregnant	females	ages	15-44	admit	to	drug	use.	 274	
Early	cocaine	exposure	has	been	well-documented	to	induce	a	suite	of	age-related	 275	
consequences.	Infants	exposed	to	early	cocaine	exposure	(ECE)	have	shown	difficulty	in	 276	
controlling	arousal	[72],	have	divided	attention	[73],	and	display	alteration	in	 277	
discriminatory	attention	[74].	In	toddlers,	the	effect	of	ECE	has	been	shown	to	affect	 278	
sustained	attention,	response	times	[75,	76],	impulse	control	[77],	communication	skills	 279	
[78],	and	planning	and	task	organization	[79].	Brain	imaging	on	a	group	of	exposed	 280	
children,	aged	8	to	10,	displayed	a	decrease	in	overall	grey	matter	and	thalamic	and	 281	
putamen	volumes	[80].	Similar	research	has	indicated	reductions	in	corpus	callosum	 282	
regions,	additional	decreases	in	grey	matter	of	the	occipital	and	parietal	lobes,	and	a	 283	
decrease	in	circular	cerebral	blood	flow	[81,	82].	Dopaminergic	areas,	such	as	the	left	 284	
and	right	caudate	nuclei,	have	shown	to	be	diminished	in	children	of	addicted	mothers	 285	
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[83].	Results	of	these	studies	are	often	confounded	by	multiple	factors	including	 286	
malnutrition,	multiple	drug	use,	tobacco	use,	low	socioeconomic	status,	route	of	drug	 287	
administration,	and	gestational	time	and	duration	of	use.	Because	of	these	confounding	 288	
variables,	it	is	often	difficult	to	attribute	causation	to	a	single	factor.	Researchers	have	 289	
aimed	to	overcome	this	and	other	ethical	hurdles	with	the	use	of	animal	models	 290	
allowing	a	greater	understanding	of	the	effects	of	prenatal	cocaine	exposure.	 291	
Studies	investigating	the	negative	effects	of	ECE	on	early	development	in	animal	 292	
models	have	allowed	for	more	controlled	designs.	These	studies	allow	researchers	to	 293	
account	for	confounding	variables	such	as	multi-drug	use	and	malnutrition.	Numerous	 294	
studies	have	indicated	gestational	cocaine	has	led	to	significant	effects	on	mammalian	 295	
birthweight	[84-86].	ECE	in	primates	demonstrated	significant	decreases	in	volume	and	 296	
in	brain	weights	as	well	as	alterations	in	the	formation	of	cerebral	cortical	layers	I-IV		 297	
[86].	Here,	radioactive	labeling	of	thymidine	to	tract	cell	migration	demonstrated	 298	
improper	movement	of	cortical	neurons	during	brain	development.	Animal	imaging	 299	
studies	suggested	volumetric	differences	in	reward-associated	brain	regions	indicative	 300	
of	damage	in	axonal	myelination	as	a	result	of	cocaine	exposure	[26].	These	observed	 301	
differences	in	neuronal	development	however	have	been	controversially	reported.	 302	
Further,	gestational	cocaine	exposure	has	been	shown	to	hinder	myelogenesis	in	 303	
synaptic	pathways	of	the	brainstem	of	mice	[87].	The	physiological	response	of	the	brain	 304	
has	been	shown	to	be	affected	by	ECE.	Metabolic	responses	as	measured	by	glucose	 305	
utilization	were	shown	markedly	reduced	by	ECE	in	the	limbic	and	hypothalamic	regions	 306	
[88].	These	results	also	indicated	a	sexually	dimorphic	response	between	male	and	 307	
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female	rats	with	reductions	in	glucose	utilization	seen	in	more	regions	of	the	male	brain	 308	
than	the	female	brain.	Importantly,	this	study	implied	ECE	resulted	in	decreased	brain	 309	
metabolic	responses.	Cocaine	exposure	has	been	demonstrated	to	alter	brain	 310	
physiology	and	structure.	These	differences	have	also	been	demonstrated	to	effect	 311	
communication	within	reward	pathways	of	these	brains.		 312	
Cocaine’s	effect	on	neuronal	communication	and	synaptic	transmission	occur	 313	
due	to	their	immediate	changes	in	neurotransmitters	that	are	released.	This	increased	 314	
release	of	dopamine	and	other	neurotransmitters	is	thought	to	govern	the	behavioral	 315	
responses	of	exposed	organisms.	Moreover,	the	release	of	neurotransmitters	is	subject	 316	
to	sensitization	following	recurrent	use	and	can	result	in	changes	of	the	mesolimbic	 317	
pathway.	The	alterations	seen	in	the	mesolimbic	pathway	occur	by	modified	expression	 318	
of	gene	governing	reward.	Cocaine	has	been	shown	to	act	on	gene	expression	and	 319	
neuronal	regulation	early	in	development	[89].	Research	has	demonstrated	that	the	 320	
timing	of	ECE	changes	nodal-related	protein	expression	and	its	related	transcription	 321	
factors	in	whole	larval	zebrafish	samples.	Modifications	in	expression	that	did	occur	in	 322	
the	transcription	factors	important	for	developmental	genes	were	unique	to	the	time	 323	
that	the	exposure	occurred.	The	authors	quantified	these	changes	using	quantitative	 324	
PCR		and	demonstrated	that	there	was	up-	and	down-regulation	of	these	gene	resulting	 325	
from	the	different	temporal	exposure	to	cocaine	at	24	hpf	and	48	hpf	[89].	This	 326	
exposure	to	cocaine	at	24	hpf	and	48	hpf	led	to	increased	and	decreased	expression	of	 327	
tyrosine	hydroxylase	and	the	dopamine	transporter,	respectively.	Further,	alterations	in	 328	
the	spatial	arrangement	of	transcription	factors	that	enable	dopaminergic	and	 329	
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GABAergic	neuronal	development	then,	are	thought	to	also	control	the	structural	 330	
development	of	the	reward	pathways	[90].	These	changes	may	be	what	contributes	to	 331	
changes	in	sensitivity	to	the	drug	in	subsequent	exposure	events.	Moreover,	another	 332	
study	noticed	significant	difference	in	axonal	bundling	in	the	anterior	cingulate	cortex	of	 333	
ECE	rabbits,	as	well	as	increases	in	the	GABAergic	neuronal	projections	[91].	Stanwood	 334	
et	al.	(2001)	immunologically	stained	for	tyrosine-hydroxylase,	the	rate-limiting	enzyme	 335	
for	catecholamine	synthesis	and	found	increased	staining	regions	densely	populated	 336	
within	pyramidal	neurons.	This	suggested	the	potential	for	increased	excitatory	 337	
responses	and	was	indicative	of	structural	alterations	within	the	limbic	system	and	 338	
prefrontal	cortex	pathways.	ECE	was	shown	to	modify	neuronal	plasticity	in	animal	 339	
models	with	embryonic	exposure.	Patel	et	al.(2012)	showed	that	prenatal	exposure	led	 340	
to	changes	in	neural	stem	cell	production	in	the		subventricular	zone.	They	used	 341	
immunohistochemistry	to	label	for	the	protein	nestin	within	type	A	and	C	progenitor	 342	
cells.	The	results	indicated	changes	in	distribution	of	this	protein	that	differed	between	 343	
the	genders	of	the	adult	mouse	brain.	Taken	together,	these	results	indicate	that	 344	
cocaine	has	long-term	impact	on	the	adult	brains	of	animals	exposed	to	ECE,	leading	to	 345	
changes	in	neuronal	networks	and	signaling.		 346	
Behavioral	analyses	have	indicated	that	ECE	can	contribute	to	abnormalities	in	 347	
social	behaviors	[93].	In	human	research	studies,	ECE	was	correlated	to	earlier	onset	of	 348	
sexual	activity	[94].	The	occurrence	of	early	sexual	behavior	was	strengthened	by	the	 349	
coincidence	of	early	stress,	namely	exposure	to	violence.	Third	trimester	ECE	in	children	 350	
of	approximately	7	years	of	age	displayed	a	positive	correlation	between	this	exposure	 351	
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and	increased	impulsivity,	inattention,	and	increased	hyper-activity	[95].	Longitudinal	 352	
studies	have	indicated	an	increased	undertaking	of	risky	behaviors	in	adolescent	males	 353	
reported	with	ECE	[96].	This	increased	risk-taking	behavior	was	associated	with	increase	 354	
hostility	and	a	lack	of	impulse	control	[97,	98].	Examination	of	ECE	adolescents	identified	 355	
potential	alterations	in	oxytocin	pathways	leading	to	increases	in	aggressive	tendencies	 356	
into	adulthood	[99].	These	results	support	the	claim	that	ECE	provides	lasting	behavioral	 357	
consequences	in	individuals	of	ECE.	Unfortunately,	with	human	studies,	there	are	 358	
confounding	variables	such	as	multi-substance	abuse,	malnutrition,	and	parental	 359	
investment	that	complicate	the	interpretation	of	these	results.			 360	
Animal	studies	of	behavior	have	substantiated	some	of	the	observed	deficits	in	 361	
human	behavior	as	the	result	of	ECE.	In	memory	and	learning	analyses,	mice	with	ECE	 362	
performed	poorly	when	compared	to	untreated	controls	and	were	delayed	in	the	 363	
sensitization	to	pain	in	foot-shock	experiments	[100].	Mice	pups	with	ECE	have	been	 364	
shown	to	wall-climb	less	than	untreated	controls	indicative	of	abnormalities	in	 365	
catecholamine	levels	in	the	striatum	[101].	These	mice	also	showed	learning	 366	
abnormalities	in	matching	maternal	milk	to	their	mother’s	odor	when	tested	against	 367	
pair-wise	controls.	The	behavioral	aberrations	as	described	are	likely	the	result	of	 368	
altered	cognitive	development	as	the	result	of	ECE.	Cocaine	acts	within	dopaminergic	 369	
neurons	leading	early	researchers	to	investigate	how	ECE	played	a	role	in	dopaminergic	 370	
neurons.	Mammalian	studies	indicated	that	ECE	produced	an	uncoupling	of	D1	 371	
dopamine	receptors,	which	may	lead	to	long-term	behavioral	dysfunction	[102].	 372	
Neurotransmitters	can	act	as	morphogens	as	well	as	survival	factors	during	 373	
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development	and	are	critical	to	neuronal	circuitry	formation,	so	any	disruption	during	 374	
this	time	period	has	lasting	consequences	on	central	nervous	system	function.	Animal	 375	
models	exposed	to	ECE	displayed	abnormal	grown	in	neuronal	dendrites	in	brain	areas	 376	
associated	with	cognitive	function	and	emotional	regulation	[103].	Moreover,	numerous	 377	
animal	model	studies	have	indicated	alterations	in	signaling	cascades	of	neuronal	 378	
circuitry	[104,	105].	A	study	was	conducted	using	mice	in	an	attempt	to	determine	any	 379	
cognitive	deficits	that	resulted	from	ECE.	Researchers	assessed	levels	of	Bdnf	and	its	 380	
downstream	effector,	TrkB.	Here,	levels	of	the	phosphorylated	(thus,	activated)	TrkB	as	 381	
well	as	the	levels	of	Bdnf	mRNA	were	longitudinally	increased	in	the	frontal	cortex	[104].	 382	
This	increased	activation	and	increased	expression	may	contribute	to	neuroplastic	 383	
changes	seen	in	organisms	with	ECE.	A	similar	study	addressing	how	the	neuroplasticity	 384	
comes	about	identified	changes	in	AMPAR	receptor	function.	Research	by	Baskshi	et	al.	 385	
(2011)	suggested	ECE	affected	regulatory	proteins	that	control	the	AMPAR	receptor.	 386	
Altered	function	of	these	receptors	is	thought	to	contribute	to	long-term	potentiation	 387	
and	long-term	depression	of	synaptic	connections.	Thus,	ECE	may	contribute	to	the	 388	
neuroplastic	changes	in	reward	circuitry	that	are	thought	to	alter	behavior.	Cocaine	 389	
exposure	to	the	developing	brain	has	lasting	consequences,	but	the	effects	of	ECE	are	 390	
not	restricted	to	the	nervous	system	and	can	negatively	impact	a	broad	range	of	 391	
physiologic	responses	with	detrimental	results	for	the	individual.	For	example,	ECE	has	 392	
been	demonstrate	to	also	have	longitudinal	effects	on	the	cardiovascular	system	[106].		 393	
From	the	mentioned	research,	it	is	clear	that	cocaine	produces	numerous	 394	
adverse	outcomes	for	individuals	with	ECE.	Placental	mammals	provide	a	sound	model	 395	
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system	for	mimicking	the	effects	of	ECE,	but	also	include	several	limitations.	Because	of	 396	
the	internal	development	of	placental	animals,	malnutrition	can	be	a	confounding	 397	
variable	for	interpreting	the	results	of	addictive	drug	studies.	Malnutrition	as	a	result	of	 398	
ECE	has	been	disputed	within	studies	indicating	food	consumption	and	weight	gain	did	 399	
not	significantly	differ,	but	results	are	controversial	[85,	107].	Mammalian	model	 400	
systems	include	another	unique	confound.	Because	of	their	internal	development	the	 401	
location	of	the	developing	embryo	within	the	uterus	may	affect	the	amount	of	blood	 402	
flow	the	individual	receives.	It	has	been	experimentally	determined	that	oxygen	amount	 403	
and	correlatively	the	amount	of	blood	the	embryo	receives	may	determine	some	 404	
cellular	fates	[108].	This	differential	blood	flow	may	in	turn,	affect	the	concentration	of	 405	
drug	the	developing	pup	receives.	This	confound	may	affect	the	interpretation	of	 406	
longitudinal	experiments	with	ECE.	Additionally,	due	to	this	internal	development,	 407	
important	organ	systems	including	the	brain,	liver,	and	heart	cannot	be	visualized	 408	
without	a	cull.	Zebrafish	provide	a	large	scale	solution	to	these	problems	and	have	been	 409	
recently	used	in	addiction	and	behavioral	studies	[109-111].	 410	
	 411	
Zebrafish	as	an	Ideal	Model	Organism	 412	
Zebrafish	(Danio	rerio)	have	become	a	highly	utilized	vertebrate	model	organism.	 413	
These	small	fish	possess	many	advantages	for	researchers	investigating	mechanisms	 414	
underlying	complex	disease.	The	easy	manipulation	of	the	small	genome	aids	in	 415	
introducing	genetic	mutations,	leading	to	the	generation	of	a	myriad	of	mutant	lines	 416	
that	are	valuable	to	investigate	developmental	mechanisms	and	disease	processes.	The	 417	
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external	fertilization	of	zebrafish	embryos	allows	researchers	to	control	developmental	 418	
microenvironments	and	to	reduce	maternal	variables	like	malnutrition	that	can	impact	 419	
egg	formation.	Also,	unlike	the	use	of	mammalian	organisms,	zebrafish	development	 420	
can	be	viewed	in	a	noninvasive	manner.	The	small	brain	size	of	the	adult	zebrafish	is	 421	
advantageous	because	it	can	be	easily	observed	using	intravital	imaging	equipment	 422	
[112].	Additional	advantages	when	using	zebrafish	are	the	large	clutch	sizes	and	 423	
relatively	short	generation	time	[113].		In	addition,	the	zebrafish	possess	many	 424	
physiological	features	that	are	homologous	to	those	of	higher	vertebrates.		The	 425	
zebrafish	brain	has	an	amygdala-like	structures	and	a	reward	circuitry	that	is	 426	
comparable	to	the	mammalian	brain	[114].	As	a	result,	zebrafish	are	an	ideal	model	to	 427	
assess	the	neurophysiologic	and	behavioral	consequences	of	ECE.	In	addition,	there	is	a	 428	
high	percentage	of	an	amino	acid	structural	homology	between	zebrafish	and	 429	
mammalian	dopaminergic	receptors	(D2	and	D3),	making	zebrafish	an	ideal	system	for	 430	
studying	the	pharmacology	of	drugs	of	addiction	[115].		 431	
	Darland	and	colleagues	have	demonstrated	the	utility	of	the	zebrafish	model	to	 432	
investigate	the	behavioral	effect	of	cocaine	and	have	linked	these	effects	to	genetic	and	 433	
physiological	responses.	Previous	studies	from	our	lab	provided	evidence	of	a	dose- 434	
dependent,	cocaine-induced	conditioned	place	preference	(CPP)	in	the	zebrafish	model	 435	
[116].	Interestingly,	mutagenized	family	lines	of	zebrafish	were	insensitive	to	the	effect	 436	
of	cocaine	within	these	behavioral	studies,	although	specific	genetic	links	were	not	 437	
identified	at	that	time.	Using	the	percentage	of	individuals	displaying	impaired	CPP,	it	 438	
was	suggested	that	this	modified	response	was	the	result	of	a	Mendelian	inherited,	 439	
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single	gene	mutation	within	gene	networks	of	the	dopaminergic	pathway.	This	indicated	 440	
zebrafish	as	a	model	for	behaviors	associated	with	reward.	 441	
Research	has	also	suggested	that	zebrafish	respond	physiologically	to	cocaine	in	 442	
a	dose-dependent	manner	[117].	Cocaine’s	effect	on	the	cardiac	system	is	mediated	by	 443	
both	the	central	and	peripheral	nervous	systems	[118].	In	the	central	nervous	system,	 444	
research	suggests	that	cocaine	results	in	increased	sympathetic	brainstem	activation	 445	
[119].	In	the	peripheral	nervous	system,	the	sympathetic	inhibition	of	epinephrine	 446	
reuptake	or	a	probable	increase	in	adrenal	medullary	stimulation	leads	to	increases	in	 447	
heart	rate	and	blood	pressure	[120].	Indeed,	pharmacologic	agents	have	been	used	to	 448	
test	adrenergic	activity	at	sympathetic	terminals	in	the	peripheral	nervous	system	[117].	 449	
In	this	study,	it	was	observed	that	as	cocaine	dose	was	increased,	the	heart	rate	of	adult	 450	
zebrafish	increased	in	a	dose-dependent	manner.	The	addition	of	a	ß-adrenergic	 451	
antagonist	attenuated	this	increase	in	heart	rate	in	the	adult	fish.	Conversely,	 452	
concurrent	treatment	with	an	a-adrenergic	antagonist	strengthened	the	effect	of	 453	
cocaine	on	heart	rate	increase.	Further,	5-day	old	zebrafish	treated	with	increased	 454	
concentration	of	cocaine	showed	this	dose-dependent	increase	in	heart	rate	as	well.	 455	
This	demonstrated	the	adrenergic	systems	control	over	heart	rate	was	downstream	of	 456	
cocaine’s	effect	as	a	monoamine.	The	results	of	these	studies	suggest	zebrafish	are	a	 457	
valuable	model	for	the	study	of	addictive	drugs.	As	zebrafish	are	prone	to	lasting	 458	
physiological	consequence	to	ECE	and	share	molecular	regulatory	pathways	with	 459	
mammals	[106],	this	model	is	ideal	for	investigating		how	ECE	generates	lasting	 460	
behavioral	alterations	governed	by	gene	expression.	A	critical	question	in	the	field	of	 461	
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addiction	is	how	are	the	gene	expression	and	behavioral	changes	linked	to	ECE.	 462	
Emerging	evidence	suggests	a	role	for	epigenetics	in	these	processes.		 463	
	 464	
Epigenetics	Mechanisms	and	Intergenerational	Inheritance	 465	
Epigenetics	is	a	means	by	which	environmental	factors	generate	persistent	 466	
changes	in	gene	expression.	Epigenetic	modification	occurs	through	a	covalent	 467	
attachment	of	some	functional	group	to	a	promoter	sequence	or	DNA	associated	 468	
proteins	that	can	modify	that	segment	of	DNA’s	transcriptional	potential.	DNA	 469	
modification	has	been	observed	as	an	attachment	of	methyl	groups	directly	to	the	DNA	 470	
sequence	or	as	an	attachment	of	these	methyl	groups	to	histone	proteins.	Several	 471	
mechanisms	have	been	documented	that	led	to	differential	DNA	transcription.	 472	
Attachment	of	acetyl	groups	to	histone	proteins	has	been	well	documented	as	a	means	 473	
altering	transcription.	Vassoler	et	al.	(2013)	and	his	team	of	researchers	detected	 474	
increases	in	Bdnf	expression	as	well	as	Bdnf	protein	in	the	reward	circuitry	of	these	male	 475	
offspring.	Researcher	observed	an	increased	acetylation	of	histone	3	in	the	Bdnf	 476	
promoter	regions	in	the	sperm	of	self-administering	paternal	mice.		Acetylation	at	these	 477	
histone	proteins	leads	to	the	introduction	of	a	positive	charge,	which	changed	the	 478	
accessibility	of	chromatin	wrapped	on	its	histone.	In	this	open	state,	transcription	of	this	 479	
gene	can	occur	at	a	greater	rate.	These	results	taken	together	suggest	that	the	 480	
substance	abuse	phenotype	was	passed	on	to	offspring.	This	inheritance	suggested	an	 481	
epigenetic	event	was	occurring	and	permitted	the	passing	on	of	drug-related	behaviors.	 482	
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	As	mentioned,	epigenetic	alterations	constitute	changes	in	gene	expression	via	 483	
mechanisms	that	do	not	alter	the	genetic	code	itself.	Rather	these	changes	in	expression	 484	
are	the	result	of	the	thermodynamic	probability	for	the	RNA	polymerases	to	interact	 485	
with	and	access	the	template	strand.	Complex	DNA	as	a	double	stranded	molecule	is	 486	
wrapped	around	histone	proteins	forming	a	nucleosome.	There	are	four	histone	 487	
proteins	(H2A,	H2B,	H3,	H4)	that	associate	together	and	form	this	nucleosome	octamer.	 488	
Chromatin	with	‘open’	regions	are	termed	euchromatin,	while	regions	tightly	wrapped	 489	
around	these	histone	proteins	are	termed	heterochromatin	and	are	active	or	inactive	for	 490	
transcription,	respectively.	Chemical	groups	that	can	form	an	attachment	to	either	DNA	 491	
or	the	histone	proteins	change	the	accessibility	of	gene	transcripts	to	the	transcriptional	 492	
machinery,	thus	changing	access	to	template	DNA.	This	accessibility	is	controlled	by	 493	
multiple	molecular	and	enzymatic	means,	including	modifications	to	the	amino	acid	tails	 494	
of	the	histone	proteins,	the	addition	of	acetyl	groups,	methyl	groups,	phosphoryl	 495	
groups,	or	methylation	of	the	DNA	sequence	itself	[121].	 496	
The	effects	of	several	epigenetic	alterations	have	been	reported	in	the	literature.	 497	
One	model	for	chromatin	remodeling	that	has	been	highly	investigated	is	the	addition	of	 498	
acetyl	groups	onto	key	histone	amino	acids	by	enzymes	termed	histone	 499	
acetyltransferases.	The	addition	of	negatively	charged	acetyl	groups	typically	to	lysine	or	 500	
other	positively	charged	amino	acids	neutralizes	their	charge,	loosening	the	coiling	of	 501	
DNA	to	the	histone	proteins	and	promoting	transcription[122].	Another	highly	studied	 502	
modification	occurring	at	histone	tails	is	the	addition	of	methyl	groups	by	histone	 503	
methyltransferases.	Unlike	the	addition	of	acetyl	groups,	the	addition	of	methyl	groups	 504	
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carries	no	charge	and	is	thought	to	not	affected	that	stability	of	the	interaction	between	 505	
DNA	and	chromatin.	Methyl	groups	can	be	added	to	histone	tails	as	single	methyl,	di- 506	
methyl,	or	tri-methyl	groups.	These	additions	have	varying	effects	on	transcription	at	 507	
histone	tails	depending	on	the	amino	acid	targeted	as	well	as	the	overall	epigenetic	 508	
landscape	[123].	In	a	study	conducted	by	Maze	et	al.	(2010),	researchers	reviewed	the	 509	
role	of	a	particular	histone	dimethyltransferase,	G9a,	which	regulated	the	methylation	 510	
of	the	transcription	factor	ÑFosB	[124].	In	this	study,	experimental	knockdown	of	the	 511	
G9a	dimethyltransferase	strengthened	preference	for	cocaine	in	mouse	behavioral	 512	
assays	by	augmenting	dendritic	projections	in	the	nucleus	accumbens	of	mice	[124].	 513	
Another	group	of	methyltransferases	add	methyl	groups	directly	to	the	DNA	strand,	 514	
ideally	named	DNA	methyltransferases	(Dnmts).	Research	has	indicated	five	known	 515	
mammalian	Dnmts:	Dnmt1,	Dnmt2,	Dnmt3a,	Dnmt3b,	and	DnmtL	[125].	The	zebrafish	 516	
genome	has	undergone	a	duplication	event	and	thus	possess	a	unique	set	of	Dnmts	 517	
homologous	to	the	mammalian	enzymes.	Mammalian	Dnmt1	has	been	shown	to	 518	
methylate	CpG	rich	regions	and	act	to	sustain	methylation	patterns	in	cells	undergoing	 519	
replication	[126,	127].	Dnmt1	has	been	mentioned	in	methylation	maintenance	and	is	 520	
highly	expressed	in	cells	undergoing	mitotic	processes	[128].	Results	of	mutant	lines	 521	
studies	indicated	that	mouse	embryonic	stem	cells	with	the		Dnmt1-/-	genotype	showed	 522	
no	significant	decrease	in	de	novo	methylation	[129].	These	results	suggested	that	de	 523	
novo	methylation	was	largely	catalyzed	by	Dnmt3a	and	Dnmt3b.	In	the	zebrafish,	 524	
Dnmt3a	is	represented	as	dnmt6	and	dnmt8	[130].	Mammalian	Dnmt3b	is	represented	 525	
in	the	zebrafish	as	dnmt3,	dnmt4,	dnmt5,	and	dmnt7[131].	Indeed,	another	means	of	 526	
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epigenetic	regulation	used	to	modify	gene	expression	includes	a	group	of	small	 527	
noncoding	RNAs	called,	microRNA	(miRNA).	These	are	typically	around	21	nucleotides	in	 528	
length	and	act	to	modify	gene	expression	patterns	through	complementary	binding.		 529	
RNA	strand	complementarity	to	target	sequence	prevents	the	binding	of	transcriptional	 530	
machinery,	consequently	regulating	the	transcription	of	that	particular	mRNA.	Research	 531	
has	demonstrated	this	mechanism	may	play	a	role	in	some	drug-seeking	behaviors	and	 532	
addictive	neuropsychiatric	disorders[132].	Research	has	suggested	that	alterations	seen	 533	
in	the	expression	of	genes	involved	in	memory	and	neuronal	plasticity,	such	as	bdnf	 534	
occurs	through	these	small	miRNAs.		 535	
Epigenetic	mechanisms	have	been	implicated	in	the	responsiveness	to	 536	
psychostimulants	and	drugs	of	abuse[121].	Research	conducted	by	Baker-Andresen	et	 537	
al.	(2015)	explored	methylation	patterns	in	the	medial	prefrontal	cortex	of	mice	[133].	 538	
Following	the	recurrent	self-administration	of	cocaine,	genome-wide	sequencing	 539	
showed	differential	methylation	patterns	in	29	genomic	regions	of	the	mouse	prefrontal	 540	
cortex	when	compared	against	untreated	controls.	Interestingly,	differential	 541	
methylation	patterns	were	observed	following	a	period	of	cocaine	abstinence,	 542	
suggesting	cocaine	induced	lasting	changes	in	brain	regions	associated	with	high	 543	
cognition,	planning	and	sensory	integration	[133].	In	another	study,	rats	subjected	to	 544	
chronic	cocaine	exposure	showed	decreased	drug	seeking	behaviors	when	treated	with	 545	
L-methionine,	a	methyl-donating	compound	[134].	Dr.	Wright	and	her	team	observed	 546	
increases	in	the	expression	of	DNA	methylating	enzymes,	Dnmt3a	and	Dnmt3b,	in	the	 547	
nucleus	accumbens.	Additionally,	the	expression	of	a	Fos	family	gene	within	the	nucleus	 548	
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accumbens	and	prefrontal	cortex	was	decreased	by	L-Methionine	treatment.	These	 549	
results	indicated	DNA	methylation	may	play	a	role	in	addiction	and	in	potentiating	 550	
addictive	behaviors	within	reward	pathways	by	means	of	gene	expression	regulation	 551	
[134].	Alterations	in	methylation	patterns	at	certain	CpG	islands	of	gene	promoters	have	 552	
been	indicated	to	alter	transcriptional	potential,	thus	permanently	changing	gene	 553	
transcription	[135,	136].	If	substance	abuse	in	an	adult	organism	can	contribute	to	 554	
sustained	DNA	methylation	changes,	maintenance	of	these	patterns	could	contribute	to	 555	
similar	behavior	in	offspring,	with	the	potential	for	particular	vulnerability	in	those	 556	
individuals	exposed	during	brain	formation.		The	work	presented	here	will	test	the	 557	
hypothesis	that	ECE	leads	to	persistent	changes	in	gene	expression	as	the	result	of	an	 558	
epigenetic	mechanism	and	that	these	changes	in	expression	govern	reward-seeking	 559	
behaviors.	We	predict	that	epigenetic	modification	resulting	from	ECE	can	provide	 560	
lasting	gene	expression	changes	and	subsequently	affect	physiology	and	behavior	in	 561	
future	generations.	 562	
	 563	
	 564	
	 	 565	
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METHODS	AND	MATERIALS	 566	
	 	 567	
Fish	husbandry		 568	
Zebrafish	(Danio	rerio)	were	raised	at	the	University	of	North	Dakota	and	 569	
fostered	according	to	recommended	protocols	(The	Zebrafish	Book,	Animal	Welfare	 570	
Assurance	#A3917-01,	protocol	1403-7)	on	a	stand-alone	water	system	from	Aquatic	 571	
Habitats	[137].	Water	for	fish	underwent	reverse	osmosis	with	0.3	g/L	Instant	Ocean	 572	
(Instant	Ocean	Spectrum	Brands,	Blacksburg,	VA,	USA)	and	0.1	g/L	bicarbonate	and	 573	
conditioned	on	the	system	to	our	specifications,	hereafter	known	as	fish	water.	Fish	 574	
experience	a	10-14	dark-light	cycle.	In	the	morning,	fish	are	fed	brine	shrimp	and	in	the	 575	
afternoon	with	pelleted	food.	All	fish	tested	behaviorally	are	from	an	AB	line	obtained	 576	
from	Harvard	Biological	Laboratories	(Harvard	University,	Cambridge	MA)	and	bred	in	 577	
house	for	10	years.	Larval	fish	from	a	reporter	line	that	use	the	a-tubulin	promoter	to	 578	
express	green	fluorescence	protein	(GFP)	within	the	central	nervous	system	were	used	 579	
for	embryonic	tissue	harvest	[138].	GFP	is	expressed	in	the	forebrain	structure	of	adult	 580	
and	larval	zebrafish	and	was	used	to	distinguish	tissues	for	dissection	(Figure	3).		 581	
	 582	
	 583	
	 584	
	 585	
	 586	
	 587	
	 588	
	 589	
	 	 	
	
	 28	
	 590	
	 591	
	 592	
	 593	
Drug	Exposure	Model		 594	
	 595	
Overall	Experimental	Design	 596	
Figure	1:	The	treatment	paradigm	outlining	the	overall	experimental	design	is	shown.	 597	
Fish	embryos	were	collected	and	washed	on	d0	defined	as	fertilization.	Initial	treatment	 598	
began	on	d1	in	a	6-well	plate	with	drug	being	replaced	each	morning	(d2	and	d3).	Drug	 599	
was	removed	on	d4	and	washed	away	(3X).	Fish	for	longitudinal	experiments	including	 600	
adult	breeding,	CPP	and	Hi	Seq	experiments	were	placed	on	the	stand	alone	system	on	 601	
d5.	Longitudinal	experiments	were	conducted	at	6-8	mos.	F1	fish	were	tested	 602	
behaviorally	or	used	for	methylation	experiments	(5-mC)	at	8	months.	 603	
	 604	
The	basic	experimental	paradigm	is	outlined	in	Figure	1.	To	model	ECE,	fish	were	 605	
collected	the	morning	following	a	parental	cross.	Embryos	were	rinsed	with	fresh	fish	 606	
water	and	placed	in	a	petri	dish	at	d0.	The	following	day	fish	were	staged	and	screened	 607	
for	defects.	Healthy	specimens	at	a	density	of	25-40	fish/well	were	placed	in	a	6-well	 608	
plate	and	treated	with	concentrations	(0μM,	2.5	μM,	5	μM,	10	μM,	and	20μM)	of	 609	
cocaine	(Sigma-Aldrich,	NIDA)	as	done	previously	[106,	117].	Previous	data	from	our	lab	 610	
showed	adult	zebrafish	display	a	dose-dependent	behavioral	response	to	cocaine	in	the	 611	
ranges	tested	here.	Parental	generation	(F0)	zebrafish	were	treated	with	cocaine	 612	
hydrochloride	dissolved	in	5ml	of	fish	water	on	d1-d3.	We	chose	this	developmental	 613	
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window	of	3-day	treatment	as	it	shows	little	neurotoxicity	and	is	thought	to	have	little	 614	
effect	on	dopaminergic	architecture	of	the	developing	larval	zebrafish	[106].	On	the	d4,	 615	
fish	were	rinsed	3	times	to	remove	cocaine	and	on	d5	placed	on	the	system.	Parental	 616	
fish	(F0)	from	each	treatment	group	were	raised	and	crossed	at	6	months	to	produce	the	 617	
F1	generation	of	zebrafish.	This	cross	produced	a	clutch	that	did	not	experience	a	second	 618	
exposure	to	cocaine.	Fish	of	both	F0	and	F1	were	then	tested	behaviorally	using	a	 619	
conditioned	place	preference	assay	at	6-8	months	of	age.		 620	
	 Another	group	of	F0	fish	were	generated	to	experience	ECE	with	a	simultaneous	 621	
treatment	of	Chlorogenic	Acid	(CA).	CA	acts	to	inhibit	the	dnmt	enzymes	[139].	DNA	 622	
methylation	occurs	through	the	enzymatic	action	of	DNA-methyltransferases	at	the	5’	 623	
position	of	cytosine	residues.	Methyl	groups	are	donated	from	S	–adenosyl-	1	– 624	
methionine.	CA	is	a	dietary	catechol	thought	to	non-competitively	inhibit	methylation	by	 625	
increasing	concentrations	of	S-adenosyl-	1	–homocysteine	in	turn	reducing	 626	
concentrations	of	S	–adenosyl-	1	–methionine,	the	methyl	group	donor	[140].	Dose- 627	
response	experiments	were	conducted	to	determine	an	optimal	concentration	that	had	 628	
no	effect	on	survival.	Measurements	of	body	length	were	conducted	with	live	 629	
anesthetized	fish	using	a	ruler	with	recordings	collected	in	millimeters.	Weights	for	 630	
these	anesthetized	fish	were	recorded	with	the	scale	tared	to	100mL	of	water.	 631	
Percentages	of	survival	were	calculated	based	on	the	number	of	viable	specimens	 632	
relative	to	the	initial	clutch	size.	From	this	experiment,	it	was	determined	that	1	μM	CA	 633	
was	the	threshold	concentration	that	allowed	for	adequate	sample	size.	Chlorogenic	 634	
acid	must	be	dissolved	in	dimethyl	sulfoxide	(DMSO)	at	a	stock	concentration	of	1	μM.	 635	
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The	groups	for	these	experiments	include	an	untreated	group,	a	group	treated	with	1	 636	
μM	DMSO,	a	group	with	10	μM	cocaine,	a	group	treated	with	1	μM	CA,	and	a	group	 637	
treated	with	1	μM	and	10	μM	cocaine	hydrochloride.	This	treatment	occurred	as	 638	
described	above.	Fish	were	raised	into	adulthood	and	tested	at	8	months	using	 639	
Conditioned	Place	Preference	(CPP).		 640	
	 641	
CPP	Behavioral	Assay	 642	
CPP	was	adapted	and	recorded	as	previously	described	[116,	141].	Briefly,	the	 643	
testing	apparatus	is	a	3-chambered	rectangular	tank	depicted	in	Figure	2.	Each	chamber	 644	
contained	1L	of	fish	water	and	included	2	removable	partitions.	These	removable	 645	
partitions	(or	barriers)	divide	the	lane	into	3	compartments;	the	middle	section	contains	 646	
twice	the	volume	of	the	two	smaller	chambers	of	each	lane	(500	ml	and	250	ml,	 647	
respectively;	1	liter	total).		To	allow	fish	to	freely	explore	the	testing	apparatus,	passable	 648	
barriers	were	in	place	that	had	a	1”	diameter	hole	in	their	centers.	These	were	then	 649	
replaced	with	a	solid	barrier	for	the	isolations	in	the	front	or	back	chamber	(Figure	2).	 650	
Darland	et	al.	(2012)	measured	water	flow	between	the	larger	compartment	and	the	 651	
smaller	compartments	using	phenol	red	and	determined	water	exchange	was	minimal	 652	
(data	not	shown)	[141].	Each	lane	remains	separate	from	its	adjacent	lane	and	allows	 653	
visualization	of	neighboring	test	subjects.	Due	to	the	anatomical	features	of	zebrafish	 654	
eyes,	it	is	likely	that	the	fish	use	additional	extended	visual	cues.	The	rear	portion	of	the	 655	
tank	has	duct	tape	wrapped	around.	The	proximal	compartment	is	left	open.	Each	3- 656	
chamber	testing	tank	is	isolated	from	the	adjacent	testing	apparatus	by	a	white	 657	
cardboard	divider.	The	test	tank	allows	for	3	fish	to	be	tested	together.	The	initial	day	of	 658	
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testing	included	a	40-minute	swim	allowing	for	acclimation	to	the	novel	test	 659	
environment.	Fish	are	placed	in	the	center	section	of	their	lane	and	allowed	to	explore	 660	
the	lane	with	open	partitions	in	place.	The	2nd	and	3rd	days	included	two	isolation	events	 661	
without	cocaine	treatment	for	30-minutes	each	following	an	8-minute	baseline	 662	
measurement.	The	isolation	occurred	by	removing	the	open	partitions	and	replacing	 663	
with	closed	barrier.	On	day	2,	the	isolation	occurred	first	in	the	front	section	for	30- 664	
minutes	and	then	again	in	the	rear	compartment	for	30-minutes.	Day	3,	the	isolation	 665	
events	occur	first	in	the	rear	for	30-minutes	and	then,	the	front	section	for	30-minutes.	 666	
Baseline	measurements	occurred	before	the	isolation	events	on	Day	2	and	3.	On	day	4,	 667	
preference	for	either	the	front	or	rear	section	is	recorded	during	the	baseline	 668	
measurement	and	determined	during	the	isolation	events.	The	first	isolation	occurs	in	 669	
the	chamber	the	fish	preferred	the	most	and	the	last	isolation	occurred	the	chamber	 670	
preferred	the	least.		 671	
It	is	on	this	day	of	CPP	testing	that	conditioning	occurs.	Cocaine	hydrochloride	 672	
was	dissolved	in	fish	water	and	added	to	the	least	preferred	chamber	during	the	second	 673	
isolation	event.	Day	5,	the	conditioning	was	conducted	identical	to	day	4.	Day	6	 674	
consisted	of	a	baseline	measure	to	quantify	any	potential	change	in	preference	as	the	 675	
result	of	conditioning.	Measurements	were	recorded	two	separate	ways	due	to	limited	 676	
technologic	resource.		In	one	lab,	measurements	were	recorded	using	TopScan3.00	 677	
(TopScan	3.00	Clever	System	Inc.	2011).	In	the	other	lab,	preference	was	recorded	using	 678	
a	ternary	code,	where	1	indicated	presence	in	the	front	chamber,	2	in	the	central	 679	
chamber,	and	3	in	the	rear	compartment.		Fish	that	did	not	move	were	scored	as	‘0’	to	 680	
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reflect	the	characteristic	freezing	behavior	associated	with	a	stress	response	in	 681	
zebrafish.	Any	fish	exhibiting	these	stress-related	behaviors,	such	as	freezing,	for	greater	 682	
than	50%	of	the	reading	were	excluded	from	analysis.	CPP	experimental	protocol	was	 683	
adjusted	to	account	for	behavioral	results.	Optimal	assay	concentrations	were	based	on	 684	
previously	published	work.	Darland	et	al.	(2001)	showed	that	adult	zebrafish	display	a	 685	
dose-dependent	response	to	cocaine	using	CPP,	with	the	optimal	range	from	0	to	20	 686	
mg/mL	[116].	In	addition,	we	have	shown	that	zebrafish	respond	physiologically	to	 687	
cocaine	in	a	dose-dependent	manner,	with	a	characteristic	shift	in	cardiac	function	 688	
[117].	For	both	behavioral	and	physiological	assays,	peak	responsiveness	to	cocaine	 689	
occurs	at	the	concentration	of	10	mg/mL	(10	μM).	Based	on	these	studies,	we	treated	 690	
our	initial	cohorts	of	zebrafish	with	a	submaximal	cocaine	concentration	of	5mg/mL	to	 691	
determine	any	change	in	longitudinal	responsiveness.		 692	
	 The	F0	generation	CPP	included	an	untreated	control,	2.5	μM/L	cocaine,	5	μM/L	 693	
cocaine,	10	μM/L	cocaine,	and	20	μM/L	cocaine.	These	concentrations	were	shown	to	 694	
initiate	a	behavioral	response	in	a	dose	dependent	manner	[116,	117,	141].	In	 695	
preliminary	studies	with	the	F1	generation,	preliminary	studies	we	observed	some	 696	
change	in	preference	in	untreated	fish.	To	account	for	this	phenomenon,	we	adjusted	 697	
the	CPP	protocol.	Experimental	results	indicated	an	innate	preference	to	the	front	 698	
chamber,	regardless	of	cocaine	treatment.	Changes	in	the	location	of	isolations	from	the	 699	
zebrafish	preferred	chamber	to	isolations	occurring	only	in	the	rear	chamber	led	to	 700	
greater	conditioned	response.	We	added	another	control	group	to	confirm	that	the	 701	
observed	behavior	was	a	direct	result	of	cocaine	exposure.	We	treated	a	group	of	fish	 702	
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with	2.5,	5,	and	10	μM/L	lidocaine,	an	anesthetic.	Lidocaine	acted	as	a	negative	control	 703	
because	it	can	imitate	the	local	anesthetic	action	similar	to	cocaine,	but	does	not	 704	
stimulate	reward	by	inhibiting	monoamine	transporters.		 705	
	 706	
CPP	Assay	Tank	 707	
Figure	2:	CPP-testing	apparatus	is	shown.	Arrows	indicate	isolation	chambers.	The	red	 708	
arrow	indicates	the	back	chamber	and	the	blue	arrow	indicates	the	front	chamber.	Each	 709	
isolation	chamber	has	a	removable	divider	with	a	hole	in	its	center	allowing	free	 710	
exploration.	Conditioning	occurs	in	the	back	chamber	with	an	impassable	barrier	in	 711	
place.		 712	
	 713	
Tissue	Collection	and	Brain	Dissections	 714	
In	order	to	determine	the	affect	cocaine	exposure	had	on	gene	expression,	we	 715	
collected	telencephalic	tissue	from	larval	and	adult	zebrafish	on	the	basis	that	this	 716	
region	is	thought	house	regions	that	are	structurally	homologous	to	mammals	and	are	 717	
responsible	for	the	rewarding	properties	of	cocaine,	including	the	nucleus	accumbens	 718	
and	dorsal	striatum	[142].	The	critical	regions	are	outlined	in	GFP	expressing	fish	and	 719	
reflect	the	areas	dissected	(Figure	3).	We	have	previously	demonstrated	that	cocaine	 720	
exposure	led	to	significant	gene	expression	changes	in	the	regions	of	adult	brain	[141].	 721	
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To	ensure	no	suffering	occurred	to	the	animals,	they	were	first	anesthetized	in	tricaine	 722	
(methanesulfonate,	Sigma-Aldrich)	then	sacrificed	with	dissections	conducted	 723	
essentially	as	described	[141].The	adult	zebrafish	head	was	removed	at	the	7th	 724	
pharyngeal	arch	and	a	sharpened	surgical	probe	was	used	to	pierce	the	teleost	skull	 725	
medially	and	circumlaterally.	The	skull	was	then	peeled	away	to	expose	the	rostral	 726	
portion	of	the	diencephalon	and	the	entire	telencephalon.	Using	small	surgical	spring	 727	
scissors,	an	incision	was	made	to	separate	the	caudal	telencephalon	from	the	rostral	 728	
diencephalon.	This	cut	enters	through	the	diencephalic	ventricle	caudally	to	the	dorsal	 729	
telencephalic	area.	Then,	rostral	cuts	were	made	to	separate	telencephalic	tissue	from	 730	
the	olfactory	bulb.	To	separate	the	telencephalic	tissue	from	optic	tissue,	the	surgical	 731	
scissor	was	inserted	into	the	mediolateral	space	in	the	eye	socket	clipping	off	the	optic	 732	
nerve.	The	cartilage	surrounding	the	socket	was	then	cut	away	to	expose	the	ventral	 733	
telencephalon	and	optic	chiasm.	An	incision	at	the	optic	chiasm	freed	the	 734	
telencephalon.	Which	was	then	be	removed	from	the	‘cradle’	of	cartilage	using	forceps.	 735	
Two	telencephalons	were	used	per	sample.	Care	was	taken	to	ensure	that	no	tissue	 736	
cross-contamination	occurred	during	the	dissections.		 737	
Embryonic	dissections	were	done	to	harvest	larval	telencephalic	tissue.	Green	 738	
fluorescent	expressing	larval	zebrafish	were	anesthetized	within	a	petri	dish	using	 739	
tricaine	and	collected	in	a	RNAlater	solution.	Larval	fish	were	then	centrifuged	(≥10,000	 740	
rcf).	Then,	larvae	were	placed	in	a	new	petri	dish	with	600	μL	RNA	later	and	viewed	 741	
under	a	fluorescent	scope.	In	order	to	collect	the	corresponding	telencephalic	tissue	in	 742	
the	larval	zebrafish,	fish	were	laid	on	a	lateral	side	and	the	eyes	was	removed	using	a	 743	
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tungsten	needle.	The	developing	telencephalon	then	lay	dorsal	to	the	olfactory	bulb	and	 744	
could	be	excised.	Because	of	the	small	tissue	sample	present	within	the	larval	 745	
telencephalon	each	treatment	group	would	include	>50	telencephalons.	 746	
	 747	
	 748	
Zebrafish	Reward	Circuitry	 749	
Figure	3:	Shown	above	are	telencephalons	of	A)	an	adult	and	B)	a	larval	zebrafish	 750	
expressing	Green	Fluorescent	Protein.	A)	is	a	magnified	image	of	the	adult	zebrafish	 751	
forebrain	structure.	B)	is	a	magnified	image	of	the	larval	zebrafish	forebrain.	 752	
	 753	
Genetic	Material	Preparation	and	Gene	Expression	Verification		 	 754	
Quantitative	polymerase	chain	reaction	experiments	(qPCR)	were	used	to	take	 755	
advantage	of	the	linear	nature	at	which	DNA	is	amplified	to	determine	the	amount	of	a	 756	
known	sequence.	Detection	appears	as	PCR	products	accumulate	during	the	exponential	 757	
amplification	steps	of	the	PCR	reactions.	Here,	the	first	substantial	increase	in	the	PCR	 758	
products	reflected	increased	detection	of	the	fluorescent	marker	and	the	initial	amount	 759	
of	our	targeted	sequences.	We	anesthetized	and	culled	groups	of	ECE	larvae	at	5dpf	and	 760	
longitudinal	adults	at	6	months.	Dissections	were	conducted	to	collect	telencephalic	 761	
tissue	from	adult	and	larval	zebrafish.	Adult	samples	were	gender	matched	and	two	 762	
forebrains	constituted	one	sample.		 763	
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To	begin,	our	tissue	collections	were	chemically	manipulated	to	produce	total	 764	
RNA.	Collected	tissues	were	stored	in	RNAlater	solution	or	collected	and	immediately	 765	
used	to	generate	RNA.	RNA	was	purified	using	an	RNeasy	kit	(the	Qiagen	RNeasyÒ	Mini	 766	
Kit).		Briefly,	aliquots	of	a	solution	containing	10µL	of	b-mercaptoethanol	in	1mL	of	 767	
buffer	RTL	were	added	to	the	tissue	samples	and	homogenized	for	approximately	10	 768	
seconds.	The	samples	were	then	centrifuged	at	full	speed	(15000	rcf)	for	3	minutes	and	 769	
the	supernatant	transferred	to	a	new	centrifuge	tube.	Samples	were	then	treated	with	 770	
one	volume	(700	µL)	of	70%	ethanol,	prior	to	transfer	to	a	spin	column.	The	spin	column	 771	
was	centrifuged	at	10000	rcf	for	1	minute,	the	supernatant	was	discarded	and	the	 772	
remaining	sample	was	added	and	centrifuged.	In	the	spin	column,	350µL	of	reagent	 773	
RW1	was	added	and	centrifuged	at	10000	rcf	for	30	seconds.	The	flow	through	was	 774	
discarded	and	an	aliquot	of	10	µL	DNase	and	70	µL	reagent	RDD	was	added	to	each	 775	
column	and	allow	incubate	at	room	temperature	for	15’	to	remove	residual	genomic	 776	
DNA	contamination.	The	column	was	washed	with	350	µL	of	reagent	RW1	and	 777	
centrifuged	at	10000	rcf	for	30	seconds.	Supernatant	was	again	discarded.	The	spin	 778	
column	was	treated	with	500	µL	reagent	RPE	and	spun	at	10000	rcf	for	30	seconds,	with	 779	
this	step	repeated,	but	was	then	centrifuged	for	2	minutes	at	10000	rcf.	The	top	of	the	 780	
spin	column	was	transferred	to	a	dry	collection	tube	and	spun	for	1	minute	at	>15000	 781	
rcf.	The	top	of	the	spin	column	was	removed	and	placed	in	another	new,	dry	collection	 782	
tube.	Finally,	30	µL	of	RNase-free	water	was	added	to	the	tube	and	incubated	for	1’	at	 783	
room	temperature.	This	was	followed	by	a	1’	centrifuge	at	8	rcf	to	elute	the	total	bound	 784	
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RNA.	The	samples	were	analyzed	for	purity	using	a	Nano	drop	and	then	placed	in	a	-80oC	 785	
freezer	for	storage.		 786	
From	our	RNA	samples,	we	generated	complementary	DNA	(cDNA)	using	two	 787	
separate	reverse	transcription	kits.	iScript	contained	all	the	necessary	components	for	 788	
reverse	transcription	of	first	strand	DNA	synthesis	except	the	RNA	template.	Briefly,	a	 789	
total	sample	of	20	µL	cDNA	was	produced.	Each	sample	required	4	µL	of	iScript	reagent	 790	
and	the	equivalent	of	200ng	of	RNA,	with	the	remaining	volume	filled	with	RNase-free	 791	
water.	The	other	kit	was	from	Applied	Biosystems,	RNA	PCR	core	kit	that	produced	40	µL	 792	
of	cDNA.	Here,	reverse	transcription	mixture	need	was	generated	prior	to	use	and	 793	
added	to	an	equivalent	of	200ng	of	RNA.	Each	sample	required	8	µLMgCl2,	4	µL	of	 794	
reaction	buffer,	4	µL	of	the	5	dNTPs,	2	µL	of	RNase	inhibitor,	2	µL	of	reverse	 795	
transcriptase,	1	µL	oligos,	and	1	µL	of	random	hexamers.	These	amounts	were	pipetted	 796	
into	one	stock	solution	and	each	sample	received	34	µL	of	this	solution.	The	remaining	 797	
volume	was	an	equivalent	of	200ng	of	RNA	template	and	RNase-free	water.	Incubation	 798	
of	samples	from	both	kits	was	done	according	to	their	respective	protocols.		 799	
Real	time	qPCR	was	carried	out	in	order	to	quantify	the	specific	gene	of	interest	 800	
expressed	in	our	tissue	samples.	Further	manipulation	of	our	cDNA	samples	was	 801	
required	for	this	step.	Master	mixes	for	the	respective	gene	were	generated	that	 802	
contained	0.5	µL	of	the	forward	and	reverse	primers(nmol),	9.5	µL	RNase-free	water,	 803	
and	12.5	µL	SyberGreen	(Bio-Rad	Laboratories,	Inc).	This	volume	was	pipetted	into	96- 804	
well	plated	with	2	µL	of	cDNA	from	our	ECE	groups	for	RT-qPCR	analysis.	Real	time	qPCR	 805	
reactions	were	carried	out	in	the	CFX86	Real-Time	System	C1000	Touch	Thermal	Cycler.	 806	
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Reactions	were	conducted	according	to	protocol.	Briefly,	Taqman	protocol	occurred	in	3	 807	
phases.	Phase	1	occurred	at	95o	C	for	3	minutes.	Phase	2	and	3	were	repeated	39	times	 808	
for	amplification	of	the	desired	gene	fragment.	Phase	2	ran	for	10	seconds	at	95o	C	and	 809	
phase	3	occurred	at	60o	C	for	30	seconds.	Each	gene	was	plated	in	triplicate.	Primers	 810	
were	produced	so	that	the	forward	primer	was	complementary	and	had	slight	overlap	 811	
with	the	reverse	primer	for	each	gene	(Integrated	DNA	Technologies,	Inc.).	This	overlap	 812	
prevented	the	inclusion	of	genomic	DNA	in	our	samples.		Primers	used	in	these	 813	
experiments	are	described	in	Table	1.		 814	
	 815	
Next	Generation	Sequencing	and	Transcriptome-wide	Analysis		 816	
In	order	to	observe	which	genes	govern	the	acute	and	longitudinal	result	of	 817	
cocaine	exposure,	we	utilized	Next-gen	RNA	sequencing	(RNA-seq)	techniques.	 818	
Generally,	Hi-sequencing	technologies	use	an	Illumina	approach	to	produce	high- 819	
throughput	sequencing	data.	Briefly,	RNA-Seq	works	in	a	series	of	three	steps:	1)	sample	 820	
preparation,	2)	Sequence,	and	3)	analysis.	RNA-seq	is	a	type	of	whole	transcriptomic	 821	
shotgun	sequencing	that	relies	on	the	existence	of	a	series	of	short	reads	that	resulted	 822	
in	30	million	50	bp	single	end	reads	for	each	gene.	It	is	an	ideal	approach	to	observe	the	 823	
transcriptome	during	a	disease	or	drug	induced	state.	For	our	experiment,	Hi-Seq	RNA	 824	
analysis	was	conducted	by	the	University	of	North	Dakota	Epigenetic	Core	Facility.	 825	
Library	preparation	and	Illumina	Sequencing	was	performed	by	the	core	facility	at	the	 826	
University	of	Minnesota	and	differential	expression	analysis	was	performed	by	Adam	 827	
Scheidegger	at	UND’s	core	facility.	Tissue	samples	were	generated	using	the	paradigm	 828	
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shown	in	Figure	1.	ECE	embryos	raised	to	adults	were	then	group	to	determine	gene	 829	
acutely	sensitive	to	cocaine	exposure.	Fish	from	each	ECE	treatment	group	were	treated	 830	
in	a	mock	CPP	experiment	and	sacrificed	at	8	months	(Figure	1).	During	this	mock-CPP,	 831	
fish	from	each	embryonic	treatment	group	were	isolated	and	exposed	to	5	mg/L	for	1	 832	
hour.	Additionally,	a	group	of	fish	from	each	embryonic	cocaine	concentration	were	left	 833	
untreated.	For	each	of	the	ECE	groups	treated	with	mock-CPP	and	those	left	untreated,	 834	
three	replicates	were	done	for	a	total	of	24	total	samples.		Fish	from	untreated	and	 835	
treated	groups	were	then	sacrificed.	Groups	from	the	F0	generation	at	each	embryonic	 836	
treatment	concentration	were	analyzed	following	a	mock-CPP	experiment.	A	cohort	of	 837	
ECE	fish,	that	were	left	untreated	with	the	mock	CPP	experiment,	from	each	embryonic	 838	
cocaine	concentration	were	also	analyzed.	Then	comparisons	were	conducted	 839	
comparing	all	mock-CPP	exposed	fish	against	all	untreated	ECE	fish.	This	comparison	 840	
revealed	a	list	of	genes	likely	affected	by	cocaine	exposure	and	these	were	termed	 841	
cocaine	sensitive	genes	(CS	genes).	A	file	of	CS	genes	was	arranged	according	to	log2	 842	
increase	and	significant	p-value.	From	this,	the	top	150	CS	genes	were	identified.	Our	 843	
top	150	genes	were	then	assessed	for	interactions	among	each	other.	Expression	of	 844	
these	genes	was	analyzed	at	each	cocaine	concentration.	This	allowed	us	to	compare	 845	
the	change	in	expression	of	these	CS	genes.		 846	
In	order	to	determine	any	interactions	within	our	list	of	genes,	I	used	the	 847	
database	STRING	[143].	STRING	generates	a	dense	web	of	direct	and	indirect	protein	 848	
interactions	based	on	literary	review,	experimental	data,	and	estimated	functionality.	 849	
Our	RNA-seq	data	gave	an	interesting	array	of	protein	interactions	and	clusters	that	I	 850	
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investigated	using	qPCR.	Genes	appearing	at	focal	points	of	these	clusters	were	selected	 851	
for	further	investigation.		 852	
	 853	
Bisulfite	Sequencing	Analysis	 854	
To	further	test	the	hypothesis	that	methylation	of	DNA	governing	CS	genes	is	 855	
altering	the	reward	behavior	of	our	F1	longitudinal	zebrafish,	we	collected	telencephalic	 856	
tissue	for	a	0,	a	2.5,	a	10,	and	a	20	mg/L	ECE	cohort	for	bisulfite	sequencing.	Bisulfite	 857	
sequencing	treats	each	DNA	segment	with	bisulfite,	which	will	convert	unmethylated	 858	
cytosine	residues	to	uracil.	Cytosines	that	possess	a	methyl	group	will	be	left	untouched,	 859	
and	in	this	way,	bisulfite	sequencing	gives	individual	nucleotide	resolution	of	 860	
methylation	patterns.	Fish	were	first	culled	in	a	pair	and	each	sample	consisted	of	two	 861	
male	fish.	If	two	males	were	not	available	for	each	sample,	we	matched	gender	at	a	1:1	 862	
ratio.	Because	methylation	often	affects	transcription	at	the	promoter	site	we	needed	 863	
to	generate	genomic	DNA	(gDNA).	A	Quick-DNA	kit	(Zymo	Research;	Irvine,	CA)	was	used	 864	
for	this	purpose	according	to	manufacturer’s	protocol.	Briefly,	dissected	tissue	samples	 865	
(≤25mg)	were	prepared	as	previously	described	and	added	to	a	protease	buffer	(95µL	 866	
nuclease	free	H20,	95µL	Solid	Tissue	Buffer,	and	10µL	Proteinase	K;	per	sample)	and	 867	
mixed	thoroughly	for	incubation.	The	incubation	occurs	for	approximately	3	hours	at	 868	
55oC.	Following	incubation	samples	were	centrifuged	at	12000	rcf	for	1	minute	to	 869	
separate	out	any	insoluble	material.	Samples	were	then	transferred	to	new	centrifuge	 870	
tubes	and	400µL	Genomic	Binding	Solution	was	added.	Solutions	were	mixed	and	added	 871	
to	a	spin	column	for	centrifugation	at	12000	rcf	for	1	minute.	The	flow	through	and	 872	
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collection	tubes	were	discarded.	The	spin	column	was	transferred	to	a	new	collection	 873	
tube,400µL	DNA	Pre-wash	Buffer	was	added,	and	spun	for	1	minute	at	12000	rcf.	The	 874	
collection	tube	was	emptied	and	700µL	gDNA	Wash	Buffer	was	added	and	centrifuged	 875	
for	1	minute	at	12000	rcf.	The	collection	tube	was	again	emptied,	200µL	gDNA	Wash	 876	
Buffer	was	added,	and	the	column	was	spun	for	1	minute	at	12000	rcf.	The	collection	 877	
tube	was	then	treated	with	50µL	of	Elution	Buffer	in	a	new	collection	tube,	incubated	at	 878	
room	temperature	(20-25oC)	for	5	minutes,	and	finally	centrifuged	for	1	minute.	 879	
Genomic	DNA	of	our	samples	was	then	assessed	for	purity	using	a	nanodrop	and	sent	 880	
for	bisulfite	sequencing.	Whole	genome	Bisulfite	sequencing	was	performed	by	Zymo	 881	
Research.	Differentially	methylated	genes	were	sorted	by	p-value	and	data	was	 882	
complied	with	the	top	2000	genes.	Samples	from	0mg/L	and	2.5mg/L	F1	zebrafish	were	 883	
also	sent	for	hydroxymethylation	studies,	with	DNA	collected	as	previously	described.	A	 884	
complete	list	of	significantly	hydroxymethylated	genes	was	produced	based	on	 885	
significant	based	on	p-value.	 886	
	 887	
Statistical	analysis	 888	
All	statistical	analysis	was	conducted	using	GraphPad	Prism	7.0g	®	(GraphPad	 889	
Software,	Inc.,	La	Jolla,	CA).	Normality	of	groups	was	assessed	using	D’Agostino	and	 890	
Pearson	normality	test.		ECE	groups	used	in	CPP	were	analyzed	for	average	cocaine- 891	
induced	behavioral	changes	using	one-way	ANOVA.	Groups	were	compared	against	one	 892	
another	and	against	control	fish	using	Bonferroni’s	multiple	comparisons	test.	Kruskal- 893	
Wallis	test	was	used	to	analyze	experiments	in	which	the	assumptions	of	one-way	 894	
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ANOVA	could	not	be	met.	Groups	tested	included	longitudinally	raised	zebrafish	that	 895	
were	treated	with	previously	determined	concentrations	of	cocaine	that	include	0,	2.5,	 896	
5,	10,	and	20mg/L	[106,	116,	117,	141].	Individual	behavioral	experiments	were	 897	
analyzed	using	Repeated	Measures	ANOVA.	Baseline	one	1	(BL1)	was	excluded	from	this	 898	
analysis	due	to	a	novelty	effect.	Any	significant	results	were	followed	up	with	a	 899	
Bonferroni’s	correction.	Testing	to	compare	untreated	fish	against	all	treated	groups	 900	
from	the	F1	cohorts	were	transformed	using	the	log	transformation	to	account	for	 901	
deviations	from	normality.	Untreated	and	treated	fish	were	then	compared	using	Mann- 902	
Whitney	test	as	assumptions	of	the	student	t-test	could	not	be	met.	Due	to	the	large	 903	
group	variability,	we	analyzed	group	variances	using	the	Brown-Forsythe	test.		 904	
Expression	data	was	normalized	to	the	reference	gene	ef1a	[106,	116].	Cocaine	 905	
sensitivity	of	our	gene	selected	for	validation	was	done	by	comparing	all	ECE	groups	of	 906	
fish	left	untreated	to	all	ECE	groups	acutely	treated	using	student’s	t-test.		In	order	to	 907	
compare	expressional	changes,	one-way	ANOVA	was	used	to	determine	any	differences	 908	
among	ECE	groups.		Multiple	comparisons	were	done	using	Dunnett’s	multiple	 909	
comparisons	test	to	compare	all	groups	against	the	0	coc	group.	When	determining	 910	
difference	among	all	groups,	Tukey’s	multiple	comparisons	test	was	used.	In	order	to	 911	
determine	any	significant	affect	between	ECE	treatment	concentration	and	longitudinal	 912	
acute	cocaine	exposure	on	gene	expression	we	used	a	two-way	ANOVA.	Multiple	 913	
comparisons	were	done	using	Dunnett’s	multiple	comparisons	test	to	compare	all	 914	
groups	against	untreated,	0	mg/mL	ECE	controls. 915	
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	 916	
	 917	
RESULTS	 918	
	 919	
	 920	
CPP	Results	in	the	Parent	Generation	 921	
Parental	generation	fish	that	were	treated	embryonically	with	the	five	ECE	 922	
dosages	were	raised	and	tested	with	CPP	to	determine	any	differential	behaviors	 923	
attributed	to	early	drug	exposure	(Figure	4).	We	hypothesized	that	ECE	would	generate	 924	
increased	sensitivity	to	acute	cocaine	exposure	in	the	adult	zebrafish.	Previous	studies	 925	
indicated	zebrafish	responded	in	a	dose-dependent	manner	with	maximal	behavioral	 926	
responses	occurring	at	10	mg/mL	[116,	141].	Given	this	bell-shaped	curve,	we	wanted	to	 927	
test	our	hypothesis	and,	therefore,	conducted	our	behavioral	assays	with	a	submaximal	 928	
dose	of	5	mg/mL.	The	column	represented	by	Unt	CPP	included	fish	from	all	ECE	groups	 929	
that	were	untreated	during	CPP	testing.	These	fish	showed	no	significant	differences	in	 930	
conditioned	preference	when	tested	without	cocaine	(p<0.35,	F=1.24,	df=24).	There	was	 931	
significant	CPP	behavior	when	comparing	treated	fish	from	each	ECE	treatment	group	 932	
against	untreated	fish	(for	0	mg/L	p<0.02;	for	2.5	mg/L	p<0.03;	for	5	mg/L	p<0.01;	for	10	 933	
mg/L	p<0.001).	The	ECE	treatment	group	exposed	at	the	highest	concentration	of	20	 934	
mg/L	did	not	display	significant	CPP	behavior.	Our	results	shown	in	Figure	4,	 935	
demonstrated	a	bell-shaped	curve	indicating	maximal	response	in	ECE	treatment	groups	 936	
exposed	at	10	mg/L.	CPP	values	recorded	for	the	10	mg/L	ECE	fish	were	also	significantly	 937	
higher	than	fish	exposed	at	the	highest	concentration	during	their	development,	20	 938	
mg/L	(p<0.02).		 939	
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	 940	
CPP	Data	in	Parent	Zebrafish	Cohorts	 941	
Figure	4:	Cocaine	induced	conditioned	place	preference	change	in	embryonically	treated	 942	
adult	zebrafish.	Error	bars	represent	±95%,	*	indicates	p<	0.05,	**	indicates	p<	0.01,	***	 943	
indicates	p<	0.001	when	comparing	against	untreated	fish	from	all	ECE	groups	using	 944	
Dunnett’s	multiple	comparisons	test	[106].	 945	
	 946	
	 947	
Illumina	Sequencing	of	F0	Zebrafish	Cohorts		 948	
Groups	of	zebrafish	with	ECE	were	used	for	Hi-Seq	transcriptome	analysis.	This	 949	
was	conducted	to	develop	a	profile	of	gene	expression	changes	induced	by	acute	 950	
cocaine	exposure	and	to	analyze	how	these	changes	were	influenced	by	ECE.	RNA-Seq	 951	
analysis	was	conducted	by	the	University	of	North	Dakota	Epigenetic	Core	Facility.		Adult	 952	
F0	fish	from	each	embryonic	treatment	concentration	(0,	2.5	5,	10,	and	20	mg/mL)	were	 953	
assigned	to	two	groups	for	analysis.	One	group	was	left	untreated.	Another	group	was	 954	
treated	acutely	with	5	mg/mL	cocaine	for	one	hour	in	a	mock-CPP	experiment.	Fish	from	 955	
the	four	ECE	groups	that	were	left	untreated	were	combined	and	compared	to	the	four	 956	
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ECE	groups	of	the	mock	CPP	exposed	fish.		Each	of	the	four	ECE	groups	was	replicated	 957	
three	times	allowing	comparison	to	be	made	between	12	groups.	These	comparisons	 958	
were	conducted	to	give	a	list	of	CS	genes	with	highly	significant	p-values.	Following	this	 959	
comparison,	we	returned	to	the	untreated	and	mock-CPP	exposed	experiments	for	 960	
comparison	of	each	ECE	group	separately.	This	was	done	to	interpret	any	effect	that	ECE	 961	
had	on	CS	gene	expression	in	response	to	acute	cocaine	exposure	later	in	life.	Analysis	 962	
of	untreated	and	mock-CPP	exposed	fish	gave	a	list	of	thousands	of	genes	thought	to	be	 963	
cocaine	sensitive.	In	the	top	150	genes,	as	determined	by	adjusted	significant	p-values,	 964	
more	than	half	of	these	CS	genes	showed	cocaine-induced	expression	changes	that	was	 965	
affected	by	ECE.	When	comparing	the	mock-CPP	treated	and	untreated	groups	of	ECE	 966	
fish,	a	log	change	in	expression	was	observed.	The	changes	in	the	expression	of	our	CS	 967	
genes	revealed	that	there	was	a	bell-shaped	curve	in	their	expression	that	reflected	the	 968	
pattern	seen	in	behavioral	work,	in	that,	expression	was	highest	in	the	groups	exposed	 969	
embryonically	to	10	mg/mL	in	both	untreated	and	acutely	treated	adults.	This	 970	
expression	tapered	off	at	the	maximal	ECE	concentration.	The	top	150	CS	genes	that	 971	
displayed	this	pattern	of	dose-dependent	increased	expression	were	entered	into	 972	
STRING	database	to	determine	possible	interactions	among	our	genes	[143].	The	results	 973	
of	our	STRING	diagram	analysis	using	these	genes	indicated	clustering	of	genes,	some	of	 974	
which	have	been	implicated	in	addiction	related	research	[30,	48].	The	STRING-diagram	 975	
of	clustered	genes	is	shown	with	critical	hubs	circled	(Figure	5).	Several	genes	within	 976	
these	hubs	were	subsequently	analyzed	for	their	expression	using	qRT-PCR,	including	 977	
bdnf,	∆fosb,	inhbab,	ddx5,	eif4a1a,	nr4a3,	odc1,	arf5,	arg2,	per2,	and	mgarp.	We	also	 978	
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highlighted	nrxn3a	even	though	we	did	not	try	to	validate	it,	because	this	gene	was	also	 979	
significantly	hypermethylated	and	hydroxymethylated	in	the	F1	generation.		 980	
	 981	
STRING	Diagram	of	CS	Genes	 982	
Figure	5:	Example	of	STRING	database	image.	Shown	above	are	the	top	150	most	 983	
significantly	affected	genes	according	to	HI-Seq.	Circles	indicate	unique	clusters	of	genes	 984	
of	which	we	selected	CS	genes	for	validation	using	qRT-PCR.		 985	
	 986	
	 987	
	 988	
Verification	of	CS	Sensitive	Clusters	 989	
The	STRING	database	diagram	shown	in	Figure	5	depicts	the	clustering	of	genes.	 990	
Based	on	these	clusters,	genes	thought	to	play	central	roles	among	the	hubs	were	 991	
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selected	for	validation.	These	included	bdnf,	∆fosb,	inhbab,	ddx5,	eif4a1a,	nr4a3,	odc1,	 992	
arf5,	arg2,	per2,	and	mgarp.	Quantitative	PCR	was	used	to	quantify	the	expression	in	 993	
untreated	fish	from	all	ECE	groups	and	compare	it	against	acutely	treated	fish	from	each	 994	
ECE	groups	for	each	gene	to	validate	results	of	Hi-Seq	analysis.	Grouping	fish	left	 995	
untreated	and	those	treated	from	each	ECE	group	did	not	lead	to	any	clear	indication	of	 996	
cocaine	sensitivity	among	these	genes.	To	determine	any	interaction	between	acute	 997	
cocaine	exposure	in	adult	zebrafish	with	ECE	and	the	untreated	groups	with	ECE	and	its	 998	
effect	on	gene	expression,	two-way	ANOVA	was	conducted.	According	to	two-way	 999	
ANOVA,	there	was	not	a	significant	interaction	between	ECE	treatment	and	acute	 1000	
cocaine	exposure	on	gene	expression	in	any	of	our	selected	genes.	Due	to	the	lack	of	 1001	
interaction	found	from	the	two-way	ANOVA,	effects	on	gene	expression	as	the	result	of	 1002	
ECE	and	acute	cocaine	exposure	in	the	adult	was	analyzed	using	one-way	ANOVA.	This	 1003	
result	would	identify	any	effect	on	gene	expression	that	was	the	direct	result	of	ECE.	All	 1004	
other	genes	were	then	normalized	to	ef1a	as	it	has	been	demonstrated	as	a	robust	 1005	
housekeeping	gene	in	previous	work	[116].		One-way	ANOVA	reported	no	difference	in	 1006	
gene	expression	of	ef1a	in	either	the	treated	or	untreated	groups.	Early	cocaine	 1007	
exposure	had	no	significant	effect	on	the	expression	of	bdnf,	odc1,	fosb,	ddx5,	nr4a3,	 1008	
arf5,	arg2,	eif4a1a,	and	per2	according	to	one-way	ANOVA.	Significant	variation	was	 1009	
observed	in	several	genes.	There	were	significant	differences	among	the	variances	in	 1010	
bdnf,	ddx5,	and	nr4a3	(p<0.038,	F4,21=3.081;	p<	0.001,	F4,21=6.992;	p<	0.012,	F4,21=4.222,	 1011	
respectively).	One-way	ANOVA	did	indicate	some	significant	expression	differences	 1012	
between	groups	with	ECE	based	on	acute	treatment,	indicating	an	effect	caused	by	ECE	 1013	
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in	subsequent	exposure	to	cocaine.	The	gene	expression	of	inhibin	a	beta	(inhbab)	was	 1014	
significantly	modified	by	drug	treatment	(p<0.014,	F4,21=3.979).	The	Brown-Forsythe	test	 1015	
indicated	that	there	was	significant	variance	among	the	groups	(p<	0.0001,	F4,21=	90.27).		 1016	
Dunnett’s	multiple	comparisons	indicated	the	treated	2.5	mg/L	ECE	group	was	 1017	
significantly	elevated	when	compared	to	treated	fish	from	the	0	mg/mL	ECE	cohort	 1018	
(Figure	6,	p<	0.05,	df=18).	The	student’s	t-test	did	not	indicate	any	significant	difference	 1019	
when	comparing	treated	and	untreated	fish	within	an	ECE	treatment	group.	The	 1020	
mitochondria-localized	glutamic	acid-rich	proteins	(mgarp)	was	also	significantly	 1021	
different	among	untreated	and	treated	ECE	groups	(p<0.028,	F4,21,	=3.367)	with	 1022	
significant	variance	found	among	these	groups	(p<0.0001,	F4,21=	34.37).	Dunnett’s	 1023	
multiple	comparisons	test	indicated	significantly	increased	expression	in	the	treated	2.5	 1024	
mg/L	group	when	compared	to	treated	zebrafish	with	0	mg/mL	ECE	(Figure	7,	p<	0.021,	 1025	
df=18).	The	student’s	t-test	did	not	indicate	any	significant	difference	when	comparing	 1026	
treated	and	untreated	groups	within	an	ECE	group.	 1027	
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	 1028	
Adult	Zebrafish	Expression	of	inhibin	A	beta	 1029	
Figure	6:	Expression	changes	of	inhbab	comparing	untreated	adult	zebrafish	with	 1030	
treated	ECE	groups.	Error	bars	represent	±95%	CI,	inhbab		has	been	normalized	to	ef1a,	 1031	
*	indicates	p<	0.05	when	compared	against	untreated	controls	using	Dunnett’s	multiple	 1032	
comparisons	test.	(+)	indicates	zebrafish	treated	acutely	with	cocaine	in	adulthood.	(-)	 1033	
indicates	untreated	zebrafish	with	ECE.	The	agTrans	on	the	y-axis	represents	attograms	 1034	
of	transcript.		 1035	
	 1036	
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	 1037	
Adult	Zebrafish	Expression	of	mitochondrial	glutamic	acid	rich	protein		 1038	
Figure	7:	Expression	changes	of	mgarp	comparing	untreated	adult	zebrafish	with	treated	 1039	
ECE	groups.	Error	bars	represent	±95%	CI,	mgarp		has	been	normalized	to	ef1a,	*	 1040	
indicates	p<	0.05	when	compared	against	untreated	controls	using	Dunnett’s	multiple	 1041	
comparisons	test.	(+)	indicates	zebrafish	treated	acutely	with	cocaine	in	adulthood.	(-)	 1042	
indicates	untreated	zebrafish	with	ECE.	The	agTrans	on	the	y-axis	represents	attograms	 1043	
of	transcript.	 1044	
		 	 1045	
Quantification	of	gene	expression	was	analyzed	in	larval	zebrafish	in	order	to	 1046	
demonstrate	any	expressional	changes	attributed	to	ECE.	Again,	expression	data	was	 1047	
normalized	to	the	housekeeping	gene	ef1a,	which	was	shown	to	be	unaffected	by	ECE	 1048	
(p<	0.74,	F4,40=	0.4989).	The	expression	of	bdnf	was	significantly	affected	according	to	 1049	
one-way	ANOVA	by	ECE	(p<	0.05,	F3,32=	3.846).	Dunnett’s	multiple	comparisons	 1050	
indicated	a	significant	elevation	in	the	expression	of	the	bdnf	gene	as	the	ECE	 1051	
concentration	increased	from	the	untreated	to	2.5mg/L	group	(Figure	8;	p<	0.05,	df=	 1052	
32).	There	was	no	significant	difference	amongst	other	treatment	groups	when	 1053	
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compared	to	untreated	larvae.	Delta	fosB	was	found	significantly	different	among	the	 1054	
ECE	treatment	groups	(p<	0.01,	F3,32=	6.06).	When	multiple	groups	were	compared	using	 1055	
Dunnett’s	test,	the	10	mg/mL	treated	larva	displayed	significantly	decreased	gene	 1056	
expression	when	compared	against	the	0	mg/mL	group	(Figure	9;	p<	0.05,	df=32).	 1057	
Expression	of	∆fosB	was	significantly	decreased	in	the	20	mg/mL	treated	larval	zebrafish	 1058	
(p<0.05,	df=32).	Odc1	was	not	significantly	altered	due	to	ECE	treatment	(p<0.169).	One- 1059	
way	ANOVA	indicated	significant	difference	in	expression	in	nr4a3	due	to	ECE	(Figure	10,	 1060	
p<0.05,	F3,32=4.443).	Dunnett’s	multiple	comparisons	test	reported	decreased	 1061	
expression	in	all	groups	when	compared	against	the	control	(p<0.05	for	all	ECE	groups	 1062	
compared	to	0mg/mL,	DF=32).	One-way	ANOVA	indicated	significant	eif4a1a	expression	 1063	
changes	attributed	to	ECE	(Figure	11,	p<	0.001,	F3,32=8.272).	Dunnett’s	multiple	 1064	
comparisons	indicated	all	groups	experienced	a	decrease	in	eif4a1a	expression	(Figure	 1065	
11;	p<0.01	for	2.5mg/L,	p<0.001	for	10mg/L,	and	p<	0.001	for	20mg/L).	Tukey’s’	multiple	 1066	
comparison	revealed	there	were	no	significant	differences	in	eif4a1a	when	comparing	 1067	
the	treated	groups	amongst	each	other.	The	gene	expression	of	ddx5	was	significantly	 1068	
modified	by	ECE	when	tested	using	one-way	ANOVA	(p<	0.05,	F3,32=3.255).	Dunnett’s	 1069	
multiple	comparisons	testing	indicated	2.5	mg/mL	treated	larval	zebrafish	showed	a	 1070	
significant	decrease	in	expression	when	compared	against	untreated	controls	(Figure	12,	 1071	
p<0.05,	DF=32).	The	arf5	gene	was	differentially	expressed	due	to	ECE	(p<0.05,	 1072	
F3,32=3.986).	For	arf5,	according	to	Dunnett’s	multiple	comparisons,	there	was	 1073	
significant	differences	among	all	treated	groups	compared	to	controls	(Figure	13,	p<0.05	 1074	
for	all	ECE	groups	compared	to	0mg/mL,	DF=32).	Tukey’s	multiple	comparisons	test	 1075	
	 	 	
	
	 52	
identified	no	significant	differences	when	comparing	treated	groups.	The	gene	mgarp	 1076	
also	exhibited	differential	expression	due	to	ECE	in	larval	zebrafish	(p<	0.05,	F3,32=3.209).	 1077	
Dunnett’s	test	indicated	increased	cocaine	concentration	during	embryonic	 1078	
development	significantly	lessened	mgarp	expression	when	compared	against	controls	 1079	
(Figure	14;	p<0.05	for	2.5	mg/L,	p<0.05	for	10	mg/L;	DF=32).	The	gene	inhbab	showed	a	 1080	
general	trend	of	decreased	gene	expression,	but	one-way	ANOVA	revealed	no	 1081	
significant	difference	among	groups	(p=	0.069,	F4,40=2.364).	Additionally,	there	was	no	 1082	
affect	detected	in	the	expression	of	per2	and	arg2	among	the	ECE	treated	groups.	 1083	
	 1084	
Larval	Zebrafish	Expression	of	brain-derived	neurotrophic	factor		 1085	
Figure	8:	Expression	changes	of	the	bdnf	gene	was	seen	in	embryos	treated	with	 1086	
cocaine.	Error	bars	represent	±	95%	CI,	bdnf	has	been	normalized	to	ef1a,	*	indicates	p	<	 1087	
0.05	when	compared	to	the	untreated	control	group	using	Dunnett’s	multiple	 1088	
comparison	test.	The	agTrans	on	the	y-axis	represents	attograms	of	transcript.	 1089	
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	 1090	
Larval	Zebrafish	Expression	of	FBJ	murine	osteosarcoma	factor	B	 1091	
Figure	9:	Expression	changes	of	the	fosb	gene	seen	in	embryos	treated	with	cocaine.	 1092	
Error	bars	represent	±95%	CI,	fosb	has	been	normalized	to	ef1a,	*	indicates	p<	0.05	 1093	
when	compared	against	all	group	means	using	Dunnett’s	multiple	comparisons	test.	The	 1094	
agTrans	on	the	y-axis	represents	attograms	of	transcript.	 1095	
	 1096	
Larval	Zebrafish	Expression	of	nuclear	receptor	protein	subfamily	4		group	A	member	3	 1097	
Figure	10:	Expression	changes	of	the	nr4a3	gene	seen	in	embryos	treated	with	cocaine.	 1098	
nr4a3	has	been	normalized	to	ef1a.	Error	bars	represent	±95%	CI,		*	indicates	p<	 1099	
0.05when	comparing	against	untreated	ECE	larva	using	Dunnett’s	multiple	comparisons	 1100	
test.	 1101	
	 	 	
	
	 54	
	 1102	
Larval	Zebrafish	Expression	of	eukaryotic	translation	initiation	factor	4A1A	 1103	
Figure	11:	Expression	changes	of	the	eif4a1a	gene	seen	in	embryos	treated	with	 1104	
cocaine.	eif4a1a	has	been	normalized	to	ef1a.	Error	bars	represent	±95%	CI,		*	indicates	 1105	
p<	0.05,	**	indicates	p<	0.01,	***	indicates	p<	0.001	when	comparing	against	untreated	 1106	
larval	using	Dunnett’s	multiple	comparisons	test.	The	agTrans	on	the	y-axis	represents	 1107	
attograms	of	transcript.	 1108	
	 1109	
Larval	Zebrafish	Expression	of	DEAD	box	helicase	5	 1110	
Figure	12:	Expression	changes	of	the	ddx5	gene	was	seen	in	embryos	treated	with	 1111	
cocaine.	Error	bars	represent	±	95%	CI,	ddx5	has	been	normalized	to	ef1a,	*	 1112	
indicates	p	<	0.05	and	**	indicates	p<	0.01	when	compared	to	the	untreated	control	 1113	
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group	using	Dunnett’s	multiple	comparison	test.	The	agTrans	on	the	y-axis	represents	 1114	
attograms	of	transcript.	 1115	
	 1116	
Larval	Zebrafish	Expression	of	ADP-ribosylation	factor	4	 1117	
Figure	13:	Expression	changes	of	the	arf5	gene	seen	in	embryos	treated	with	cocaine.	 1118	
Error	bars	represent	±95%	CI,	arf5		has	been	normalized	to	ef1a,	*	indicates	p<	0.05	 1119	
when	compared	against	all	group	means	using	Dunnett’s	multiple	comparisons	test.	The	 1120	
agTrans	on	the	y-axis	represents	attograms	of	transcript.	 1121	
	 1122	
Larval	Zebrafish	Expression	of	mitochondrial	glutamic	acid	rich	protein	 1123	
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Figure	14:	Expression	changes	of	the	mgarp	gene	seen	in	embryos	treated	with	cocaine.	 1124	
Error	bars	represent	±95%	CI,	mgarp		has	been	normalized	to	ef1a,	*	indicates	p<	0.05	 1125	
when	compared	against	untreated	controls	using	Dunnett’s	multiple	comparisons	test.	 1126	
The	agTrans	on	the	y-axis	represents	attograms	of	transcript.	 1127	
	 1128	
	 1129	
F1	Generation	CPP	Assay	Result	 1130	
	 The	parent	generation	fish	exposed	embryonically	to	cocaine	(0,	2.5,	10,	and	20	 1131	
mg/mL)	were	crossed	to	produce	the	F1	generation	of	fish.	The	F1	generation	was	raised	 1132	
to	determine	any	persisting	behavioral	effects	that	ECE	may	have	on	their	offspring.	 1133	
Repeated	measures	ANOVA	was	conducted	within	individual	CPP	experiments	to	 1134	
determine	any	differential	CPP	behavior	that	may	be	occurring	between	individual	 1135	
baseline	measurements.	In	addition	to	acutely	exposing	our	ECE	cohorts	to	varying	 1136	
concentrations	of	cocaine,	we	also	tested	with	three	concentrations	of	lidocaine	(2.5,	5,	 1137	
and	10	mg/mL)	to	serve	as	an	additional	control.	Lidocaine	has	an	anesthetic	property	 1138	
similar	to	cocaine,	but	does	not	affect	monoamine	transport	or	reward	and	has	been	 1139	
demonstrated	to	work	on	voltage-gated	Na+	channels	in	a	similar	manner	[144,	145].	 1140	
Lidocaine	treatment	did	not	generate	differential	CPP	within	any	ECE	group	according	to	 1141	
repeated-measures	ANOVA.	ECE	appeared	to	affect	how	F1	zebrafish	responded	to	the	 1142	
testing	apparatus	as	untreated	fish	gave	generally	higher	CPP-responses.	Repeated	 1143	
measures	ANOVA	indicated	no	significant	differences	among	baseline	recordings	in	any	 1144	
F1	zebrafish	in	experiments	testing	with	1	mg/mL.	F1	zebrafish	showed	different	 1145	
conditioning	responses	in	our	behavioral	assay	based	on	cocaine	treatment.	Repeated	 1146	
measures	ANOVA	indicated	the	conditioning	potential	in	the	F1	zebrafish	in	our	 1147	
experiment	was	dependent	on	the	ECE	of	the	parent	generation.		 1148	
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F1	groups	were	acutely	tested	at	different	concentrations	of	cocaine	including	1	 1149	
mg/L,	2.5	mg/L,	5	mg/L	and	10	mg/L.	Comparisons	were	made	to	determine	any	 1150	
differences	that	treatment	had	on	F1	fish	when	compared	to	untreated	controls.	 1151	
Lidocaine	did	not	induce	CPP	at	any	dose	used	and	the	CPP	response	was	not	 1152	
significantly	different	when	compared	to	one	another.	Lidocaine	treated	groups	were	 1153	
then	pooled	for	sake	of	comparison	in	Figure	15.	One-way	ANOVA	was	conducted	 1154	
comparing	all	untreated	fish	from	each	ECE	group	and	indicated	there	was	not	a	 1155	
significant	difference	in	CPP	behavior	(p=0.98).	Because	of	this,	fish	from	all	cohorts	of	 1156	
ECE	treatment	were	combined.	Comparisons	were	then	made	comparing	pooled	groups	 1157	
of	all	fish.	Pooling	of	F1	fish	from	each	ECE	group	that	were	acutely	treated,	left	 1158	
untreated,	and	exposed	to	lidocaine	were	compared	with	one-way	ANOVA	and	 1159	
demonstrated	significant	different	CPP	behavior	(p<0.01,	F2,304=6.107,	data	not	shown).	 1160	
Tukey’s	post	hoc	experiment	indicated	no	significant	difference	among	untreated	and	 1161	
treated	fish	(p=0.17).	CPP	behavior	was	significantly	higher	in	treated	fish	when	 1162	
compared	to	fish	exposed	to	acute	lidocaine	treatment	(p<0.01,	DF=304).			 1163	
Analysis	of	longitudinal	behavior	in	the	F1	generation	based	on	ECE	 1164	
concentration	revealed	altered	responsiveness	based	on	acute	cocaine	treatment	 1165	
concentration	(Figure	15).		Results	showed	that	only	the	0	ECE	group	displayed	 1166	
significant	CPP	in	the	F1	(p<0.001,	F5,67=4.787).	According	to	Tukey’s	multiple	 1167	
comparisons	testing,	0	F1	fish	responded	significantly	higher	to	2.5	mg/mL	cocaine	when	 1168	
compared	against	our	lowest	treatment	concentration	([1	mg/mL],	p<0.05,	DF=67).	CPP	 1169	
data	from	the	2.5	F1	cohort	appeared	to	be	unaffected	by	acute	cocaine	concentration,	 1170	
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as	there	were	no	significant	behavioral	differences	observed	(p=0.41).	The	10	ECE	F1	 1171	
group	did	not	display	differential	behavioral	preference	resulting	from	acute	cocaine	 1172	
exposure	(p=0.06).	Graphic	representation	of	CPP	experiments	conducted	in	the	10	F1	 1173	
group	suggested	heightened	CPP	behavior	in	a	dose-dependent	manner	with	maximal	 1174	
responses	occurring	at	2.5	mg/mL,	though	not	significantly	different.	The	20	F1	cohort	 1175	
did	not	present	with	differential	CPP	behavior	based	on	acute	cocaine	treatment	 1176	
(p=0.54).	The	results	of	CPP	testing	in	the	F1	groups	of	zebrafish	indicate	a	cocaine	 1177	
insensitivity.	 1178	
	 1179	
CPP	Assay	Data	in	F1	Cohorts	of	Zebrafish	 1180	
Figure	15:	Cocaine	induced	conditioned	place	preference	change	in	F1	generation	ECE	 1181	
zebrafish.	Data	has	been	pooled	from	zebrafish	from	each	ECE	treatment	and	compared	 1182	
based	on	acute	cocaine	treatment.	Error	bars	represent	±95%.	 1183	
	 1184	
	 1185	
	 1186	
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Analysis	of	5-mC	and	5-HmC	Attachment	Across	the	Genome	 1187	
For	this	experiment,	F1	generation	fish	were	culled	and	gDNA	was	produced	for	 1188	
bisulfite	sequencing.	Methylation	and	hydroxymethylation	data	were	collected	and	 1189	
analyzed	to	determine	if	CS	gene	expression	was	modified	by	changes	in	the	DNA	 1190	
epigenetic	state	to	explain	our	decreased	sensitivity	in	the	F1	generation.	Whole	 1191	
genomic	methylation	patterns	of	hyper-	and	hypomethylation	were	observed	across	all	 1192	
25	zebrafish	chromosomes	at	increasing	concentration	of	ECE	cocaine	exposure	(2.5,	10,	 1193	
20	mg/L)	and	compared	against	an	untreated	cohort.	Differences	seen	among	whole	 1194	
genome	methylation	patterns	were	analyzed	by	comparing	individual	genomic	 1195	
sequences	across	the	various	doses	and	by	methylation	status,	either	hyper-	or	 1196	
hypomethylated.	One-way	ANOVA	indicated	that	both	significant	hypermethylation	and	 1197	
hypomethylation	occurred	on	all	zebrafish	chromosomes.	Overall,	therefore,	global	DNA	 1198	
methylation	is	shown	to	be	unaffected	by	ECE.	An	example	can	be	seen	on	chromosome	 1199	
3	in	Figure	16.	Hypermethylation	was	significantly	affected	on	chromosome	3	(p=0.006,	 1200	
F2,210=5.252).	Multiple	comparisons	test	with	Bonferroni’s	correction	indicated	a	 1201	
significant	decrease	in	hypermethylation	between	2.5	mg/L	and	the	20	mg/L	cohorts	 1202	
(p=0.006,	df=210,	mean	diff.=	-0.04).	Chromosome	3	also	displayed	differences	in	its	 1203	
hypomethylation	comparing	increased	cocaine	exposure	against	0	mg/L	longitudinal	fish	 1204	
(p<	0.0001,	F2,269=47.18).	Hypomethylation	was	increased	in	both	the	10	(mean	 1205	
diff.=0.08)	and	the	20	mg/L	(mean	diff.=0.10)	F1	groups	when	compared	to	the	lowest	 1206	
dose,	2.5	mg/L	(Figure	16,	p<0.0001,	df=269	for	both	comparisons).	Global	 1207	
hydroxymethylation	was	also	unaffected	by	ECE	in	the	F1	generation.		 1208	
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Differential	methylation	patterns	were	observed	among	numerous	genes	when	 1209	
comparisons	were	made	between	ECE	treatment	and	untreated	groups	(0	vs	2.5,	0	vs	 1210	
10,	0	vs	20).	Venn	diagrams	were	constructed	to	determine	overlap	among	the	top	2000	 1211	
genes	that	were	significantly	hypermethylated	in	each	of	the	three	comparisons.	As	 1212	
shown	in	Figure	17,	there	was	minimal	(<5%)	overlap	between	the	890	genes	that	were	 1213	
shown	to	be	significantly	hypermethylated	as	the	result	of	increasing	ECE	in	F1	zebrafish.	 1214	
Similarly,	a	Venn	diagram	was	constructed	comparing	hypomethylation	of	the	979	genes	 1215	
among	the	F1	generation	of	ECE	fish	revealing	ECE	produced	patterns	of	 1216	
hypomethylation	that	were	relatively	unique	to	each	F1	ECE	group	including	little	 1217	
overlap	between	the	three	ECE	groups	(<5%).	Figure	18	shows	the	hypomethylation	of	 1218	
the	979	genes	as	ECE	concentration	increased	in	F1	groups.	The	addition	of	data	to	these	 1219	
Venn	diagrams	was	done	to	determine	any	interaction	between	the	methylation	and	 1220	
hydroxymethylation	status.	Grouping	of	the	890	genes	thought	to	be	differentially	 1221	
hypermethylated	with	the	17,743	genes	affected	by	hydroxymethylation	revealed	very	 1222	
little	overlap	between	modified	genes.	The	results	of	this	comparison	indicated	39	genes	 1223	
(0.2%)	were	found	in	samples	with	differential	hypermethylation	and	 1224	
hydroxymethylation	(Figure	19).	The	grouping	of	the	979	differentially	hypomethylated	 1225	
genes	as	the	result	of	F1	ECE	and	genes	thought	to	be	hydroxymethylated	in	2.5	mg/mL	 1226	
F1	zebrafish	revealed	there	was	also	minimal	overlap	(Figure	20).	Globally,	then	it	 1227	
appears,	unique	genes	are	affected	by	ECE	primarily	in	the	F1	generation.	Venn	diagrams	 1228	
with	the	inclusion	of	our	top	150	CS	genes	generated	little	overlap	as	well.	Comparisons	 1229	
of	CS	genes	with	the	three	comparison	groups	of	F1	ECE	hypomethylated	genes	revealed	 1230	
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there	was	no	gene	overlap.	The	analysis	of	CS	genes	compared	to	genes	 1231	
hypermethylated	in	the	three	comparison	groups	revealed	a	single	gene,	neurexin	3a,	 1232	
was	found	in	all	four	(Figure	21).	The	list	of	CS	genes	was	then	assessed	for	overlap	 1233	
within	genes	thought	to	be	hydroxymethylated	in	2.5	F1	zebrafish.	Here,	128	of	the	top	 1234	
150	CS	genes	were	shown	to	overlap	within	the	5-HmC	gene	list	(data	not	shown).	 1235	
Analysis	showed	there	was	differential	methylation	states	occurring	along	the	validated	 1236	
CS	genes.	Figure	22	appears	to	show	a	pattern	of	increased	hypermethylation	of	these	 1237	
genes	in	F1	of	the	2.5	ECE	group	while	the	F1	fish	with	higher	ECE	(10	and	20	mg/mL	 1238	
cocaine)	suggested	hypomethylation.	Hydroxymethylation	of	CS	genes	is	shown	in	 1239	
Figure	23.	The	CS	genes	displayed	general	decreases	in	5-HmC	attachment.		The	results	 1240	
of	our	methylation	and	hydroxymethylation	studies	indicate	little	global	effect	resulting	 1241	
from	ECE	in	the	F1	generation.	There	was	little	overlap	observed	between	genes	hyper-	 1242	
and	hypomethylated	when	compared	to	the	CS	genes	revealed	from	Hi-Seq	analysis.	 1243	
There	was	also	little	overlap	of	hydroxymethylated	genes	by	2.5	mg/mL	cocaine	in	the	F1	 1244	
group	when	compared	to	our	CS	genes	and	genes	hyper-	and	hypomethylated	in	F1	ECE	 1245	
groups.	These	experiments	revealed	nrxn3a	as	a	commonly	affected	gene	among	these	 1246	
studies.	 1247	
	 1248	
	 1249	
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	 1250	
Chromosomal	Methylation	of	Chromosome	3	 1251	
Figure	16:	Differences	seen	in	hypermethylation	and	hypomethylation	resulting	from	 1252	
treatment	with	increasing	cocaine	concentration.	Error	bars	represent	the	95%	 1253	
confidence	interval.	**	indicates	p<0.01	and	p<0.001	according	to	Tukey’s	multiple	 1254	
comparisons	tests.	Each	bar	seen	above	represents	difference	in	methylation	patterns	at	 1255	
that	acute	treatment	concentration	when	compared	to	untreated	samples.		 1256	
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	 1257	
Venn	Diagram	of	Hypermethylated	Gene	in	F1	Zebrafish	 1258	
Figure	17:	Venn	diagram	representing	hypermethylated	genes	based	on	ECE	treatment.	 1259	
0	vs	2.5	represents	380	genes	hypermethylated	when	comparing	the	2.5	F1	cohort	 1260	
against	the	0	F1	cohort.	0	vs	10	represents	356	gene	hypermethylated	when	comparing	 1261	
10	F1	cohort	against	the	0	F1	cohort.	0	vs	20	represents	415	genes	hypermethylated	 1262	
when	comparing	20	F1	cohort	against	the	0	F1	cohort.	 1263	
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	 1264	
Venn	Diagram	of	Hypomethylated	Gene	in	F1	Zebrafish	 1265	
Figure	18:	Venn	diagram	representing	hypomethylated	genes	based	on	ECE	treatment.	0	 1266	
vs	2.5	represents	392	genes	hypomethylated	when	comparing	the	2.5	F1	cohort	against	 1267	
the	0	F1	cohort.	0	vs	10	represents	414	genes	hypomethylated	when	comparing	10	F1	 1268	
cohort	against	the	0	F1	cohort.	0	vs	20	represents	431	genes	hypomethylated	when	 1269	
comparing	20	F1	cohort	against	the	0	F1	cohort.	 1270	
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	 1271	
Venn	Diagram	of	Hypermethylated	&	Hydroxymethylated	Genes	in	the	F1	Zebrafish		 1272	
Figure	19:	Venn	diagram	representing	hypermethylated	genes	based	on	ECE	treatment	 1273	
when	compared	with	17,743	hydroxymethylated	genes	in	the	F1.	0	vs	2.5	represents	380	 1274	
genes	hypermethylated	when	comparing	the	2.5	F1	cohort	against	the	0	F1	cohort.	0	vs	 1275	
10	represents	356	genes	hypermethylated	when	comparing	10	F1	cohort	against	the	0	F1	 1276	
cohort.	0	vs	20	represents	415	genes	hypermethylated	when	comparing	20	F1	cohort	 1277	
against	the	0	F1	cohort.	 1278	
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	 1279	
Venn	Diagram	of	Hypomethylated	&	Hydroxymethylated	Genes	in	the	F1	Zebrafish		 1280	
Figure	20:	Venn	diagram	representing	hypomethylated	genes	based	on	ECE	treatment	 1281	
compared	against	17,743	hydroxymethylated	genes	in	the	F1.	0	vs	2.5	represents	392	 1282	
genes	hypomethylated	when	comparing	the	2.5	F1	cohort	against	the	0	F1	cohort.	0	vs	 1283	
10	represents	414	genes	hypomethylated	when	comparing	10	F1	cohort	against	the	0	F1	 1284	
cohort.	0	vs	20	represents	431	genes	hypomethylated	when	comparing	20	F1	cohort	 1285	
against	the	0	F1	cohort.	 1286	
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	 1287	
Venn	Diagram	of	Hypermethylated	Genes	in	F1	Zebrafish	and	CS	Genes	 1288	
Figure	21:	Venn	diagram	comparing	150	CS	genes	with	genes	demonstrated	differential	 1289	
hypermethylated	in	the	F1	fish.	0	vs	2.5	represents	380	genes	hypermethylated	when	 1290	
comparing	the	2.5	F1	cohort	against	the	0	F1	cohort.	0	vs	10	represents	356	genes	 1291	
hypermethylated	when	comparing	10	F1	cohort	against	the	0	F1	cohort.	0	vs	20	 1292	
represents	415	genes	hypermethylated	when	comparing	20	F1	cohort	against	the	0	F1	 1293	
cohort.	Neurexin	3a	is	revealed	as	a	unique	overlap	among	the	four	comparisons.	 1294	
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	 1295	
Methylation	Ratio	Among	CS	Genes	 1296	
Figure	22:	Methylation	of	CS	genes.	The	data	was	reported	as	methyl	group	attachment	 1297	
to	total	methylation	site	of	a	chromosomal	segment	ratio.	The	y-axis	represents	the	 1298	
difference	in	methylation	ratio	between	each	ECE	concentration	and	untreated	fish.	 1299	
Listed	along	the	x-axis	is	the	gene	name	and	in	parentheses	are	the	read	numbers	found	 1300	
at	each	cocaine	concentration.	Bars	represent	the	difference	in	average	methyl	reads	 1301	
along	the	gene	segment.	 1302	
	 1303	
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	 1305	
5-HmC	Read	Numbers	on	CS	Genes		 1306	
Figure	23:	Hydroxymethylation	patterns	on	several	CS	genes.	The	y-axis	represents	net	 1307	
numbers	of	HmC	groups	found	at	read	sites	of	the	CS	genes.	Listed	along	the	x-axis	is	 1308	
the	gene	name	and	in	parentheses	are	the	read	numbers	found	in	zebrafish	from	the	2.5	 1309	
F1	ECE	when	compared	against	untreated	0	F1	zebrafish	 1310	
	 1311	
CPP	Assay	in	Cohorts	of	Zebrafish	Exposed	to	CA	 1312	
	 1313	
Testing	the	hypothesis	that	longitudinal	behavioral	changes	are	governed	by	 1314	
DNA	methylation,	we	generated	longitudinal	adult	zebrafish	treated	with	a	potent	DNA	 1315	
methyltransferase	inhibitor,	chlorogenic	acid	(CA).	Groups	included	an	untreated	 1316	
control,	1µM		dimethyl	sulfoxide	(DMSO,	as	the	vehicle	control),	10	µM	cocaine,	1µM	 1317	
DMSO+10	µM	cocaine,	1	µM	CA,		and	1	µM	CA+10	µM	cocaine.	Fish	were	raised	to	8	 1318	
months	and	tested	sing	the	CPP	assay.	Initial	behavioral	results	were	analyzed	across	all	 1319	
testing	days	using	repeated-measures	ANOVA.	It	was	observed	that	when	treated	as	 1320	
adults,	fish	exposed	embryonically	with	1	µM	CA+10	µM	cocaine	showed	significant	 1321	
changes	in	preference	in	CPP	testing	(Figure	24,	p<0.0081,	F	2.811,	22.49	=	5.183).	No	other	 1322	
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embryonic	treatment	conditions	led	to	significant	differences	in	baseline	 1323	
measurements.		 1324	
One-way	ANOVA	reported	differential	behavioral	outcomes	based	on	 1325	
chlorogenic	treatment	groups	(Figure	25,	p<0.005,	F6,172=3.183).	In	these	experiments,	 1326	
post-hoc	testing	using	Bonferroni’s	correction	indicated	a	significant	increase	the	CPP	 1327	
response	of	fish	treated	embryonically	with	1	µM	CA+10	µM	cocaine	when	compared	 1328	
against	fish	left	untreated	embryonically	(p=0.0033,	df=172,	mean	diff=-15.3%).	Fish	 1329	
treated	embryonically	with	1	µM	CA	displayed	significantly	less	CPP-like	behavior	when	 1330	
compared	to	the	1	µM	CA+10	µM	cocaine	treatment	group	(Figure	25,	p=0.032,	df=172,	 1331	
mean	diff=	-15.%).	Though	not	statistically	significant,	a	pattern	emerged	that	groups	 1332	
with	ECE	displayed	greater	changes	in	CPP	when	compared	to	fish	left	untreated,	 1333	
suggesting	cocaine	as	a	principle	factor	contributing	to	longitudinal	behavioral	 1334	
differences.		 1335	
Subsequent	to	behavioral	experimentation,	fish	were	analyzed	to	determine	any	 1336	
effect	that	embryonic	treatment	may	have	had	on	survival	(%),	weight	(g),	length	(mm)	 1337	
and	gender	ratio	(%).	Among	the	groups	survival	was	as	follows:		untreated	control	 1338	
41.2%,	1µM	DMSO	96.6%,	10	µM	cocaine	72.8%,	1µM	DMSO+10	µM	cocaine	52.5%	,	1	 1339	
µM	CA	85%	,	and	1	µM	CA+10	µM	cocaine	55%.	Among	these	treatment	groups,	one- 1340	
way	ANOVA	indicated	significant	differences	among	the	weights	within	each	treatment	 1341	
group	(Figure	26,	p<0.0001,	F5,130=23.57).	Follow	up	experiments	were	conducted	to	 1342	
determine	any	significant	differences	among	treatment	groups.	According	to	 1343	
Bonferroni’s	multiple	comparisons	test,	1µM	DMSO	had	a	significant	effect	on	weight	 1344	
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when	compared	against	untreated	controls	(p=0.025,	df=130,	mean	diff=0.100	g).	The	 1345	
cohort	treated	with	10	1µM	cocaine	lead	to	a	significant	decrease	in	weight	when	 1346	
compared	to	untreated	control	(p<0.0001,	df=130,	mean	diff=0.10	g).	This	trend	 1347	
continued	among	the	other	treatment	groups.	The	cohort	treated	with	1	µM	DMSO+10	 1348	
µM	cocaine	were	shown	to	have	a	significant	decrease	in	weight	against	untreated	 1349	
controls	(p<0.0001,	df=130,	mean	diff=	0.08	g).	Treatment	with	1	µM	CA	led	to	the	 1350	
largest	significant	decrease	in	weight	among	a	cohort	when	compared	against	untreated	 1351	
controls	(p<0.0001,	df=130,	mean	diff=0.126	g).	Lastly,	treatment	of	the	cohort	of	fish	 1352	
with	1	µM	CA+10	µM	cocaine	weighed	significant	less	when	compared	against	 1353	
untreated	controls	(p<0.0001,	df=130,	mean	diff=0.079	g).	Using	Bonferroni’s	correction	 1354	
to	compare	all	groups	against	one	another,	it	was	noted	that	differences	in	weight	did	 1355	
occur.	Fish	from	the	chlorogenic	acid	cohort	weighed	significantly	less	when	compared	 1356	
against	the	1µM	DMSO	cohort	(p<0.0001,	df=130,	mean	diff=	0.084	g).	Treatment	with	 1357	
1µM		DMSO+10µM	generated	a	cohort	that	was	significantly	heavier	than	those	of	the	 1358	
cohort	treated	with	1µM	CA	(p<0.001,	df=130,	mean	diff=0.045	g).	Treatment	of	a	 1359	
cohort	of	fish	with	1	µM	CA+10	µM	cocaine	lead	to	significant	weight	gain	when	 1360	
compared	against	fish	treated	with	1	µM	CA	alone	(p<0.0007,	df=130,	mean	diff=-0.047	 1361	
g).	Length	of	zebrafish	was	also	significantly	differentiated	among	the	treated	groups	 1362	
with	the	chlorogenic	acid	experiment	according	to	one-way	ANOVA	(Figure	27,	 1363	
p<0.0001,	F5,130=10.08).	Treatment	with	1µM	DMSO	had	no	significant	effect	on	length	 1364	
of	zebrafish	when	compared	against	the	untreated	cohort	(p>0.999).	The	fish	treated	 1365	
embryonically	with	10	µM	cocaine	were	significantly	shorter	when	compared	to	 1366	
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untreated	controls	(p<0.0006,	df=130,	mean	diff=2.77	mm).	Untreated	controls	 1367	
displayed	significantly	greater	lengths	when	compared	against	1µM	DMSO+10µM	 1368	
cocaine	(p<0.029,	df=130,	mean	diff=2.16	mm).	The	cohort	treated	with	1	µM	CA	was	 1369	
significantly	shorter	in	overall	length	when	compared	against	untreated	control	 1370	
zebrafish	(p<0.0001,	df=130,	mean	diff=4.06	mm).	The	difference	in	length	was	 1371	
attenuated	when	a	cohort	was	treated	embryonically	with	1	µM	CA+10	µM	cocaine	 1372	
(p<0.014,	df=130,	mean	diff=2.30	mm).	The	cohort	treated	with	1	µM	CA	was	 1373	
significantly	shorter	when	compared	with	fish	treated	embryonically	with	1µM	DMSO	 1374	
(p<0.0001,	df=130,	mean	diff=	2.74	mm).	Comparisons	of	1	µM	DMSO+10	µM	cocaine	 1375	
against	the	cohort	treated	with	1	µM	CA	indicated	a	significant	decrease	in	overall	 1376	
length	(p<0.012,	df=130,	mean	diff=	1.88	mm).	The	comparison	of	cohorts	treated	with	 1377	
1	µM	CA	and	1	µM	CA+10µM	cocaine	suggested	that	the	addition	of	10	µM	cocaine	 1378	
attenuated	the	decrease	in	length	seen	in	the	1	µM	CA	group	(p<0.024,	df=130,	mean	 1379	
diff=-1.75	mm).		 1380	
It	is	important	to	consider	the	effect	that	population	density	may	have	had	on	 1381	
these	recordings.	Due	to	the	differential	survival	of	the	untreated	cohort,	populations	of	 1382	
fish	in	the	untreated	housing	tank	were	low.	This	would	coincidently	allow	for	greater	 1383	
growth	among	these	fish.	In	order	for	validity	of	these	experiments	to	be	considered,	 1384	
the	experimental	measures	would	need	to	be	repeated.	 1385	
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	 1386	
Repeated	Measures	ANOVA	in	Zebrafish	Exposed	to	1	µM	CA+10	µM	coc	 1387	
Figure	24:	Preference	of	zebrafish	according	to	conditioned	chamber.	Initial	drug	 1388	
administration	begins	following	BL3	and	is	repeated	following	CPP1.	CPP2	shows	change	 1389	
in	chamber	preference.	*	denotes	p<0.05	when	comparing	mean	of	each	group	with	 1390	
Bonferroni	correction.		 1391	
	 1392	
	 1393	
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	 1394	
Overall	CPP	Data	in	Zebrafish	Exposed	to	CA	 1395	
Figure	25:	Change	in	cocaine	conditioned	place	preference	to	5mg/L	cocaine	treated	 1396	
chamber	in	epigenetic	drug	exposed	longitudinal	zebrafish.	**	denotes	p<0.01	when	 1397	
compared	against	untreated	controls	with	Bonferroni’s	correction.	Error	bars	represent	 1398	
the	±95%	CI.	 1399	
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	 1400	
CA	Experiment	Zebrafish	Weights	 1401	
Figure	26:	Weight	associated	with	embryonic	treatment	zebrafish	with	dimethyl	 1402	
sulfoxide	(DMSO),	10	µM	cocaine	(coc),	1	µM	DMSO	+10	µM	coc,	1	µM	chlorogenic	acid	 1403	
(CA),	and	1	µM	CA+	10	µM	coc.	*denote	p<0.05	and	****	denotes	p<000.1	when	 1404	
compared	against	untreated	controls	using	Bonferroni’s	multiple	comparisons.	Error	 1405	
bars	represent	the	±95%CI.		 1406	
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	 1407	
CA	Experiment	Zebrafish	Lengths	 1408	
Figure	27:	Length	associated	with	embryonic	treatment	zebrafish	with	dimethyl	 1409	
sulfoxide	(DMSO),	10	µM	coc,	1	µM	DMSO	+10	µM	coc,	1	µM	CA,	and	1	µM	CA+	10	µM	 1410	
coc.	*denote	p<0.05,	***	denotes	p<0.001	****	denotes	p<0.0001	when	compared	 1411	
against	untreated	controls	using	Bonferroni’s	multiple	comparisons.	Error	bars	 1412	
represent	the	±95%CI. 1413	
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	 1414	
DISCUSSION	 1415	
	 1416	
The	results	of	our	study	indicated	ECE	in	the	zebrafish	generated	longitudinal	 1417	
behavioral	and	gene	expressional	consequences.	Zebrafish	treated	at	increasing	 1418	
concentrations	of	cocaine	during	embryonic	development	showed	a	dose-dependent	 1419	
CPP	response	when	exposed	to	cocaine	again	as	adults.	Our	results	were	indicative	of	a	 1420	
longitudinal	behavioral	changes	attributed	to	ECE.	Analysis	of	gene	expression	in	 1421	
forebrain	structure	of	larval	and	adult	zebrafish	demonstrated	differential	expression	 1422	
that	was	also	dependent	on	ECE	concentration.	Larval	zebrafish	displayed	a	dose- 1423	
dependent	suppression	in	CS	gene	expression	as	cocaine	concentration	increased.	RNA- 1424	
Seq	revealed	a	list	of	CS	genes.	Validation	of	the	RNAi-Seq	results	of	select	CS	gene	 1425	
expression	in	adult	zebrafish	forebrain	was	unsuccessful.	Gene	expression	of	several	of	 1426	
the	selected	CS	genes	in	adult	zebrafish	did	not	appear	significantly	affected	by	ECE.	It	 1427	
may	be	that	the	limited	number	of	samples	used	for	these	experiments	did	not	allow	for	 1428	
significant	differences	to	be	observed.	As	a	possible	explanation	for	changes	in	CPP	 1429	
behavior	and	gene	expression,	we	investigated	DNA	methylation	patterns,	globally	and	 1430	
along	select	CS	genes.	Bisulfite	sequencing	revealed	little	effect	on	global	methylation,	 1431	
but	we	observed	alterations	in	hyper-	and	hypomethylation	along	several	CS	genes.	The	 1432	
CpG	islands	detected	were	observed	in	several	promoter	and	coding	regions	of	our	 1433	
selected	genes.	The	addition	of	methyl	groups	to	these	regions	may	have	longitudinal	 1434	
effects	on	gene	expression,	transcriptional	potential,	and	gene	isoform	availability.	The	 1435	
addition	of	5-hydroxymethylcytosine	(5-HmC)	was	also	shown	to	be	modified	by	the	 1436	
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exposure	to	2.5	mg/mL	cocaine	along	numerous	genes.	In	addition,	the	pattern	of	5- 1437	
HmC	addition	on	our	CS	genes	indicated	that	exposure	reduced	the	relative	number	of	 1438	
these	epigenetic	modifiers.	It	may	be	that	these	5-HmC	groups	are	a	priming	state	of	 1439	
methylation,	in	that,	the	addition	of	5-HmC	acts	as	an	intermediate	between	methyl	 1440	
group	attachment	and	hypomethylation.		Cohorts	treated	with	chlorogenic	acid	 1441	
demonstrated	longitudinally	altered	behavior.	Our	results	suggest	insult	exposure	 1442	
during	critical	developmental	time	periods	has	lasting	consequences	for	behavior	and	 1443	
gene	expression.		 1444	
	 1445	
ECE	Led	to	Differential	Responses	to	Cocaine	 1446	
	 Cocaine	exposure	during	embryonic	development	and	how	it	sequentially	affects	 1447	
behavior	has	been	investigated	in	several	model	organisms.	Our	work	has	indicated	that	 1448	
maximum	behavioral	response	in	adult	zebrafish	occurred	with	increasing	cocaine	 1449	
concentration	up	to	10	mg/mL	[116].	Within	our	study,	F0	zebrafish	exposed	at	 1450	
increasing	doses	of	cocaine	during	an	early	developmental	window	showed	significant	 1451	
increases	in	conditioned	preference	when	tested	at	8	months	of	age.	These	behavioral	 1452	
results	were	generated	with	acute	treatment	of	a	lower	cocaine	concentration	of	5	 1453	
mg/mL,	indicating	an	increase	in	sensitivity	to	cocaine.	This	CPP	behavior	was	again	seen	 1454	
to	be	dose-dependent.	ECE	concentrations	attenuated	the	CPP	response	in	all	F1	fish	 1455	
treated	with	cocaine.	These	fish	did	not	display	a	conditioned	response,	instead	 1456	
behaving	similarly	to	untreated	controls,	appearing	to	be	insensitive	to	cocaine.	This	 1457	
result	has	been	supported	in	the	literature.	In	a	study	with	ECE,	male	rats	were	taught	to	 1458	
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self-administer	cocaine	and	their	offspring,	specifically	males,	demonstrated	a	 1459	
subsequent	lessening	of	cocaine	self-administration	and	as	well	as	decrease	[146].	In	 1460	
this	study	conducted	by	Vassoler	et	al.	(2012),	this	inherited	endophenotype	was	the	 1461	
correlated	with	longitudinal	acetylation	at	histone	proteins	associated	with	Bdnf	 1462	
promoter	sites.	This	result	then,	suggests	that	self-administration	of	cocaine	in	the	 1463	
parental	generation	led	to	prolonged	changes	in	behavioral	responsiveness	to	cocaine.	 1464	
Taken	together,	the	results	of	our	study	may	indicate	that	ECE	in	zebrafish	led	to	a	 1465	
longitudinal	insensitivity	to	cocaine	in	CPP	assays.		 1466	
Analysis	of	CPP	behavior	in	offspring	of	zebrafish	exposed	to	ECE	demonstrated	 1467	
an	intergenerational	effect	that	can	be	attributed	to	cocaine.	We	used	a	range	of	acute	 1468	
cocaine	concentrations	to	assess	possible	altered	sensitivity	of	F1	zebrafish	cohorts.	CPP	 1469	
testing	was	shown	only	significantly	affected	in	the	0	F1	cohort.	The	F1	cohorts’	 1470	
behavioral	results	suggested	that	ECE	in	the	F0	has	an	intergenerational	effect.	There	did	 1471	
appear	to	be	an	increasing	response	at	the	lowest	acute	dose	(1	mg/mL),	suggesting	 1472	
that	there	actually	was	a	positive	response	on	cocaine	sensitivity,	but	variability	was	too	 1473	
high	to	be	certain.	This	variability	can	imply	that	some	F1	fish	with	ECE	did	respond	 1474	
highly	to	cocaine.	It	may	be	that	these	individuals	are	more	susceptible	to	self- 1475	
administration	and	addiction	as	the	result	of	intergenerational	cocaine	exposure.	Here,	 1476	
these	fish	gave	a	large	CPP	response	to	low	acute	cocaine	exposure.	In	future	studies,	F1	 1477	
fish	with	large	CPP	responses	to	low	acute	exposure	could	be	isolated	following	the	CPP	 1478	
assay.	These	‘high-responders’	could	then	be	crossed,	raised,	and	genetically	analyzed.	 1479	
The	results	of	this	experiment	may	substantiate	who	succumbs	to	familial	addiction	and	 1480	
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how	ECE	produced	lasting	behavioral	changes.	Further	investigation	will	be	required	to	 1481	
determine	this	result.	In	addition,	F1	had	a	higher	background	response	than	that	seen	 1482	
in	the	F0	and	CA	CPP	experiments.	This	may	have	masked	any	positive	CPP	responses	of	 1483	
F0	ECE	on	F1	fish.	The	response	of	the	zebrafish	to	lidocaine	and	the	low	response	to	1	 1484	
mg/mL	in	the	0	mg/mL	ECE	fish	provide	further	evidence	that	the	baseline	values	in	the	 1485	
F1	fish	were	very	high.	Further	studies	will	be	need	to	explain	the	source	of	this	high	 1486	
baseline	activity.	 1487	
A	number	of	studies	have	investigated	how	early	or	prenatal	cocaine	exposure	 1488	
has	affected	behavior	in	individuals	with	ECE	and	their	offspring.	Prenatal	cocaine	 1489	
exposure	in	mice	was	demonstrated	to	weaken	the	acquisition	of	cocaine	induced	CPP- 1490	
like	behavior	[147].	The	results	described	herein	offer	evidence	that	high	levels	of	ECE	 1491	
led	to	cocaine	insensitivity	in	adulthood.	Malanga	et	al.	(2007)	reported	behavioral	 1492	
testing	in	mice	using	CPP.	Within	their	study,	preference	was	significantly	affected	by	 1493	
physical	properties	of	the	testing	chamber,	specifically	color.	Similar	to	our	result,	it	was	 1494	
reported	that	behavioral	response	showed	an	inverted	U-shape,	with	maximal	 1495	
behavioral	responses	occurring	at	submaximal	treatment	concentrations.		CPP-behavior	 1496	
returns	to	control	following	treatment	with	maximal	treatment	concentrations.	From	 1497	
this	result,	the	authors	conclude	that	prenatal	exposure	to	high	concentrations	of	 1498	
cocaine	attenuated	the	conditioning	effect	of	cocaine	treatment	in	adulthood.	ECE	may	 1499	
also	have	affected	how	the	mice	responded	to	a	novel	environment.	In	a	study	with	rats,	 1500	
chronic	cocaine	exposure	resulted	in	a	greater	stress-response	as	measured	by	 1501	
corticosterone	levels	in	subjects	undergoing	the	open-field	assay	[148].	This	chronic	 1502	
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cocaine	exposure	then	led	to	longitudinal	alterations	in	stress-response	signaling	and	 1503	
stress	behavior.	The	novelty	of	the	new	environment	may	have	acted	as	a	new	stressor	 1504	
for	the	zebrafish	of	our	experiment.	Taken	these	results	together,	it	may	be	that	ECE	in	 1505	
zebrafish	altered	the	stress-response	behavior	and	partially	explains	the	high	baseline	 1506	
recordings	of	untreated	fish.	The	results	of	our	study	may	further	substantiate	the	result	 1507	
of	the	Malanga	et	al	(2007)	study.	ECE	in	zebrafish	led	to	increased	CPP	responsiveness	 1508	
in	the	F0.	Malanga	et	al.	(2008)	has	further	demonstrated	that	prenatal	exposure	to	 1509	
cocaine	increases	the	rewarding	nature	of	acute	cocaine	exposure	later	in	adulthood	of	 1510	
mice	using	brain	imaging	techniques	[149].	The	increased	rewarding	potential	of	cocaine	 1511	
shown	in	this	study	was	sex	dependent.	In	a	self-administration	experiment,	 1512	
gestationally	exposed	male	mice	were	more	likely	to	acquire	the	criteria	for	self- 1513	
administration	than	untreated	control	mice	[150].	In	the	work	done	by	Rocha	et	al.	 1514	
(2002)	the	percent	of	mice	that	acquired	cocaine	self-administration	displayed	a	bell- 1515	
shape	curve,	similar	to	the	result	of	our	CCP	data.	These	mice	were	also	shown	to	self- 1516	
administer	cocaine	more	readily.	Taken	together	then,	it	is	clear	that	ECE	generates	 1517	
longitudinal	effects	on	behavior	and	on	the	reward	response.	Other	researchers	have	 1518	
shown	that	ECE	produced	deficits	in	conditioned	learning	[151],	which	could	justify	a	 1519	
poor	learning	and	behavioral	response.	Spatial	learning	has	also	been	shown	to	be	 1520	
stunted	due	to	ECE	[152].	Several	studies	conducted	to	assess	working	and	spatial	 1521	
memory	have	indicated	poor	performance	when	compared	against	untreated	controls	 1522	
[153].	Mice	tested	in	Morris	maze	scored	significantly	worse	than	their	untreated	 1523	
controls	and	demonstrated	a	delay	in	successful	goal	completion	when	tested	using	 1524	
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Barnes	maze	test.	This	effect	on	working	memory	may	contribute	to	the	CPP	data	 1525	
observed	in	the	Malanga	et	al	(2007)	study.	Similar	to	some	mice	model	studies	of	 1526	
prenatal	cocaine	exposure,	our	zebrafish	did	not	display	significant	effects	on	 1527	
locomotive	behavior	indicative	of	acute	stress	(data	not	shown).	Cocaine	has	been	 1528	
correlated	with	hypersensitivity	to	acute	stress	in	the	mouse	model	[147].	Analysis	of	 1529	
distance	traveled	in	behavioral	apparatus	did	not	vary	among	the	groups.	Lastly,	the	F1	 1530	
cohort	of	zebrafish	left	untreated	demonstrate	a	high	basal	CPP	response	without	acute	 1531	
treatment.	High	basal	response	in	this	group	may	be	the	result	of	ECE	in	parental	 1532	
generations.	The	stress	of	the	novel	testing	environment	likely	contributed	to	this	result.		 1533	
The	intergenerational	effects	of	cocaine	exposure	and	associated	changes	are	an	 1534	
area	of	active	research.	One	possible	explanation	for	the	intergenerational	change	in	 1535	
sensitivity	to	rewarding	substance	is	a	shift	in	the	epigenetic	landscape	that	leads	to	 1536	
changes	in	gene	expression	that	effectively	sensitize	an	individual	[154,	155].	Vassoler	et	 1537	
al.	(2013)	reported	a	robust	acetylation	change	on	histone	proteins	of	Bdnf	promoter	in	 1538	
male	rats	as	the	result	of	male	sires	with	self-administration	of	cocaine.	This	provided	 1539	
evidence	of	intergenerational	consequence	as	the	result	of	drug	exposure.	Interestingly,	 1540	
this	epigenetic	modification	was	not	observed	in	female	rats.	Modifications	in	Bdnf	 1541	
mRNA	were	thought	to	be	due,	in	part,	to	changes	observed	in	the	sperm	of	cocaine- 1542	
experience	paternal	rats.	Additional	sexually	dimorphic	differences	in	responses	have	 1543	
been	observed	with	cocaine	sensitivity.	Intracranial	studies	of	mice	analyzing	the	 1544	
threshold	of	brain	stimulation	following	prenatal	cocaine	exposure	demonstrated	a	 1545	
lowering	of	threshold	stimulation,	indicating	increased	rewarding	nature	of	cocaine	 1546	
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[149].	Measurements	were	recorded	from	cortical	neuronal	bundles	thought	to	be	 1547	
associated	with	reward.	Rewarding	stimulation	would	cause	these	neurons	to	fire,	and	it	 1548	
was	demonstrated	that	prenatal	cocaine	exposure	lowered	the	threshold	of	excitability	 1549	
for	these	neurons.	This	result	was	observed	to	occur	only	in	male	mice.	The	threshold	of	 1550	
excitability	was	not	significantly	lowered	in	female	mice.	This	differential	effect	due	to	 1551	
gender	may	account	for	several	differences	observed	in	our	study.	Reports	of	 1552	
differential	effects	on	cocaine	sensitivity	following	ECE	may	reflect	the	large	variance	 1553	
observed	in	our	CPP	data.			 1554	
Our	CPP	experiments	did	include	some	technical	limitations	that	limit	the	types	 1555	
of	inferences	we	can	make	from	our	results.	We	were	unable	to	separate	male	and	 1556	
female	zebrafish	in	our	behavioral	work	due	to	limiting	sample	numbers.	We	had	 1557	
previously	demonstrated	that	cocaine	had	no	significant	effect	on	gender	in	zebrafish,	 1558	
but	within	each	cohort,	numbers	were	not	adequate	to	separate	male	and	female	fish	 1559	
for	CPP	assays	[106].	Due	to	reports	of	sexually	dimorphic	responses	both	behaviorally	 1560	
and	physiologically	to	cocaine	in	mammalian	studies,	future	studies	with	zebrafish	 1561	
should	investigate	the	role	that	sex	may	have	in	the	responsiveness	to	cocaine.	In	 1562	
addition,	intergenerational	analysis	of	ECE	on	F1	fish	would	not	truly	include	cocaine- 1563	
naïve	cohorts.	As	their	parent’s	germ	line	cells	were	exposed	to	cocaine	as	a	result	of	 1564	
their	ECE	treatment,	transgenerational	effects	on	cocaine	sensitivity	will	need	to	be	 1565	
carried	out	through	the	F2	generation.	Following	the	results	of	CPP	in	the	F1	cohorts,	it	 1566	
became	clear	that	fish	appeared	to	become	insensitive	to	cocaine	concentration	as	 1567	
touched	on	previously.	Further	investigation	using	increasingly	lower	cocaine	 1568	
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concentrations	would	further	have	explained	this	change	in	sensitivity.	Additional	 1569	
studies	will	need	to	be	conducted	to	elucidate	the	affect	ECE	has	on	transgenerational	 1570	
behavior	and	physiological	sensitivity.	 1571	
		 1572	
ECE	Produced	Longitudinal	Changes	in	Gene	Expression:		 1573	
	 In	order	to	link	changes	in	gene	expression	to	the	altered	behavioral	responses,	 1574	
we	analyzed	transcriptome-wide	changes	in	zebrafish	forebrain	tissue	in	response	to	 1575	
ECE	and	acute	cocaine	exposure.	Running	RNA-Seq	analysis	on	cohorts	of	ECE	fish	 1576	
following	acute	adult	exposure	generated	large	lists	of	differentially	expressed	genes.	 1577	
Narrowing	this	expanse	using	significance	values	gave	lists	of	thousands	genes	modified	 1578	
at	the	differing	ECE	concentrations.	Here,	we	selected	the	top	150	genes	with	more	than	 1579	
half	showing	a	dose-dependent	increase	in	expression.	Attempts	to	explain	how	the	 1580	
changes	in	genes	throughout	the	transcriptome	interact	with	one	another	in	circuit	was	 1581	
done	using	a	protein	association	program	known	as	the	STRING	database.	We	observed	 1582	
groupings	of	these	genes	in	association	with	genes	highly	linked	to	addiction	research	 1583	
[143].	The	clustering	of	genes	highly	characterized	in	addiction	research	led	us	to	 1584	
attempt	verification	of	their	expression	in	zebrafish	(Figure	5).	This	was	done	using	 1585	
quantitative	PCR.	One	gene	network	determined	following	our	analysis	included	bdnf,	 1586	
fosb,	mapk8,	and	inhbab.	These	genes	have	been	loosely	reported	in	connection	with	 1587	
one	another	based	on	literary	review.	Chronic	drug	use	has	been	shown	to	modify	 1588	
dopamine	concentration,	as	well	as	tyrosine	hydroxylase	and	bdnf	expression	[40,	156].	 1589	
Increased	Bdnf	has	been	shown	to	have	a	negative	effect	on	the	rewarding	properties	of	 1590	
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morphine	[157].	Bdnf	supplementation	lessened	synaptic	firing	character	in	the	ventral	 1591	
tegmental	area	after	mice	were	trained	to	self-administer,	whereas	reduction	of	Bdnf	 1592	
expression	led	to	increases	self-administration	of	opioids	in	CPP	testing.	Transgenic	 1593	
mouse	lines	expressing	polymorphisms	in	the	Bdnf	gene	displayed	compounded	 1594	
compulsive	reward	seeking	behaviors	in	response	to	alcohol	exposure	[30].	Transgenic	 1595	
lines	possessing	an	amino	acid	substitution	on	the	Bdnf	gene	showed	elevated	alcohol	 1596	
consumption.	This	alcohol	consumption	was	attenuated	by	virally	supplemented	wild- 1597	
type	Bdnf	protein	[30].	Bdnf	has	also	been	investigated	in	association	with	the	 1598	
rewarding	actions	of	cocaine.	Acute	cocaine	exposure	promoted	increased	Bdnf	 1599	
concentration	through	its	TrkB-signaling	[36].	The	expression	of	Bdnf	has	been	shown	to	 1600	
increase	its	expression	in	a	dose-dependent	manner	and	persistent	pattern	after	chronic	 1601	
cocaine	exposure	[40].	This	increase	in	expression	after	chronic	exposure	is	thought	to	 1602	
be	the	result	of	increased	phosphorylation	of	its	CREB	activator.	Studies	of	Bdnf	 1603	
expression	in	mice	with	ECE	indicated	a	significant	decrease	in	Bdnf	expression	at	 1604	
embryonic	day	15	[104].	Longitudinally,	however,	Bdnf	demonstrated	increase	signaling	 1605	
activity	in	the	dorsal	midbrain	through	its	TrkB	receptor	as	well	as	displayed	increased	 1606	
mRNA	expression.	As	chronic	drug	exposure	changes	upstream	regulators,	it	can	 1607	
contribute	to	lasting	behavioral	consequences	downstream.	One	of	its	downstream	 1608	
interactions	was	shown	to	occur	with	fosb.	 1609	
The	fos	transcription	factor	shown	in	our	STRING	interaction	diagram	has	been	 1610	
reported	to	play	a	functional	role	in	the	reward	associated	with	drugs	of	abuse.	 1611	
Research	has	suggested	the	fos	transcription	factor	as	a	means	to	produce	a	robust	 1612	
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change	in	brain	[158].	Delta	FosB	has	been	shown	to	accumulate	in	several	neuronal	 1613	
projections	following	obsessive	behaviors	and	produces	lasting	behavioral	changes	[42,	 1614	
43].	Cocaine	has	been	shown	to	induce	increased	expression	of	multiple	isoforms	of	the	 1615	
Fos	transcription	factors	within	the	nucleus	accumbens	and	its	associated	brain	regions	 1616	
of	mice	[159].	Chronic	cocaine	use	is	thought	to	prevent	the	buildup	of	fos	family	 1617	
transcription	factors,	and	lead	to	adaptive	and	constant	expression	of	∆FosB	[160].	 1618	
Transgenic	mice	over-expressing	∆FosB	within	specific	striatal	neurons	showed	 1619	
significantly	more	lever	presses	for	low-dose	administrations	of	cocaine	when	compared	 1620	
to	their	home	cage	controls	[47,	48,	161].	It	was	also	shown	that	mice	that	over- 1621	
expressed	∆FosB	that	were	taught	to	self-administer,	will	continue	to	self-administer	at	 1622	
lower	doses	than	initial	training	following	behavioral	extinction	[48].	This	suggested	that	 1623	
increased	∆FosB	within	these	frontal	lobe	structures	may	increase	sensitivity	to	cocaine	 1624	
use	as	well	as	increase	vulnerability	to	maladaptive	use	and	relapse.	Early	nicotine	 1625	
exposure	in	mice	generated	increased	acquisition	of	cocaine	self-administration	 1626	
correlated	with	increased	c-fos	expression	in	the	prefrontal	cortex	[162],	suggesting	 1627	
early	developmental	insult	generates	lasting	expressional	changes.	In	agreement	with	 1628	
this,	in	a	study	using	Dutch	Belted	rabbits,	ECE	lessened	Fos	expression	following	acute	 1629	
cocaine	exposure	in	20	day	old	rabbits	in	both	the	striatum	and	the	cortex	[163].	The	Fos	 1630	
transcription	factors	are	associated	with	learning	and	memory	as	this	transcription	 1631	
factor	produces	robust	changes	in	the	brain	and	its	increased	mRNA	expression,	but	not	 1632	
translated	protein,	are	associated	with	cocaine	sensitivity	[47].	This	implies	that	ECE	 1633	
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may	lead	to	decreased	expression	of	these	transcription	factors	following	a	subsequent	 1634	
acute	exposure	to	cocaine	in	this	rabbit	model	of	addiction.		 1635	
The	last	gene	associated	with	this	cluster	was	inhbab.	Inhbab	has	been	reported	 1636	
to	play	roles	in	numerous	physiologic	processes.	As	inhbab	is	homologous	to	activin	A,	 1637	
sharing	ß	subunit,	its	roles	in	pluripotent	stem	cell	growth	and	cellular	differentiation	 1638	
have	been	reported	[164].	This	protein	is	a	member	of	the	TGF-ß	superfamily.	Its	 1639	
expression	has	been	implicated	in	ovarian	tissue	as	a	regulator	of	FSH	release.	In	 1640	
addition,	it	has	been	shown	to	play	roles	in	angiogenesis,	inflammatory	processes,	and	 1641	
immunological	responses	[165-167].	Studies	in	the	Drosophila	suggest	activin-like	 1642	
ligands	are	involved	in	neuronal	cell	development	[168].	This	result	is	in	line	with	 1643	
vertebrate	studies	implicating	this	gene	in	its	role	in	early	cell	differentiation	in	several	 1644	
cell-type	lineages	[169].	Experimental	evidence	has	suggested	that	inhbab	gene	 1645	
expression,	along	with	fos-family	proteins	and	bdnf	are	induced	following	hypoxic	brain	 1646	
injury	[170,	171].	The	expression	of	these	genes	in	response	to	hypoxic	injury	seems	to	 1647	
be	spatiotemporally	regulated	by	the	injury	itself.	Human	data	has	suggested	the	 1648	
expression	of	inhibin	protein	in	various	region	of	the	brain.	Immunochemical	 1649	
experiments	in	post-mortem	brain	tissue	has	suggested	biologically	active	forms	of		 1650	
inhibin	proteins	in	hypothalamic	and	forebrain	tissue	[172].	The	interaction	of	these	 1651	
three	genes	may	then,	play	a	neuroprotective	role	following	ECE.	 1652	
Brief	literary	review	of	these	genes	may	provide	insight	into	an	associated	 1653	
functional	relevance.	The	clustering	of	∆fosb,	bdnf,	mapk8,	and	inhbab	in	our	STRING	 1654	
diagram	may	play	roles	in	a	neuroprotective	mechanism.	Interaction	between	these	 1655	
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genes	has	been	reported	in	the	literature	in	research	involving	neuronal	protection	and	 1656	
neuronal	formation.	It	has	been	suggested	that	early	stress	in	postnatal	rat	pups	lessens	 1657	
the	expression	of	Bdnf	and	the	activation	of	a	MAP	kinase	pathway	[173].	Interactions	 1658	
seen	from	STRING	diagram	clearly	links	mapk8,	bdnf,	inhbab,	and	fosb.	Bdnf	has	been	 1659	
shown	to	provide	a	neuroprotective	mechanism	through	activation	of	secondary	 1660	
protein,	inhbab	[174].	Here,	Bdnf	acts	to	limit	neuron	damage	by	preventing	 1661	
excitotoxicity	by	repression	of	NMDA-receptor	cell	signaling.	Increased	induction	of	 1662	
∆fosb,	inhbab,	and	bdnf	have	also	been	reported	as	the	result	of	hypoxic	injury	[170].	A	 1663	
common	downstream	protein	of	the	MAPK	pathway	is	a	family	of	protein	called	jun	 1664	
proto-oncogene	(jun).	This	extracellular	signaling	has	been	associated	with	several	 1665	
intracellular	processes,	including	cell	survival	and	cell	death	[175,	176].	Jun	family	 1666	
proteins	are	cited	with	fos	family	protein	in	association	with	apoptotic	processes	in	 1667	
neurons	of	the	substantia	nigra	[177].	Fos	gene	knockout	studies	have	suggested	that	its	 1668	
protein	product	plays	a	role	in	the	prevention	of	neurodegeneration	following	 1669	
methamphetamine	exposure	[178].	Tinmarla	et	al.	(1999)	demonstrated	that	excitotoxic	 1670	
damage	to	neurons	of	the	substantia	nigra	were	coincident	with	increased	fos	 1671	
expression.	Due	to	the	reports	of	protection	against	neuronal	damage	due	to	these	 1672	
proteins,	it	is	likely	that	this	CS	gene	cluster	is	in	some	way	responsible	for	neuronal	 1673	
protection	in	our	zebrafish	following	ECE.	We	did	not	quantify	the	expression	of	mapk8	 1674	
within	the	work	of	this	thesis,	but	it	can	be	predicted	that	its	expression	would	mirror	 1675	
that	of	these	select	CS	genes.	Further,	mapk8	may	lead	to	increased	expression	of	bdnf,	 1676	
and	indirectly,	increased	expression	of	inhbab	preventing	excitotoxicity	of	neurons	 1677	
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present	in	the	forebrain	of	zebrafish.	Signaling	through	this	MAPK	pathway	may	also	 1678	
explain	the	elevated	expression	of	fos	family	transcription	factors.	These	results	will	 1679	
need	to	be	confirmed	with	future	research.			 1680	
Our	STRING	interaction	diagram	revealed	other	clusters	of	genes	that	may	prove	 1681	
valuable	in	understanding	the	effects	of	ECE.		One	such	cluster	included	several	genes	 1682	
thought	to	affect	modification	of	proteins,	transcriptional	and	translational	regulation,	 1683	
and	protein	transport	[179,	180].	DDX5	and	its	family	are	identified	as	RNA	helicases	 1684	
associated	with	multiple	cellular	processes	involving	ADP-ribosylation	and	cellular	 1685	
survival	[181].	DDX5,	also	known	as	p68,	has	been	reported	as	a	cofactor	for	RNA	 1686	
processing	and	cellular	control	[182,	183].	Experimental	evidence	has	suggested	that	 1687	
Ddx5	acts	like	a	molecular	switch	controlling	downstream	effector	proteins	responsible	 1688	
for	apoptosis	and	developmental	arrest	resulting	from	DNA	damage	[184].	Arf5	is	from	a	 1689	
family	of	GTPase	proteins	associated	with	cellular	transport	and	cell	adhesion	molecules	 1690	
[185].	It	has	been	suggested	that	Ddx5	expression	can	be	regulated	by	Arf	proteins	and	 1691	
limit	the	downstream	proteins	involved	in	the	p53	apoptotic	pathway	[186].	Arf5	has	 1692	
further	been	implicated	with	Ca2+-dependent	activator	proteins	involved	in	dense	core	 1693	
vesicular	transport	[187].	Ca2+-dependent	activator	proteins	recruits	Arf5	to	the	Golgi	 1694	
apparatus	for	proper	exocytosis	of	vesicles.	These	proteins	have	been	shown	to	be	 1695	
ubiquitously	expressed	in	the	mouse	brain	and	involved	in	the	transport	of	 1696	
catecholamines	as	well	as	Bdnf	[188].	Through	these	mechanisms	of	neurotrophin	 1697	
transport	and	regulation	of	apoptotic	processes	it	can	be	implied	that	Arf5	plays	a	 1698	
significant	role	in	neuronal	survival.	Our	STRING	interaction	diagram	indicated	these	two	 1699	
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proteins	also	interact	with	another	protein,	eif4a1a.	The	gene	product	of	Eif4a1a	is	an	 1700	
elongation	factor	that	is	ubiquitously	expressed	in	hippocampal	neurons	of	the	rat	brain	 1701	
suggesting	a	role	in	memory	plasticity	[189].	Modifications	in	the	translational	potential	 1702	
in	the	hippocampus	has	been	associated	with	spatial	memory	dysfunction	and	learning	 1703	
deficits	[190].	As	these	pathways	were	believed	to	be	affected	by	ECE,	it	may	be	that	 1704	
arf5’s	promotion	of	neuronal	proliferation	may	allow	for	Hebbian	synaptic	formation	of	 1705	
neurons	within	the	forebrain	structure.	Arf5	was	shown	to	be	differentially	expressed	as	 1706	
the	result	of	ECE	in	larval	zebrafish.		This	differential	expression	may	reflect	the	 1707	
functional	state	of	these	neurons.	As	arf5	was	shown	to	be	a	CS	gene,	this	may	indicate	 1708	
increased	strengthening	of	neuronal	synapses,	thereby	producing	lasting	behavioral	 1709	
consequences.	In	our	work	we	did	not	confirm	interaction	with	these	proteins	using	 1710	
immunochemistry	experiments.	Immunohistochemistry	experiments	may	confirm	 1711	
decreased	levels	of	ddx5	and	increased	vesicular	docking	as	the	result	of	arf5	 1712	
recruitment	to	neuronal	cell	junctions.	Further	research	is	required	for	these	questions.	 1713	
Additional	pathways	were	also	observed	due	to	the	clustering	of	CS	genes.	Namely,	 1714	
genes	involved	in	the	polyamine	synthesis	pathways.		 1715	
Proteins	associated	with	the	polyamine	pathway	were	shown	to	cluster	from	our	 1716	
analysis	with	STRING.	Polyamines	are	important	for	many	cellular	processes,	including	 1717	
cellular	communication,	cellular	proliferation,	and	early	development.	These	polyamines	 1718	
are	generated	from	arginine,	ornithine,	and	proline	and	are	converted	to	polyamines	by	 1719	
several	biochemical	pathways.	Arginine	is	converted	by	arginase	into	ornithine	which	is	 1720	
acted	on	and	decarboxylated	by	Odc1.	Research	has	indicated	Odc1	can	regulate	 1721	
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pluripotency	of	neuronal	stem	cells	[191].	Odc1	has	been	used	as	a	biomarker	for	brain	 1722	
cell	development	and	it	has	been	demonstrated	that	its	expression	is	increased	by	 1723	
gestational	cocaine	exposure	[192].	It	was	reported	that	this	differential	expression	was	 1724	
normalized	in	the	prenatal	period.	Multiple	reports	support	that	the	initial	differential	 1725	
expression	of	odc1	occurs	following	ECE,	but	that	levels	of	expression	return	to	control	 1726	
values	in	the	postnatal	period	[193].	It	is	thought,	however,	that	this	suppression	of	 1727	
odc1	during	early	prenatal	development	will	alter	development	of	neuronal	cells	of	the	 1728	
exposed	organism	[194].	Cocaine	exposure	leads	to	vasoconstriction	resulting	from	 1729	
norepinephrine	reuptake	inhibition	and	subsequent	ischemia.	This	ischemia	can	lead	to	 1730	
hypoxic	conditions	in	the	brain	and	thus,	produce	damage	to	brain	tissue.	Research	has	 1731	
suggested	that	ischemia	is	a	mechanism	that	can	contribute	to	the	suppression	of	odc1	 1732	
expression	[194].	Indeed,	reductions	in	odc1	have	been	shown	to	alter	the	synaptic	 1733	
transmission	of	catecholamines	[195].	Using	pharmacologic	means,	repression	of	odc1	 1734	
led	to	severe	attenuation	in	synaptic	development	in	catecholaminergic	neurons	in	the	 1735	
CNS	and	PNS.	Quantitatively,	the	expression	of	odc1	in	our	experiments	produced	data	 1736	
similar	to	what	has	been	reported	in	the	literature.	There	was	a	trend	of	decreased	 1737	
expression	in	larval	zebrafish,	though	expression	patterns	were	not	significantly	 1738	
different	among	ECE	groups.	Adult	odc1	expression	was	unchanged	according	to	qPCR	 1739	
as	the	result	of	zebrafish	ECE.	These	results	support	the	consequence	of	cocaine	 1740	
exposure	on	odc1	expression	that	has	been	reported	in	mammalian	model	systems.	The	 1741	
zebrafish	model	may	demonstrate	that	there	is	not	significant	effect	on	the	polyamine	 1742	
pathway	as	the	result	of	ECE.		 1743	
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Another	unique	set	of	interactions	of	the	CS	genes	was	detected	using	STRING.	 1744	
Here,	it	was	revealed	a	clustering	of	nuclear	receptor	proteins	occurred	following	ECE.	 1745	
These	receptors	belong	to	a	class	of	nuclear	receptors	that	include	nr4a1,	nr4a2,	nr4a3	 1746	
that	act	as	transcription	factors	and	function	independently	of	ligand	binding	[196].	This	 1747	
ligand	independency	labeled	them	as	orphan	receptors.	These	orphan	receptors	have	 1748	
been	associated	with	lipophilic	molecules	as	their	increased	expression	has	been	 1749	
associated	with	atherosclerosis	in	mice	[197].	This	family	of	receptors	has	also	been	 1750	
established	as	neuroprotective	proteins	and	associated	with	several	pathologies.	For	 1751	
example,	Nr4a2	has	been	shown	as	an	obligatory	factor	for	the	development	of	 1752	
dopaminergic	neurons	in	mice	[198].	This	subfamily	of	proteins	have	high	homology	 1753	
among	its	members	and	have	been	associated	with	maintenance	and	protection	of	 1754	
midbrain	dopaminergic	neurons	from	excitotoxicity	[199].	In	addition,	neuronal	cell	 1755	
damage	as	the	result	of	ischemia	and	glucose	deprivation	is	lessened	by	the	increased	 1756	
expression	of	Nr4a	family	proteins	[200].	Taken	together,	there	is	a	clear	 1757	
neuroprotective	property	of	these	proteins.	It	was	shown	to	be	among	our	CS	genes	 1758	
following	RNA-Seq	analysis	and	displayed	a	bell-shaped	pattern	of	expression.	 1759	
Verification	of	this	cocaine	sensitivity	was	conducted	and	revealed	that	nr4a3	was	 1760	
differential	expressed	in	larval	and	adult	zebrafish	tissue	samples.	Tissue	collected	from	 1761	
larval	zebrafish	demonstrated	significant	gene	repression	with	increasing	ECE	 1762	
concentrations.	Quantification	of	nr4a3	in	the	adult	zebrafish	suggested	a	bell-shaped	 1763	
expression	pattern	indicating	an	increase	in	expression	as	the	result	of	ECE,	though	 1764	
results	were	not	significant.	Studies	of	this	gene	family	have	suggested	that	activation	of	 1765	
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this	protein	is	an	early	biomarker	for	dopaminergic	neuronal	development	[198].	In	 1766	
addition,	these	protein	have	been	established	to	increase	in	their	expression	as	the	 1767	
result	of	dopaminergic	neuronal	activity	and	could	regulate	the	expression	of	dopamine	 1768	
producing	enzymes	and	dopamine	transporter	proteins	[201].	Real-time	PCR	did	not	 1769	
successfully	verify	results	of	our	RNA-Seq	as	there	was	no	differential	expression	based	 1770	
on	ECE,	but	this	may	be	the	result	of	large	variation	within	the	tissue	samples.	There	was	 1771	
a	general	trend	of	increased	expression	in	fish	with	2.5	mg/mL	ECE.	It	may	be	that	low	 1772	
doses	of	cocaine	induced	increased	expression	of	this	gene,	while	increased	 1773	
concentrations	reduced	its	expression	or	induced	a	secondary	repressor.	Further,	nr4a3	 1774	
was	shown	to	be	associated	with	an	estrogen-related	receptor	(Essra).	Knockout	 1775	
experiments	of	the	Esrra	protein	in	the	mouse	animal	model	has	suggested	a	functional	 1776	
role	in	several	behaviors,	including	grooming,	compulsivity	and	social	functioning	[202].	 1777	
Knock-out	or	knock-down	of	Esrra	in	mice	led	to	loss	of	operant	conditioning	with	food	 1778	
as	well	as	increased	grooming,	indicative	of	social	abnormality.	It	is	unclear	from	our	 1779	
work	how	direct	the	interaction	between	these	two	proteins	is,	but	because	both	are	 1780	
affected	by	cocaine	exposure,	further	analysis	may	generate	interesting	results.		 1781	
	 The	analysis	of	the	RNA-seq	data	revealed	unique	interaction	between	genes	 1782	
found	to	be	cocaine	sensitive.	Because	of	this,	we	attempted	to	verify	gene	expression	 1783	
changes	as	the	result	of	ECE	in	both	larval	and	adult	zebrafish.		Comparisons	of	acutely	 1784	
treated	fish	at	each	ECE	concentration	were	made	against	fish	from	each	ECE	treatment	 1785	
group	that	were	left	untreated,	giving	us	a	list	of	CS	genes	that	displayed	a	bell-shaped	 1786	
change	expression.	The	results	of	our	gene	validation	experiments	using	qRT-PCR	did	 1787	
	 	 	
	
	 94	
not	substantiate	this	result.	Instead,	there	was	little	demonstration	of	a	dose-dependent	 1788	
change	in	expression	among	our	genes.	In	most	cases	there	was	no	significant	difference	 1789	
among	the	expression	when	compared	to	control	fish.	In	nearly	every	tissue	sample	 1790	
there	were	large	amounts	of	variation	in	expression	of	each	CS	genes.	The	amount	of	 1791	
noise	in	comparison	to	signal	of	expression	may	have	limited	the	inference	available	 1792	
from	our	PCR	experiments.	Embryonic	expression	revealed	unexpected	results	as	well.	 1793	
The	gene	bdnf	showed	a	bell-shaped	curve	with	a	peak	in	expression	when	treated	at	 1794	
the	lowest	ECE	concentration	in	larval	expression.	This	expression	pattern	was	similarly	 1795	
observed	in	the	adult	samples.	In	larval	samples,	several	genes	displayed	a	significant	 1796	
dose-dependent	inhibition	of	gene	expression.	An	example	is	clearly	demonstrated	in	 1797	
Figure	10	of	the	results.	Untreated	larval	zebrafish	demonstrate	significantly	higher	 1798	
levels	of	gene	expression	when	compared	to	all	treated	groups.	A	critical	difference	in	 1799	
the	results	seen	in	adult	and	larval	PCR	experiments	may	lie	in	the	numbers	of	sample	 1800	
used	to	quantify	the	expression	in	our	experiments.	The	Hi-Seq	experiments	had	3	 1801	
replicates	of	each	of	the	4	treatment	groups	giving	12	comparisons.	Our	PCR	 1802	
experiments	contain	several	tissue	sample	per	amplified	sample,	but	numbers	of	fish	 1803	
from	each	treatment	ECE	cohort	was	limiting.	 1804	
The	difference	between	our	results	and	those	seen	in	the	Hi-Seq	may	also	be	the	result	 1805	
of	sample	numbers.	Moreover,	the	addition	of	methylation	groups	in	promoter	regions	 1806	
of	our	selected	gene	may	have	resulted	in	the	transcriptional	differences	observed.		 1807	
	 1808	
	 1809	
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	 1810	
ECE	Generated	Changes	in	the	Epigenetic	Landscape	 1811	
As	our	lab	proposed	that	behavior	was	longitudinally	affected	by	ECE	and	was	 1812	
governed	by	changes	in	gene	expression,	we	analyzed	DNA	methylation	as	a	means	to	 1813	
produce	intergenerational	changes	to	the	transcriptome	and	associated	behaviors.	It	is	 1814	
widely	accepted	that	DNA	methylation	is	often	associated	with	gene	silencing	[203].	The	 1815	
addition	of	methyl	moieties	to	the	5’	carbon	on	the	nucleotide	cytosine,	prevents	 1816	
protein	binding	and	alters	the	transcriptional	potential	of	the	DNA	segment.	Alterations	 1817	
in	DNA	methylation	have	been	observed	in	other	model	organisms	following	prenatal	 1818	
exposure	to	various	insults	including	heavy	metals,	nicotine,	alcohol,	and	drugs	of	abuse	 1819	
[204-207].	Alcohol	exposure	during	gastrulation	has	been	demonstrated	to	decrease	the	 1820	
presence	of	5-methylcytosine	(5-mC)	groups	along	the	neural	tube	and	impede	 1821	
development	[204].	Brain	regions	involved	in	memory	and	behavioral	motivation,	like	 1822	
the	hippocampus	have	also	been	shown	to	be	longitudinally	affected	by	early	drug	 1823	
insult.	Research	suggested	that	methamphetamine	exposure	during	gestation	led	to	 1824	
changes	in	the	epigenetic	landscape	of	hippocampal	DNA	[207].	Mice	with	this	 1825	
differential	methylation	were	also	shown	to	have	enhanced	cocaine-induced	CPP	 1826	
responses.	The	results	of	our	study	indicated	whole	chromosome	methylation	was	likely	 1827	
unaffected	by	ECE	in	the	F1	generation	of	zebrafish.	Along	the	25	zebrafish	 1828	
chromosomes,	there	was	significant	differences	seen	in	the	hypermethylation	state	as	 1829	
well	as	significant	differences	seen	the	hypomethylation	states.	Because	of	significant	 1830	
hypermethylation	as	well	as	significant	hypomethylation	along	nearly	ever	zebrafish	 1831	
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chromosome,	it	suggests	no	net	change	in	global	methylation.	This	did	not	mean	that	 1832	
along	these	chromosomes	there	were	not	significantly	changes	in	the	methylation	state	 1833	
of	genes	encoded	by	the	chromosome.	Analysis	of	genes	with	differentially	methylated	 1834	
did	indicate	some	different	methylation	patterns	based	on	the	ECE	concentration.	Low	 1835	
concentration	ECE	led	to	a	generalized	increase	in	methylation	among	our	selected	CS	 1836	
genes.	In	contrast,	high	concentration	of	ECE	generally	led	to	increased	 1837	
hypomethylation.	It	seems	from	our	result	that	each	concentration	of	cocaine	led	to	 1838	
altered	methylation	states	of	a	unique	set	of	genes.	These	concentrations	then,	 1839	
appeared	to	act	as	a	unique	stressor	to	the	transcriptome.	Hydroxymethylation	 1840	
comparisons	were	made	between	the	untreated	and	2.5	ECE	F1	group.	This	 1841	
concentration	of	ECE	led	to	an	overall	decrease	in	5-HmC	moieties	along	the	CS	genes	 1842	
previously	identified.	How	then	does	this	relate	to	the	expression	observed	within	our	 1843	
CS	genes?	As	mentioned,	each	concentration	led	to	a	unique	set	of	genes	with	 1844	
differential	methylation.	It	may	imply	that	methylation	occurred	uniquely	to	 1845	
concentrations	experienced	as	rewarding	and	unique	to	concentrations	of	cocaine	 1846	
found	as	harmful	or	stressful.		We	did	not	look	at	methylation	and	hydroxymethylation	 1847	
in	the	larval	zebrafish,	but	if	the	result	from	the	adult	methylation	data	represents	the	 1848	
methylation	state	in	larval	zebrafish	it	may	explain	the	result.	As	the	addition	of	5-mC	 1849	
moieties	was	typically	higher	in	the	2.5	F1	ECE	group,	it	may	reflect	the	decrease	in	 1850	
expression	seen	in	the	larval	groups.	The	concentration	may	have	been	a	threshold	 1851	
treatment,	keeping	expression	of	CS	genes	inhibited	regardless	of	increased	ECE	 1852	
treatment.	The	enzymes	responsible	for	the	addition	of	the	methyl	groups	are	Dnmts.		 1853	
	 	 	
	
	 97	
Because	of	the	different	functions	of	Dnmt	enzymes,	repression	may	occur	at	de	novo	 1854	
methylation	as	well	as	repression	in	the	maintenance	of	methylation	[208].	The	 1855	
conversion	of	5-mC	to	5-HmC	is	controlled	by	ten-eleven	translocase	(TET)	enzymes	and	 1856	
is	thought	to	have	demethylation	potential	[209].	It	is	through	the	oxidation	reaction	of	 1857	
these	TET	enzymes	that	demethylation	could	occur	and	could	represent	a	methylation	 1858	
intermediate	between	methylated	and	demethylated.	Analysis	of	the	gene	nr4a3	for	 1859	
example	showed	significant	reduction	in	its	expression	in	larval	zebrafish	as	ECE	dosages	 1860	
increased.	There	was	no	difference	observed	between	the	low	concentration	of	2.5	 1861	
mg/mL	and	20	mg/mL,	suggesting	the	low	dose	was	enough	to	substantially	reduce	its	 1862	
expression.	The	expression	appeared	to	recover	in	the	adult	zebrafish	following	acute	 1863	
cocaine	exposure.	There	was	significant	hypo-	and	hyper-	methylation	along	 1864	
chromosome	16,	where	nr4a3	is	found.	This	did	not	appear	along	the	chromosome	 1865	
positions	relative	to	the	location	of	this	gene.	Here,	there	was	substantial	modification	 1866	
of	5-HmC	groups	found	within	the	3’	regions	upstream	of	exons	4,	exon	6,	and	exon	9.	 1867	
This	repression	was	seen	in	several	of	our	genes,	with	a	general	increase	and	recovery	of	 1868	
expression	seen	in	the	adult	brain.	Taken	together	these	results	support	further	 1869	
investigation	into	5-HmC	addition	and	its	implication	into	intergenerational	drug	 1870	
sensitivity.	Quantitative	analysis	to	determine	the	functional	activity	of	TET	as	well	as	 1871	
the	DNMTs	in	zebrafish	would	further	clarify	the	DNA	methylation	state	resulting	from	 1872	
ECE.				 1873	
The	results	of	this	study	suggest	the	following:	 1874	
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• ECE	led	to	increased	sensitivity	in	the	F0,	which	lead	to	decreased	sensitivity	in	 1875	
the	F1	 1876	
• Validation	of	Hi-Seq	results	revealed	larval	suppression	of	select	CS	genes	by	 1877	
increasing	ECE	and	adult	expression	appeared	unaffected	 1878	
• Clustering	of	CS	genes	affected	by	ECE	appeared	to	be	involved	in	 1879	
neuroprotection		 1880	
• F1	Global	methylation	is	unaffected	by	ECE	in	the	F0,	but	select	CS	genes	showed	 1881	
differential	methylation	states	based	on	ECE	concentration	 1882	
• Modified	methylation	landscapes	as	the	result	of	CA	exposure	during	 1883	
development	led	to	differential	CPP	behavior	 1884	
	 1885	
Neurexin	the	Novel	Addiction	Gene	 1886	
Neurexin	(NRXN)	is	a	unique,	single-pass	transmembrane	protein	found	in	the	 1887	
synaptic	terminal	of	neurons	that	may	be	an	ideal	gene	for	further	addiction	research.	 1888	
Alterations	in	copy	number	and	mutations	in	this	protein	have	been	associated	with	 1889	
several	neurodevelopmental	and	neuropsychiatric	diseases.	Neurexin	has	three	genes	in	 1890	
mammals:	Nrxn1,	Nrxn2,	and	Nrxn3	and	two	isoforms	of	differing	length,	an	a-	and	a	ß-,	 1891	
generated	by	different	promoters	at	differing	splice	sites	[210-212].	These	three	 1892	
neurexin	genes	are	highly	evolutionarily	conserved.	Further	evolutionary	analysis	 1893	
indicated	that	a	specific	duplication	event	in	the	zebrafish	genome	occurred	leading	to	 1894	
different	paralogs	at	different	linkage	groups	of	this	protein,	so	there	are	six	nrxn	genes	 1895	
in	zebrafish	[213].	Research	has	also	indicated	significant	similarity	among	these	gene	 1896	
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sequences	to	neurexins	found	in	humans	[214].	Sequence	analysis	and	cloning	of	Nrxn3	 1897	
indicated	an	internal	base	position	difference	present	in	the	two	Nrxn3	genes.	This	 1898	
difference	was	shown	to	be	identical	to	the	sequence	of	base	pairs	found	within	the	 1899	
longer	Nrxn3aα	gene	and	were	seen	in	a	splice	region	[211].	The	differences	in	the	bases	 1900	
found	within	the	splice	site	led	to	a	different	translation	result,	with	one	protein	 1901	
becoming	transmembrane	and	the	other	becoming	a	secreted	protein	as	it	no	longer	 1902	
possessed	the	membrane-anchoring	carboxyl	tail	[211,	215].	The	transmembrane	 1903	
protein,	due	to	its	differing	internal	base,	undergoes	a	30	amino	acid	insertion-deletion	 1904	
mutation,	whereas	the	secreted	protein	is	produced	as	multiple	in-frame	stop	codons	 1905	
are	inserted	in	sequence.	Further,	inspection	of	glycosylation	patterns	indicated	that	 1906	
Nrxnß	undergo	similar	O-glycosylation	of	their	C-terminus	as	the	Nrxna.	This	suggests	 1907	
they	maintain	a	similar	transmembrane	orientation	in	the	neuronal	membrane.	Knock- 1908	
out	studies	of	the	three	Nrxn	genes	lead	to	development	consequence	with	varying	 1909	
severity.	Triple	knock-out	of	all	three	Nrxna	led	to	early	mortality	in	mice,	and	varying	 1910	
knock-outs	resulted	in	impaired	respiratory	function	thought	to	contribute	to	the	 1911	
mortality	[216].	Nrxnß	triple	knock-out	is	suggested	to	have	little	effect	on	survival,	but	 1912	
did	alter	glutamatergic	neuronal	transmission	and	memory	in	mice	[217].	For	these	 1913	
proteins	to	carry	out	their	function	trans-synaptically,	they	must	interact	with	other	cell	 1914	
adhesion	molecules.	One	such	protein	is	neuroligin.	Neuroligin	proteins	have	been	 1915	
suggested	to	interact	with	neurexin	proteins	on	post-synaptic	neurons	[218].	 1916	
Neuroligins	appear	as	dimers	and	contain	an	acetylcholinesterase-like	domain	that	 1917	
interacts	with	presynaptic	neurexins	in	the	extracellular	spaces	of	synaptic	junctions	 1918	
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[219].	Together	this	Ca+2-dependent	heterotetrameric	complex	is	thought	to	be	involved	 1919	
in	synaptic	maturation	and	synaptic	formation	during	synaptogenesis	[220-222].	In	the	 1920	
zebrafish	and	humans,	it	has	been	shown	early	splicing	events	are	highly	controlled	 1921	
leading	to	the	larger	expression	of	nrxna,	whereas	nrxnß	increases	in	expression	later	in	 1922	
development,	but	are	still	minimally	expressed	[214].	It	is	thought	that	the	different	 1923	
isoforms	of	neuroligin	and	neurexin	undergo	their	own	alternative	splicing	and	this	may	 1924	
govern	the	protein	complexes	that	are	found	between	the	two	proteins,	though	binding	 1925	
between	affinities	for	the	neurexin	and	neuroligin	may	be	only	slightly	different	 1926	
between	isoforms	[223].	The	neuroligins	reside	in	the	postsynaptic	membrane	and	its	 1927	
varying	isoforms	have	been	associated	with	different	inhibitory	synapses	[224,	225].	 1928	
Recent	evidence	has	supposed	that	these	neuroligin	and	neurexin	complex	play	 1929	
substantial	roles	in	social	behaviors	via	excitation	and	inhibition	control	in	the	 1930	
hippocampus	[226].	 1931	
	Human	studies	have	shown	neurexin-3	(NRXN3)	to	be	implicated	in	addiction	 1932	
and	other	mental	disorders.	In	a	study	investigating	NRXN3	single	nucleotide	 1933	
polymorphisms,	variations	in	the	NRXN3	gene	were	associated	with	smoking	and	 1934	
addictive	tendencies	[227].	A	similar	study	indicated	variation	in	the	NRXN3	gene	was	 1935	
associated	with	alcohol	dependence	and	was	correlated	with	increased	expression	of	 1936	
the	longer	isoform,	NRXN3α	[228].	Nxrn3a’s	physiologic	function	has	been	specified	 1937	
with	animal	knockout	studies.	Research	by	Aoto	el	al	(2015)	indicated	that	homozygous	 1938	
knockout	of	nrxn-3	α/β	had	impact	on	synaptic	function	in	cultured	neurons.	In	their	 1939	
study,	it	was	observed	that	conditional	knock-out	of	nrxn3	had	differential	impact	based	 1940	
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on	location	in	the	brain,	specifically	the	hippocampus	or	the	olfactory	bulb.	Specifically,	 1941	
in	cultured	neurons,	nrxn3	was	required	for	GABA	release	in	olfactory	neurons	and	is	 1942	
involved	in	AMPAR-mediated	responses	in	hippocampal	tissues	[229].	Quantitative	 1943	
research	has	suggested	that	Nrxn3ß	expression	was	altered	in	the	globus	pallidus	in	the	 1944	
mouse	brain	by	acute	cocaine	exposure	[230].	Differential	expression	of	Nrxn	isoforms	 1945	
in	this	and	other	regions	of	the	basal	ganglia	support	this	genes	role	in	the	motivational	 1946	
cues	associated	with	addiction.	Our	study	identified	substantial	epigenetic	modification	 1947	
of	neurexin	genes	and,	interestingly,	it	was	the	only	gene	found	hypermethylated	in	all	 1948	
three	of	the	ECE	treatment	groups	when	compared	to	CS	genes	in	the	F1.	Methylation	 1949	
data	indicated	a	differential	methylation	state	along	the	DNA	encoding	the	neurexin	 1950	
gene.	The	shorter	isoform,	nrxnß,	as	stated	previously,	is	expressed	in	smaller	quantities	 1951	
when	compared	against	the	longer	isoform	[214].	The	results	of	our	bisulfite	sequencing	 1952	
experiment	did	not	reveal	numerous	5-mC	or	5-HmC	attachments	along	the	nrxn3ß	 1953	
sequence.	The	methylation	patterns	of	nrxn3a	indicated	unique	methylation	patterns	 1954	
along	the	DNA	sequence.	Using	the	Ensemble	sequences	of	this	protein	it	was	seen	that	 1955	
an	increase	in	methyl	moieties	were	found	at	doses	higher	than	2.5mg/ml	around	exon	 1956	
17.	This	increased	methyl	attachment	was	seen	on	the	shorter	isoforms	of	the	nrxn3	 1957	
gene.	Methylation	ratio	differences	suggested	low	doses	of	cocaine	led	to	 1958	
hypomethylation	whereas	increasing	cocaine	to	10	mg/ml	led	to	hypermethylation	in	 1959	
the	same	regions	along	the	segment.	Hypomethylation	as	a	result	of	low	cocaine	 1960	
treatment	continued	along	the	DNA	segment	until	around	intronic	region	18.		A	change	 1961	
in	the	methylation	landscape	of	this	gene	was	observed	as	the	result	of	increasing	 1962	
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cocaine	exposure.	The	increased	concentration	of	cocaine	exposure	in	the	F1	coincided	 1963	
with	methyl	attachment	at	positions	matched	to	the	longer	isoforms.	These	differential	 1964	
methylation	patterns	may	contribute	to	varying	splicing	capabilities,	thus	providing	 1965	
limited	generation	of	the	various	isoforms.	The	study	of	this	gene	in	our	experiment	also	 1966	
revealed	differences	in	hydroxymethylation	along	the	chromosome.	The	bisulfite	 1967	
sequencing	method	cannot,	however,	distinguish	between	5mC	and	5HmC	groups	[231].	 1968	
Observation	of	our	5-mC	and	5-HmC	groups	at	various	positions	show	no	overlap	along	 1969	
our	nrxn3.	These	differential	results	may	produce	alterations	in	the	entropically	 1970	
favorable	neuroligin-neurexin	complexes	that	present	early	in	synaptogenesis.	Due	to	 1971	
the	timing	of	synaptogenesis	and	our	early	cocaine	treatment,	it	is	likely	that	these	cell	 1972	
adhesion	molecules	and	their	expression	are	modified.	Due	to	reports	of	different	 1973	
complexes	responsibility	in	excitatory	and	inhibitor	neurons	within	the	brain,	it	is	likely	 1974	
that	alterations	here	may	longitudinally	affect	behavior.	Research	suggests	the	 1975	
importance	of	these	proteins	in	synaptic	formation	and	protein	folding	[232,	233].	Here,	 1976	
reductions	in	neuronal	cell	formation	and	stability	as	the	result	of	neurexin	knock-down	 1977	
may	produce	augmented	brain	regions	critical	in	higher	cognitive	processes,	including	 1978	
motivation	and	reward.	Knockout	studies	specific	to	the	reward	circuitry	could	identify	 1979	
specific	roles	to	the	nrxn3	gene	in	the	zebrafish	as	they	relate	to	reward	and	motivation.	 1980	
As	shown,	differential	methylation	along	the	this	nrxn3	gene	may	generate	sequences	of	 1981	
varying	length	and	as	previously	mentioned,	alternate	splicing	along	neurexins	and	 1982	
neuroligins	contributes	to	the	complexes	that	form.	How	these	cell	adhesion	molecules	 1983	
contribute	to	reward	and	longitudinal	behavior	remains	to	be	investigated.	Due	to	the	 1984	
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readily	manipulated	lines	of	zebrafish,	knock-out	studies	of	this	kind	can	be	undertaken.	 1985	
These	results	taken	together	with	what	has	been	reported	in	the	literature	of	the	human	 1986	
and	murine	nrxn3	gene	family	imply	the	importance	in	understanding	how	these	cell	 1987	
adhesion	molecules	contribute	to	altered	reward	and	behavior	in	organism	with	early	 1988	
drug	exposure.	 1989	
	 1990	
CA	Produces	Differential	CPP	Behaviors	 1991	
Understanding	how	drug	exposure	produces	lasting	consequence	both	 1992	
behaviorally	and	genetically	may	provide	insight	into	susceptibility	toward	drug	abuse	as	 1993	
well	as	provide	potential	treatment	options.	Persistent	effects	attributed	to	early	drug	 1994	
exposure	occur	by	several	means	including	histone	methylation	and	acetylation.	For	our	 1995	
experiment	we	looked	specifically	at	DNA	methylation.	DNA	methylation	is	an	important	 1996	
process	in	regulating	gene	expression.	Methylation	arises	as	methyl	groups	are	donated	 1997	
to	CpG	dinucleotides	from	the	substrate	S-adenosylmethionine	(SAM).	DNA	methylation	 1998	
is	associated	with	transcriptional	activity	that	is	important	for	processes	like	X- 1999	
chromosome	activation,	early	developmental	processes,	cell	survival	and	differentiation,	 2000	
and	genome	integrity	[125,	126,	234].	Mammalian	Dnmts	include	three	homologs	[235].	 2001	
It	has	been	demonstrated	that	Dnmt1	is	responsible	for	the	maintenance	of	methylation	 2002	
patterns	following	DNA	replication.	This	enzyme	has	been	implicated	in	imprinting	[236].	 2003	
Dnmt3a	and	Dnmt3b	are	known	for	the	de	novo	genome	wide	methylation	of	DNA	 2004	
sequences	during	development	and	cellular	differentiation	as	well	as	in	response	to	 2005	
environmental	stimuli	[208,	234,	237].	There	is	homologous	expression	of	Dnmts	within	 2006	
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the	zebrafish	model	also	highly	involved	during	development.	The	genome	duplication	 2007	
event	of	the	zebrafish	led	to	six	paralogues	for	DNA	methylating	enzymes	[130].	Dmnt3a	 2008	
is	represented	by	dnmt6	and	dnmt8,	whereas	there	are	four	DNA	methyltransferases	 2009	
for	Dmnt3b,	namely	dnmt3,	dnmt4,	dnmt5,	and	dnmt7	[131].	Literary	review	 2010	
emphasized	some	discrepancies	with	classification	scheme	for	these	enzymes.	Teleost	 2011	
dnmt6	has	been	reported	as	dnmt3ab	and	dnmt3a2,	while	dnmt8	has	been	cited	as	 2012	
dnmt3aa	[238].	Paralogues	for	Dnmt3b	include	dnmt3	(dnmt3b3),	dnmt4	(dnmt3b1),	 2013	
dnmt5	(dnmt3b4),	and	dnmt7	(dnmt3b,dnmt3b2)	[131,	239].	Phylogenetic	analysis	has	 2014	
suggested	that	dnmt3,	dnmt5,	and	dnmt7	are	unique	to	teleosts.		 2015	
As	epigenetic	modification	continues	to	grow	in	interest,	research	continues	to	 2016	
utilize	different	pharmacologic	means	to	manipulate	these	modification	processes.	 2017	
Chlorogenic	acid	and	other	catechol-containing	polyphenols	have	been	demonstrated	to	 2018	
inhibit	DNA	methylation.	As	previously	stated,	DNA	is	methylated	at	cytosine	residues	 2019	
by	the	donation	of	a	methyl	group	from	SAM	catalyzed	by	DNMTs.	As	SAM	donates	a	 2020	
methyl	group,	SAM	is	demethylated	to	produce	S-adenosylhomocysteine	(SAH).	SAH	 2021	
acts	in	a	negative	feedback	mechanism	to	inhibit	Dnmt	enzymes	[240].	SAH	produces	 2022	
this	inhibitory	effect	allosterically	on	the	specific	Dnmts	through	the	use	of	different	 2023	
moieties	found	within	its	overall	structure	[241].	CA	contributes	to	this	inhibition	 2024	
through	its	reaction	with	Catechol-O-methyltransferase	(COMT).	Tea	catechins	like	 2025	
chlorogenic	acid	have	been	well	documented	as	efficient	substrates	for	COMT	[242,	 2026	
243].	COMT	catalyzes	the	addition	of	a	methyl	group	to	chlorogenic	acid	from	the	donor	 2027	
SAM.	Through	this	reaction,	SAM	is	demethylated	producing	SAH.	COMT-mediated	 2028	
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methylation	of	catechols	will	lower	the	endogenous	SAM	levels	while	simultaneously	 2029	
increasing	the	concentration	of	SAH.	This	conversion	of	SAM	and	consequent	 2030	
production	of	SAH	furthers	the	inhibition	of	DNMT	enzymes	[240].	Another	important	 2031	
enzymatic	function	of	COMT	is	the	degradation	of	catecholamines.	This	enzyme	is	 2032	
ubiquitously	expressed	in	nearly	all	tissues	and	in	distinct	brain	regions	in	a	small	soluble	 2033	
isoform	as	well	as	a	large	membrane	bound	isoform	[244-246].	COMT	drives	the	 2034	
exchange	of	a	methyl	group	from	SAM	to	one	of	the	two	hydroxyl	groups	present	on	the	 2035	
catecholamine	[247].	In	the	case	of	dopamine,	it	is	methylated	at	either	its	3’-	or	4’	 2036	
hydroxyl	with	preference	to	the	3’-hydroxyl.	Methylation	of	dopamine	produces	the	 2037	
metabolite	3-methoxytramine	(3-MT).	This	3-MT	is	then	further	metabolized	by	the	 2038	
enzyme	monoamine	oxidase	to	form	homovanillic	acid	[248].	This	methylation	of	 2039	
dopamine	has	also	been	suggested	to	increase	the	release	of	dopamine	from	the	 2040	
presynaptic	terminal	[249].	Inhibition	of	COMT	occurs	through	reversible	binding	by	 2041	
nitrocatechols.	These	compounds	have	the	characteristic	catechol	ring.	Some	 2042	
nitrocatechols	efficiently	cross	the	blood	brain	barrier,	including	the	drug	tolcapone	 2043	
[250,	251].	These	compounds	have	varying	incubation	times	altering	kinetic	parameters	 2044	
and	are	thought	to	competitively	inhibit	COMT.	COMT	overexpression	within	a	mouse	 2045	
model	was	demonstrated	to	lead	to	increased	capability	for	dopamine	release	within	 2046	
the	striatum	[249].	Behavioral	testing	within	this	model	system	indicated	stimulus	 2047	
responsive	learning	was	affected	and	further	investigation	indicated	that	this	was	not	 2048	
the	result	of	an	effect	on	dopamine	synthesis	or	transport,	but	possibly	that	increased	 2049	
clearance	generated	increased	release	of	dopamine	presynaptically.	Inhibition	of	COMT	 2050	
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is	suggested	to	lessen	dopamine	degradation	along	the	COMT-degradation	pathway	 2051	
[252].	The	degradation	appears	to	continue,	though	along	a	different	degradation	 2052	
pathway	using	monoamine	oxidase	enzymes.		 2053	
Our	results	demonstrated	that	CA	treatment	during	critical	windows	of	 2054	
dopaminergic	development	generated	altered	CPP	behavior	in	adult	zebrafish.	Zebrafish	 2055	
with	treatment	of	cocaine	and	CA	experienced	increased	CPP	behavior,	while	the	 2056	
treatment	with	CA	alone	appeared	to	attenuate	this	behavior.	This	may	be	explained	in	 2057	
two	ways	1)	differential	DNA	methylation	state	or	2)	a	secondary	effect	on	dopamine	 2058	
release	within	dopaminergic	pathways	that	is	regulated	by	COMT.	It	has	been	 2059	
demonstrated	that	inhibiting	Dnmt	enzymes	via	pharmacologic	means	augmented	 2060	
preference	for	cocaine	[253].	The	results	of	our	methylation	data	indicated	that	 2061	
significantly	differential	methylation	patterns	over	large	chromosomal	segments	 2062	
occurred	in	nearly	every	zebrafish	chromosome.	Additionally,	5-HmC	moieties	were	 2063	
shown	to	be	placed	along	zebrafish	DNA	after	exposure	to	a	relatively	low	dose	of	 2064	
cocaine.	How	chlorogenic	acid	treatment	during	embryonic	development	effects	this	 2065	
process	may	be	the	result	of	a	synergistic	feedback	mechanism	(Figure	28).		 2066	
	 2067	
	 2068	
	 2069	
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	 2071	
SAM	Methyl	Donating	Biochemical	Pathways	 2072	
Figure	28:	Schematic	illustration	displaying	the	transfer	of	methyl	groups	from	S- 2073	
adenosylmethionine	(SAM)	to	the	following	substrates:	Cytosine,	Chlorogenic	Acid,	and	 2074	
Dopamine.	In	each	reaction,	SAM	is	used	as	the	methyl	donor	and	leads	to	the	 2075	
production	of	S-adenosylhomocysteine	(SAH).	It	has	been	suggested	that	increased	 2076	
concentrations	of	SAH	to	demethylation	of	SAM,	may	produce	a	feedback	inhibition	of	 2077	
DNMT-mediated	DNA	methylation.	Abbreviations:	DNA	methyltransferase	enzymes,	 2078	
DNMTs;	Catechol-O-methyltransferase,	COMT;	5-mC,	5-methylcytosine;	CA-m,	 2079	
methylated	chlorogenic	acid;	m-DOP,	methylated	Dopamine.		 2080	
	 2081	
The	reactions	of	Figure	28	can	be	used	to	explain	the	findings	from	our	study.	In	 2082	
the	case	of	zebrafish	treated	solely	with	CA,	there	was	no	significant	change	in	cocaine	 2083	
induced	preference.	Embryonic	treatment	with	CA	may	have	lasting	behavioral	 2084	
consequence	in	zebrafish.	CA	may	lead	to	decreases	in	methylation	of	genes	found	in	 2085	
the	reward	circuitry	of	zebrafish	and	produce	a	longitudinal	change	in	responsiveness	to	 2086	
reward.	Further,	as	zebrafish	were	not	exposed	embryonically	to	cocaine	there	should	 2087	
be	no	change	in	sensitivity	to	the	drug	as	we	had	shown	in	the	F0	cohort.	It	would	then	 2088	
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be	implied	that	CA	exposure	led	to	differential	responsiveness	to	cocaine	longitudinally.	 2089	
Our	results	have	suggested	that	ECE	generated	an	increase	in	cocaine-induced	CPP	 2090	
behaviors	in	adult	F0	zebrafish.	Groups	of	zebrafish	treated	with	both	CA	and	cocaine	 2091	
exhibited	a	significant	increase	in	CPP-like	behaviors	following	acute	cocaine	exposure	in	 2092	
adulthood.	This	could	be	indicative	of	a	synergistic	action	of	CA	and	cocaine.	Because	of	 2093	
the	apparent	hypersensitivity	produced	by	ECE	to	subsequent	cocaine	exposure,	 2094	
additional	treatment	with	CA	may	augment	the	behavioral	response	to	cocaine	in	 2095	
zebrafish.	Because	cocaine	has	been	reported	to	inhibit	the	reuptake	of	dopamine	at	the	 2096	
synapse	[254],	acute	exposure	will	lead	to	increased	dopamine	concentration	at	the	 2097	
synapse.	It	may	be	then	that	concurrent	treatment	with	CA	embryonically	produced	 2098	
lowered	endogenous	levels	of	SAM	that	are	not	adequate	to	allow	for	the	enzymatic	 2099	
methylation	of	dopamine	by	COMT.	Because	of	this,	dopamine	will	persist	in	the	 2100	
synapse	for	a	longer	duration.	Concurrent	decreased	DNA	methylation	and	ECE	may	 2101	
enhance	the	cocaine	reward	seen	in	the	adult.	Cocaine	may	supersede	the	CA	effect	 2102	
when	treated	embryonically.	Exposure	to	CA	during	the	development	of	the	 2103	
dopaminergic	system	may	lower	the	concentration	of	endogenous	SAM	molecules.	If	 2104	
COMT	led	to	the	significant	methylation	of	chlorogenic	acid,	it	would	have	 2105	
simultaneously	reduced	the	pool	of	available	SAM	molecules	while	producing	SAH.	This	 2106	
SAH	will	continue	the	reduction	in	DNA	methylation,	while	lessening	the	methyl-donors	 2107	
available	for	catechol-containing	compounds.	As	dopamine	is	less	methylated	is	will	 2108	
remain	in	the	synapse	for	a	longer	duration.	In	animals	with	ECE	and	the	exposure	to	CA,	 2109	
dopamine	will	not	be	degraded	as	rapidly	as	well	as	its	uptake	in	the	synapse	will	be	 2110	
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inhibited	by	cocaine.	These	results	taken	together	may	explain	why	there	was	an	 2111	
increase	in	CPP-behavior	in	this	cohort	of	zebrafish.		 2112	
Chlorogenic	acid	treatment	of	zebrafish	embryos	appeared	to	have	a	significant	 2113	
longitudinal	effect	on	both	the	weight	and	length	of	the	zebrafish.	This,	however,	may	 2114	
not	be	representative	of	overall	health,	as	percentage	of	survival	were	different	among	 2115	
treatment	groups.	Because	of	the	low	survival	in	our	untreated	cohort,	low	population	 2116	
density	in	the	housing	tank	allowed	for	increased	growth	in	this	group.	This	experiment	 2117	
will	be	to	be	repeated	for	validation	of	the	result.		CA’s	effect	on	neuronal	development	 2118	
remains	under	studied.	Because	of	treatment	during	early	developmental	window,	 2119	
where	this	compound	is	generating	its	effect	is	misunderstood.	Further	research	could	 2120	
elucidate	the	longitudinal	physiologic	result	of	this	exposure.	COMT’s	involvement	in	 2121	
this	altered	behavioral	phenotype	suggests	a	need	for	further	investigation.	In	the	F0	 2122	
cohorts,	it	may	be	that	COMT	expression	is	inhibited	in	the	adult	zebrafish.	This	may	 2123	
govern	an	increase	in	dopamine	release	during	acute	exposure	to	rewarding	 2124	
compounds.	In	addition	to	cocaine’s	inhibition	of	catecholamine	reuptake,	decreased	 2125	
expression	of	catecholamine	degradative	enzymes	may	explain	the	heighted	reward	to	 2126	
ECE	exposure	individuals.	How	individual	Dnmt	enzymes	modify	the	rewarding	 2127	
properties	of	cocaine	following	ECE	remains	unknown.	Because	of	the	easy	 2128	
manipulation	of	the	zebrafish	and	the	swift	generation	of	mutant	lines,	dnmt	knock-out	 2129	
experiments	may	reveal	how	these	relate	to	cocaine-induced	methylation.		 2130	
	 	 2131	
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APPENDIX	 2133	
Table	1:	 2134	
Primer	sequences	used	for	RT-PCR	 2135	
Gene	name	 Gene	
ID	
CG	%	(F/R)		 Forward	sense		
primers	
Reverse		
primers	
Size	
(bp)	F/R	
Brain-derived	
neurotrophic	
factor		
bndf	 50.0/45.5	 cctgctgaatggtctc
ctttac	
cagctctcatggaact
gaagta	
22/22	
FBJ	murine	
osteosarcoma	
viral	oncogene	
homolog	B	
fosb	 52.6/55.0	 acgagatgaaacgct
gacc	
cgtcggttcctacactt
agc	
19/20	
Ornithine	
decarboxylase	1	
odc1	 55.6/50.0	 atgccaagctggttct
tc	
tcgctccaaacttcac
actc	
18/20	
Eukaryotic	
translation	factor	
1	alpha	
ef1a	 55.0/40.7	 ctggaggccagctca
aacat	
atcaagaagagtagt
accgctagcatt	
20/27	
Ribosomal	
protein	L13	
rpl13	 50.0/50.0	 tctggaggactgtaag
aggtatgc	
agacgcacaatcttga
gagcag	
24/22	
ADP-ribosylation	
factor	5	
arf5	 37.5/47.6	 cagaacacacagcgt
ttaatcttt	
agaaagctcctctgaa
gattc	
24/21	
nuclear	receptor	
subfamily,	group	
A,	member	3	
nr4a3	 47.4/50.0	 ttcaagaggacggtg
caaa	
cacttctggaaacggc
agta	
19/20	
Arginase	2	 arg2	 47.6/47.6	 aacagaggagatcca
caacac	
gcaactatgtcaacgg
ctaga	
21/21	
DEAD	(Asp-Glu-
Ala-Asp)	box	
helicase	5	
ddx5	 50.0/47.4	 caaattaggccggac
agaca	
tgaagagcaccaaca
tgta	
20/19	
mitochondria-
localized 
glutamic acid-rich 
protein 
	
mgarp	 50.0/47.6	 aatgtggtcacaccag
tctc	
agatttaaccgggac
gtcttc	
20/21	
Period	circadian	
clock	2	
per2	 45.5/50.0	 gtgggagacaagaaa
gagatca	
gcttggtcaaacccag
tttc	
22/20	
inhibin,	beta	Ab	 inhbab	 55.6/47.6	 ttcgcggagtcagga
gat	
ccttggctactttgag
ggaaca	
18/21	
eukaryotic	
translation	
initiation	factor	
4A1A	
eif4a1
a	
50.0/50.0	 tgagaaggagtggaa
gt	
cggcgagtgttgatga
agat	
20/20	
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